KR20230057351A - 항절단형 변이 calr-cd3 이중특이성 항체 및 의약 조성물 - Google Patents
항절단형 변이 calr-cd3 이중특이성 항체 및 의약 조성물 Download PDFInfo
- Publication number
- KR20230057351A KR20230057351A KR1020237005772A KR20237005772A KR20230057351A KR 20230057351 A KR20230057351 A KR 20230057351A KR 1020237005772 A KR1020237005772 A KR 1020237005772A KR 20237005772 A KR20237005772 A KR 20237005772A KR 20230057351 A KR20230057351 A KR 20230057351A
- Authority
- KR
- South Korea
- Prior art keywords
- ser
- gly
- thr
- val
- gln
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 15
- 238000003776 cleavage reaction Methods 0.000 title claims description 12
- 102000004082 Calreticulin Human genes 0.000 claims abstract description 207
- 108090000549 Calreticulin Proteins 0.000 claims abstract description 207
- 239000000427 antigen Substances 0.000 claims abstract description 135
- 102000036639 antigens Human genes 0.000 claims abstract description 131
- 108091007433 antigens Proteins 0.000 claims abstract description 131
- 230000027455 binding Effects 0.000 claims abstract description 123
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims abstract description 103
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 300
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 139
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 84
- 229920001184 polypeptide Polymers 0.000 claims description 73
- 238000000034 method Methods 0.000 claims description 42
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 claims description 31
- 150000001413 amino acids Chemical class 0.000 claims description 28
- 241000282414 Homo sapiens Species 0.000 claims description 26
- 108090000623 proteins and genes Proteins 0.000 claims description 19
- 239000012634 fragment Substances 0.000 claims description 18
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 9
- 239000012472 biological sample Substances 0.000 claims description 8
- 238000003745 diagnosis Methods 0.000 claims description 8
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 125000005842 heteroatom Chemical group 0.000 claims description 7
- 230000007017 scission Effects 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 206010028537 myelofibrosis Diseases 0.000 claims description 4
- 208000008601 Polycythemia Diseases 0.000 claims description 2
- 208000005485 Thrombocytosis Diseases 0.000 claims description 2
- 238000006471 dimerization reaction Methods 0.000 claims description 2
- 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 claims description 2
- 208000025113 myeloid leukemia Diseases 0.000 claims description 2
- 208000003476 primary myelofibrosis Diseases 0.000 claims description 2
- 230000009977 dual effect Effects 0.000 abstract 1
- 108010001064 glycyl-glycyl-glycyl-glycine Proteins 0.000 description 98
- 210000004027 cell Anatomy 0.000 description 83
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 73
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 73
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 67
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 60
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 54
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 53
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 51
- 108010092854 aspartyllysine Proteins 0.000 description 49
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 48
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 46
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 46
- GBYYQVBXFVDJPJ-WLTAIBSBSA-N Gly-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN)O GBYYQVBXFVDJPJ-WLTAIBSBSA-N 0.000 description 41
- 108010031719 prolyl-serine Proteins 0.000 description 40
- ZFBBMCKQSNJZSN-AUTRQRHGSA-N Gln-Val-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZFBBMCKQSNJZSN-AUTRQRHGSA-N 0.000 description 39
- 108010078144 glutaminyl-glycine Proteins 0.000 description 39
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 39
- 108010089804 glycyl-threonine Proteins 0.000 description 39
- 108010029020 prolylglycine Proteins 0.000 description 39
- 235000001014 amino acid Nutrition 0.000 description 38
- 108010050848 glycylleucine Proteins 0.000 description 38
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 37
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 35
- 108010087924 alanylproline Proteins 0.000 description 34
- 108010051242 phenylalanylserine Proteins 0.000 description 34
- 108010070643 prolylglutamic acid Proteins 0.000 description 34
- 108010073969 valyllysine Proteins 0.000 description 34
- FGWUALWGCZJQDJ-URLPEUOOSA-N Phe-Thr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGWUALWGCZJQDJ-URLPEUOOSA-N 0.000 description 33
- MKGIILKDUGDRRO-FXQIFTODSA-N Pro-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 MKGIILKDUGDRRO-FXQIFTODSA-N 0.000 description 33
- PGBMPFKFKXYROZ-UFYCRDLUSA-N Val-Tyr-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N PGBMPFKFKXYROZ-UFYCRDLUSA-N 0.000 description 33
- QNJIRRVTOXNGMH-GUBZILKMSA-N Asn-Gln-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(N)=O QNJIRRVTOXNGMH-GUBZILKMSA-N 0.000 description 32
- OLVIPTLKNSAYRJ-YUMQZZPRSA-N Asn-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N OLVIPTLKNSAYRJ-YUMQZZPRSA-N 0.000 description 32
- HMIXCETWRYDVMO-GUBZILKMSA-N Gln-Pro-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O HMIXCETWRYDVMO-GUBZILKMSA-N 0.000 description 32
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 32
- WNQKUUQIVDDAFA-ZPFDUUQYSA-N Ile-Gln-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N WNQKUUQIVDDAFA-ZPFDUUQYSA-N 0.000 description 32
- LTAWNJXSRUCFAN-UNQGMJICSA-N Phe-Thr-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LTAWNJXSRUCFAN-UNQGMJICSA-N 0.000 description 32
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 31
- SVGAWGVHFIYAEE-JSGCOSHPSA-N Trp-Gly-Gln Chemical compound C1=CC=C2C(C[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)=CNC2=C1 SVGAWGVHFIYAEE-JSGCOSHPSA-N 0.000 description 31
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 30
- RTFXPCYMDYBZNQ-SRVKXCTJSA-N Asn-Tyr-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O RTFXPCYMDYBZNQ-SRVKXCTJSA-N 0.000 description 30
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 30
- LIXBDERDAGNVAV-XKBZYTNZSA-N Thr-Gln-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O LIXBDERDAGNVAV-XKBZYTNZSA-N 0.000 description 30
- 108010038320 lysylphenylalanine Proteins 0.000 description 29
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 28
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 27
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 27
- 108010026333 seryl-proline Proteins 0.000 description 27
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 26
- IVCOYUURLWQDJQ-LPEHRKFASA-N Gln-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N)C(=O)O IVCOYUURLWQDJQ-LPEHRKFASA-N 0.000 description 26
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 26
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 26
- NJEMRSFGDNECGF-GCJQMDKQSA-N Thr-Ala-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O NJEMRSFGDNECGF-GCJQMDKQSA-N 0.000 description 26
- XHWCDRUPDNSDAZ-XKBZYTNZSA-N Thr-Ser-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O XHWCDRUPDNSDAZ-XKBZYTNZSA-N 0.000 description 26
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 25
- LGCVSPFCFXWUEY-IHPCNDPISA-N Asn-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N LGCVSPFCFXWUEY-IHPCNDPISA-N 0.000 description 25
- WTUSRDZLLWGYAT-KCTSRDHCSA-N Gly-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)CN WTUSRDZLLWGYAT-KCTSRDHCSA-N 0.000 description 25
- FBGXMKUWQFPHFB-JBDRJPRFSA-N Ile-Ser-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N FBGXMKUWQFPHFB-JBDRJPRFSA-N 0.000 description 25
- VOOINLQYUZOREH-SRVKXCTJSA-N Met-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCSC)N VOOINLQYUZOREH-SRVKXCTJSA-N 0.000 description 25
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 25
- LGIMRDKGABDMBN-DCAQKATOSA-N Ser-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N LGIMRDKGABDMBN-DCAQKATOSA-N 0.000 description 25
- ILDJYIDXESUBOE-HSCHXYMDSA-N Trp-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N ILDJYIDXESUBOE-HSCHXYMDSA-N 0.000 description 25
- 108010015792 glycyllysine Proteins 0.000 description 25
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 25
- 108010003137 tyrosyltyrosine Proteins 0.000 description 25
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 24
- IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 24
- 241000700157 Rattus norvegicus Species 0.000 description 24
- NJLQMKZSXYQRTO-FHWLQOOXSA-N Tyr-Glu-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 NJLQMKZSXYQRTO-FHWLQOOXSA-N 0.000 description 24
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 24
- 108010077245 asparaginyl-proline Proteins 0.000 description 24
- 108010047857 aspartylglycine Proteins 0.000 description 24
- GCACQYDBDHRVGE-LKXGYXEUSA-N Asp-Thr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC(O)=O GCACQYDBDHRVGE-LKXGYXEUSA-N 0.000 description 23
- CQMFNTVQVLQRLT-JHEQGTHGSA-N Gly-Thr-Gln Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O CQMFNTVQVLQRLT-JHEQGTHGSA-N 0.000 description 23
- CQGSYZCULZMEDE-UHFFFAOYSA-N Leu-Gln-Pro Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O CQGSYZCULZMEDE-UHFFFAOYSA-N 0.000 description 23
- KIZIOFNVSOSKJI-CIUDSAMLSA-N Leu-Ser-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N KIZIOFNVSOSKJI-CIUDSAMLSA-N 0.000 description 23
- HTXVATDVCRFORF-MGHWNKPDSA-N Phe-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N HTXVATDVCRFORF-MGHWNKPDSA-N 0.000 description 23
- MMJJFXWMCMJMQA-STQMWFEESA-N Phe-Pro-Gly Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)C1=CC=CC=C1 MMJJFXWMCMJMQA-STQMWFEESA-N 0.000 description 23
- VGQVAVQWKJLIRM-FXQIFTODSA-N Ser-Ser-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O VGQVAVQWKJLIRM-FXQIFTODSA-N 0.000 description 23
- WYPUMLRSQMKIJU-BPNCWPANSA-N Ala-Arg-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O WYPUMLRSQMKIJU-BPNCWPANSA-N 0.000 description 22
- ZZZWQALDSQQBEW-STQMWFEESA-N Arg-Gly-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZZZWQALDSQQBEW-STQMWFEESA-N 0.000 description 22
- XSPKAHFVDKRGRL-DCAQKATOSA-N Arg-Pro-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XSPKAHFVDKRGRL-DCAQKATOSA-N 0.000 description 22
- GMUOCGCDOYYWPD-FXQIFTODSA-N Asn-Pro-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O GMUOCGCDOYYWPD-FXQIFTODSA-N 0.000 description 22
- KTTCQQNRRLCIBC-GHCJXIJMSA-N Asp-Ile-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O KTTCQQNRRLCIBC-GHCJXIJMSA-N 0.000 description 22
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 22
- OYTPNWYZORARHL-XHNCKOQMSA-N Gln-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N OYTPNWYZORARHL-XHNCKOQMSA-N 0.000 description 22
- KOYUSMBPJOVSOO-XEGUGMAKSA-N Gly-Tyr-Ile Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KOYUSMBPJOVSOO-XEGUGMAKSA-N 0.000 description 22
- JATYGDHMDRAISQ-KKUMJFAQSA-N His-Tyr-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O JATYGDHMDRAISQ-KKUMJFAQSA-N 0.000 description 22
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 22
- AXZGZMGRBDQTEY-SRVKXCTJSA-N Leu-Gln-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O AXZGZMGRBDQTEY-SRVKXCTJSA-N 0.000 description 22
- FLCMXEFCTLXBTL-DCAQKATOSA-N Lys-Asp-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N FLCMXEFCTLXBTL-DCAQKATOSA-N 0.000 description 22
- YYKZDTVQHTUKDW-RYUDHWBXSA-N Phe-Gly-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N YYKZDTVQHTUKDW-RYUDHWBXSA-N 0.000 description 22
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 22
- LHNNQVXITHUCAB-QTKMDUPCSA-N Thr-Met-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O LHNNQVXITHUCAB-QTKMDUPCSA-N 0.000 description 22
- YGCDFAJJCRVQKU-RCWTZXSCSA-N Thr-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O YGCDFAJJCRVQKU-RCWTZXSCSA-N 0.000 description 22
- 102000036693 Thrombopoietin Human genes 0.000 description 22
- 108010041111 Thrombopoietin Proteins 0.000 description 22
- WNZRNOGHEONFMS-PXDAIIFMSA-N Trp-Ile-Tyr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O WNZRNOGHEONFMS-PXDAIIFMSA-N 0.000 description 22
- MBLJBGZWLHTJBH-SZMVWBNQSA-N Trp-Val-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 MBLJBGZWLHTJBH-SZMVWBNQSA-N 0.000 description 22
- BEIGSKUPTIFYRZ-SRVKXCTJSA-N Tyr-Asp-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O BEIGSKUPTIFYRZ-SRVKXCTJSA-N 0.000 description 22
- MJFSRZZJQWZHFQ-SRVKXCTJSA-N Val-Met-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)O)N MJFSRZZJQWZHFQ-SRVKXCTJSA-N 0.000 description 22
- 108010008355 arginyl-glutamine Proteins 0.000 description 22
- XYBJLTKSGFBLCS-QXEWZRGKSA-N Asp-Arg-Val Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC(O)=O XYBJLTKSGFBLCS-QXEWZRGKSA-N 0.000 description 21
- WMLFFCRUSPNENW-ZLUOBGJFSA-N Asp-Ser-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O WMLFFCRUSPNENW-ZLUOBGJFSA-N 0.000 description 21
- GJBUAAAIZSRCDC-GVXVVHGQSA-N Glu-Leu-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O GJBUAAAIZSRCDC-GVXVVHGQSA-N 0.000 description 21
- KAFOIVJDVSZUMD-DCAQKATOSA-N Leu-Gln-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-DCAQKATOSA-N 0.000 description 21
- IHCXPSYCHXFXKT-DCAQKATOSA-N Pro-Arg-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O IHCXPSYCHXFXKT-DCAQKATOSA-N 0.000 description 21
- SPLBRAKYXGOFSO-UNQGMJICSA-N Pro-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]2CCCN2)O SPLBRAKYXGOFSO-UNQGMJICSA-N 0.000 description 21
- QGMLKFGTGXWAHF-IHRRRGAJSA-N Ser-Arg-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGMLKFGTGXWAHF-IHRRRGAJSA-N 0.000 description 21
- UQFYNFTYDHUIMI-WHFBIAKZSA-N Ser-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CO UQFYNFTYDHUIMI-WHFBIAKZSA-N 0.000 description 21
- WLJPJRGQRNCIQS-ZLUOBGJFSA-N Ser-Ser-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O WLJPJRGQRNCIQS-ZLUOBGJFSA-N 0.000 description 21
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 21
- YXGCIEUDOHILKR-IHRRRGAJSA-N Ser-Tyr-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CO)N YXGCIEUDOHILKR-IHRRRGAJSA-N 0.000 description 21
- LKEKWDJCJSPXNI-IRIUXVKKSA-N Thr-Glu-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LKEKWDJCJSPXNI-IRIUXVKKSA-N 0.000 description 21
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 20
- 241000880493 Leptailurus serval Species 0.000 description 20
- JUJCUYWRJMFJJF-AVGNSLFASA-N Pro-Lys-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1 JUJCUYWRJMFJJF-AVGNSLFASA-N 0.000 description 20
- JZRYFUGREMECBH-XPUUQOCRSA-N Ser-Val-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O JZRYFUGREMECBH-XPUUQOCRSA-N 0.000 description 20
- GGEJHJIXRBTJPD-BYPYZUCNSA-N Gly-Asn-Gly Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GGEJHJIXRBTJPD-BYPYZUCNSA-N 0.000 description 19
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 19
- CUMXHKAOHNWRFQ-BZSNNMDCSA-N Phe-Asp-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 CUMXHKAOHNWRFQ-BZSNNMDCSA-N 0.000 description 19
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 19
- 108010044292 tryptophyltyrosine Proteins 0.000 description 19
- JVZLZVJTIXVIHK-SXNHZJKMSA-N Glu-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)O)N JVZLZVJTIXVIHK-SXNHZJKMSA-N 0.000 description 18
- UPODKYBYUBTWSV-BZSNNMDCSA-N Tyr-Phe-Cys Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CS)C(O)=O)C1=CC=C(O)C=C1 UPODKYBYUBTWSV-BZSNNMDCSA-N 0.000 description 18
- 108010087819 Fc receptors Proteins 0.000 description 17
- 102000009109 Fc receptors Human genes 0.000 description 17
- BYYNJRSNDARRBX-YFKPBYRVSA-N Gly-Gln-Gly Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O BYYNJRSNDARRBX-YFKPBYRVSA-N 0.000 description 17
- UIMCLYYSUCIUJM-UWVGGRQHSA-N Pro-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 UIMCLYYSUCIUJM-UWVGGRQHSA-N 0.000 description 17
- 108010068265 aspartyltyrosine Proteins 0.000 description 17
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 17
- 108010077112 prolyl-proline Proteins 0.000 description 17
- UGXYFDQFLVCDFC-CIUDSAMLSA-N Asn-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O UGXYFDQFLVCDFC-CIUDSAMLSA-N 0.000 description 16
- JJQGZGOEDSSHTE-FOHZUACHSA-N Asp-Thr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JJQGZGOEDSSHTE-FOHZUACHSA-N 0.000 description 16
- OHLLDUNVMPPUMD-DCAQKATOSA-N Cys-Leu-Val Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N OHLLDUNVMPPUMD-DCAQKATOSA-N 0.000 description 16
- PDUHNKAFQXQNLH-ZETCQYMHSA-N Gly-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)NCC(O)=O PDUHNKAFQXQNLH-ZETCQYMHSA-N 0.000 description 16
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 16
- QLQHWWCSCLZUMA-KKUMJFAQSA-N Leu-Asp-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QLQHWWCSCLZUMA-KKUMJFAQSA-N 0.000 description 16
- MVJRBCJCRYGCKV-GVXVVHGQSA-N Leu-Val-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O MVJRBCJCRYGCKV-GVXVVHGQSA-N 0.000 description 16
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 16
- HNDMFDBQXYZSRM-IHRRRGAJSA-N Ser-Val-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HNDMFDBQXYZSRM-IHRRRGAJSA-N 0.000 description 16
- JVTHIXKSVYEWNI-JRQIVUDYSA-N Thr-Asn-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JVTHIXKSVYEWNI-JRQIVUDYSA-N 0.000 description 16
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 238000006467 substitution reaction Methods 0.000 description 16
- NPTGGVQJYRSMCM-GLLZPBPUSA-N Gln-Gln-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NPTGGVQJYRSMCM-GLLZPBPUSA-N 0.000 description 15
- 108010065920 Insulin Lispro Proteins 0.000 description 15
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 15
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 15
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 15
- DCLBXIWHLVEPMQ-JRQIVUDYSA-N Thr-Asp-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DCLBXIWHLVEPMQ-JRQIVUDYSA-N 0.000 description 15
- MXNAOGFNFNKUPD-JHYOHUSXSA-N Thr-Phe-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MXNAOGFNFNKUPD-JHYOHUSXSA-N 0.000 description 15
- YOPQYBJJNSIQGZ-JNPHEJMOSA-N Thr-Tyr-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 YOPQYBJJNSIQGZ-JNPHEJMOSA-N 0.000 description 15
- LDKDSFQSEUOCOO-RPTUDFQQSA-N Tyr-Thr-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LDKDSFQSEUOCOO-RPTUDFQQSA-N 0.000 description 15
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 15
- 108010052774 valyl-lysyl-glycyl-phenylalanyl-tyrosine Proteins 0.000 description 15
- CSMYMGFCEJWALV-WDSKDSINSA-N Gly-Ser-Gln Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O CSMYMGFCEJWALV-WDSKDSINSA-N 0.000 description 14
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 14
- FMLRRBDLBJLJIK-DCAQKATOSA-N Pro-Leu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FMLRRBDLBJLJIK-DCAQKATOSA-N 0.000 description 14
- PRKWBYCXBBSLSK-GUBZILKMSA-N Pro-Ser-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O PRKWBYCXBBSLSK-GUBZILKMSA-N 0.000 description 14
- GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 14
- BIBYEFRASCNLAA-CDMKHQONSA-N Thr-Phe-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 BIBYEFRASCNLAA-CDMKHQONSA-N 0.000 description 14
- VFOHXOLPLACADK-GVXVVHGQSA-N Val-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N VFOHXOLPLACADK-GVXVVHGQSA-N 0.000 description 14
- 108010010147 glycylglutamine Proteins 0.000 description 14
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 14
- 108010017391 lysylvaline Proteins 0.000 description 14
- 108010038745 tryptophylglycine Proteins 0.000 description 14
- DPNZTBKGAUAZQU-DLOVCJGASA-N Ala-Leu-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N DPNZTBKGAUAZQU-DLOVCJGASA-N 0.000 description 13
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 13
- HPBNLFLSSQDFQW-WHFBIAKZSA-N Asn-Ser-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O HPBNLFLSSQDFQW-WHFBIAKZSA-N 0.000 description 13
- CUQDCPXNZPDYFQ-ZLUOBGJFSA-N Asp-Ser-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O CUQDCPXNZPDYFQ-ZLUOBGJFSA-N 0.000 description 13
- XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 description 13
- DLISPGXMKZTWQG-IFFSRLJSSA-N Glu-Thr-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O DLISPGXMKZTWQG-IFFSRLJSSA-N 0.000 description 13
- HXWALXSAVBLTPK-NUTKFTJISA-N Leu-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(C)C)N HXWALXSAVBLTPK-NUTKFTJISA-N 0.000 description 13
- QLFAPXUXEBAWEK-NHCYSSNCSA-N Lys-Val-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QLFAPXUXEBAWEK-NHCYSSNCSA-N 0.000 description 13
- BJEYSVHMGIJORT-NHCYSSNCSA-N Phe-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BJEYSVHMGIJORT-NHCYSSNCSA-N 0.000 description 13
- HZWAHWQZPSXNCB-BPUTZDHNSA-N Ser-Arg-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O HZWAHWQZPSXNCB-BPUTZDHNSA-N 0.000 description 13
- VAUMZJHYZQXZBQ-WHFBIAKZSA-N Ser-Asn-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O VAUMZJHYZQXZBQ-WHFBIAKZSA-N 0.000 description 13
- UGJRQLURDVGULT-LKXGYXEUSA-N Ser-Asn-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UGJRQLURDVGULT-LKXGYXEUSA-N 0.000 description 13
- 108010049041 glutamylalanine Proteins 0.000 description 13
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 13
- 108010050475 glycyl-leucyl-tyrosine Proteins 0.000 description 13
- 108010077515 glycylproline Proteins 0.000 description 13
- 108010034529 leucyl-lysine Proteins 0.000 description 13
- 108010024654 phenylalanyl-prolyl-alanine Proteins 0.000 description 13
- WLVLIYYBPPONRJ-GCJQMDKQSA-N Asn-Thr-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O WLVLIYYBPPONRJ-GCJQMDKQSA-N 0.000 description 12
- HTSSXFASOUSJQG-IHPCNDPISA-N Asp-Tyr-Trp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O HTSSXFASOUSJQG-IHPCNDPISA-N 0.000 description 12
- 101100072420 Caenorhabditis elegans ins-5 gene Proteins 0.000 description 12
- QFJPFPCSXOXMKI-BPUTZDHNSA-N Gln-Gln-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N QFJPFPCSXOXMKI-BPUTZDHNSA-N 0.000 description 12
- FQCILXROGNOZON-YUMQZZPRSA-N Gln-Pro-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O FQCILXROGNOZON-YUMQZZPRSA-N 0.000 description 12
- VBOBNHSVQKKTOT-YUMQZZPRSA-N Gly-Lys-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O VBOBNHSVQKKTOT-YUMQZZPRSA-N 0.000 description 12
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 12
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 12
- MIFFFXHMAHFACR-KATARQTJSA-N Lys-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN MIFFFXHMAHFACR-KATARQTJSA-N 0.000 description 12
- JDMKQHSHKJHAHR-UHFFFAOYSA-N Phe-Phe-Leu-Tyr Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)CC1=CC=CC=C1 JDMKQHSHKJHAHR-UHFFFAOYSA-N 0.000 description 12
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 12
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 12
- RPECVQBNONKZAT-WZLNRYEVSA-N Thr-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H]([C@@H](C)O)N RPECVQBNONKZAT-WZLNRYEVSA-N 0.000 description 12
- 108010027338 isoleucylcysteine Proteins 0.000 description 12
- 108010009962 valyltyrosine Proteins 0.000 description 12
- OINVDEKBKBCPLX-JXUBOQSCSA-N Ala-Lys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OINVDEKBKBCPLX-JXUBOQSCSA-N 0.000 description 11
- ZJBUILVYSXQNSW-YTWAJWBKSA-N Arg-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ZJBUILVYSXQNSW-YTWAJWBKSA-N 0.000 description 11
- WQLJRNRLHWJIRW-KKUMJFAQSA-N Asn-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)N)N)O WQLJRNRLHWJIRW-KKUMJFAQSA-N 0.000 description 11
- HNXWVVHIGTZTBO-LKXGYXEUSA-N Asn-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O HNXWVVHIGTZTBO-LKXGYXEUSA-N 0.000 description 11
- BPHKULHWEIUDOB-FXQIFTODSA-N Cys-Gln-Gln Chemical compound SC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O BPHKULHWEIUDOB-FXQIFTODSA-N 0.000 description 11
- CMYVIUWVYHOLRD-ZLUOBGJFSA-N Cys-Ser-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O CMYVIUWVYHOLRD-ZLUOBGJFSA-N 0.000 description 11
- NVEASDQHBRZPSU-BQBZGAKWSA-N Gln-Gln-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O NVEASDQHBRZPSU-BQBZGAKWSA-N 0.000 description 11
- ZNTDJIMJKNNSLR-RWRJDSDZSA-N Gln-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N ZNTDJIMJKNNSLR-RWRJDSDZSA-N 0.000 description 11
- QKWBEMCLYTYBNI-GVXVVHGQSA-N Gln-Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O QKWBEMCLYTYBNI-GVXVVHGQSA-N 0.000 description 11
- HUFCEIHAFNVSNR-IHRRRGAJSA-N Glu-Gln-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HUFCEIHAFNVSNR-IHRRRGAJSA-N 0.000 description 11
- UCZXXMREFIETQW-AVGNSLFASA-N Glu-Tyr-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O UCZXXMREFIETQW-AVGNSLFASA-N 0.000 description 11
- JSLVAHYTAJJEQH-QWRGUYRKSA-N Gly-Ser-Phe Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JSLVAHYTAJJEQH-QWRGUYRKSA-N 0.000 description 11
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 11
- RSFGIMMPWAXNML-MNXVOIDGSA-N Leu-Gln-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RSFGIMMPWAXNML-MNXVOIDGSA-N 0.000 description 11
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 11
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 11
- BPCLGWHVPVTTFM-QWRGUYRKSA-N Phe-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O BPCLGWHVPVTTFM-QWRGUYRKSA-N 0.000 description 11
- DMKWYMWNEKIPFC-IUCAKERBSA-N Pro-Gly-Arg Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O DMKWYMWNEKIPFC-IUCAKERBSA-N 0.000 description 11
- SXAGUVRFGJSFKC-ZEILLAHLSA-N Thr-His-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SXAGUVRFGJSFKC-ZEILLAHLSA-N 0.000 description 11
- QYSBJAUCUKHSLU-JYJNAYRXSA-N Tyr-Arg-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O QYSBJAUCUKHSLU-JYJNAYRXSA-N 0.000 description 11
- QUILOGWWLXMSAT-IHRRRGAJSA-N Tyr-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QUILOGWWLXMSAT-IHRRRGAJSA-N 0.000 description 11
- GZUIDWDVMWZSMI-KKUMJFAQSA-N Tyr-Lys-Cys Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CS)C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GZUIDWDVMWZSMI-KKUMJFAQSA-N 0.000 description 11
- SSYBNWFXCFNRFN-GUBZILKMSA-N Val-Pro-Ser Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SSYBNWFXCFNRFN-GUBZILKMSA-N 0.000 description 11
- NZYNRRGJJVSSTJ-GUBZILKMSA-N Val-Ser-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NZYNRRGJJVSSTJ-GUBZILKMSA-N 0.000 description 11
- 108010064235 lysylglycine Proteins 0.000 description 11
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 11
- CYXCAHZVPFREJD-LURJTMIESA-N Arg-Gly-Gly Chemical compound NC(=N)NCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O CYXCAHZVPFREJD-LURJTMIESA-N 0.000 description 10
- MFFOYNGMOYFPBD-DCAQKATOSA-N Asn-Arg-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MFFOYNGMOYFPBD-DCAQKATOSA-N 0.000 description 10
- QUAWOKPCAKCHQL-SRVKXCTJSA-N Asn-His-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N QUAWOKPCAKCHQL-SRVKXCTJSA-N 0.000 description 10
- KXUKWRVYDYIPSQ-CIUDSAMLSA-N Cys-Leu-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O KXUKWRVYDYIPSQ-CIUDSAMLSA-N 0.000 description 10
- WQWMZOIPXWSZNE-WDSKDSINSA-N Gln-Asp-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O WQWMZOIPXWSZNE-WDSKDSINSA-N 0.000 description 10
- ILKYYKRAULNYMS-JYJNAYRXSA-N Gln-Lys-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ILKYYKRAULNYMS-JYJNAYRXSA-N 0.000 description 10
- IESFZVCAVACGPH-PEFMBERDSA-N Glu-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O IESFZVCAVACGPH-PEFMBERDSA-N 0.000 description 10
- QGZSAHIZRQHCEQ-QWRGUYRKSA-N Gly-Asp-Tyr Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QGZSAHIZRQHCEQ-QWRGUYRKSA-N 0.000 description 10
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 10
- LXUJDHOKVUYHRC-KKUMJFAQSA-N Phe-Cys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CC=CC=C1)N LXUJDHOKVUYHRC-KKUMJFAQSA-N 0.000 description 10
- UNBFGVQVQGXXCK-KKUMJFAQSA-N Phe-Ser-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O UNBFGVQVQGXXCK-KKUMJFAQSA-N 0.000 description 10
- SJRQWEDYTKYHHL-SLFFLAALSA-N Phe-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=CC=C3)N)C(=O)O SJRQWEDYTKYHHL-SLFFLAALSA-N 0.000 description 10
- AFXCXDQNRXTSBD-FJXKBIBVSA-N Pro-Gly-Thr Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O AFXCXDQNRXTSBD-FJXKBIBVSA-N 0.000 description 10
- DJACUBDEDBZKLQ-KBIXCLLPSA-N Ser-Ile-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O DJACUBDEDBZKLQ-KBIXCLLPSA-N 0.000 description 10
- KEGBFULVYKYJRD-LFSVMHDDSA-N Thr-Ala-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KEGBFULVYKYJRD-LFSVMHDDSA-N 0.000 description 10
- UNURFMVMXLENAZ-KJEVXHAQSA-N Thr-Arg-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UNURFMVMXLENAZ-KJEVXHAQSA-N 0.000 description 10
- JLNMFGCJODTXDH-WEDXCCLWSA-N Thr-Lys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O JLNMFGCJODTXDH-WEDXCCLWSA-N 0.000 description 10
- BGTDGENDNWGMDQ-KJEVXHAQSA-N Val-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N)O BGTDGENDNWGMDQ-KJEVXHAQSA-N 0.000 description 10
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 10
- 239000013604 expression vector Substances 0.000 description 10
- 108010013768 glutamyl-aspartyl-proline Proteins 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 108010071097 threonyl-lysyl-proline Proteins 0.000 description 10
- 108010051110 tyrosyl-lysine Proteins 0.000 description 10
- NDUSUIGBMZCOIL-ZKWXMUAHSA-N Cys-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)N NDUSUIGBMZCOIL-ZKWXMUAHSA-N 0.000 description 9
- KSMSFCBQBQPFAD-GUBZILKMSA-N Cys-Pro-Pro Chemical compound SC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 KSMSFCBQBQPFAD-GUBZILKMSA-N 0.000 description 9
- JILRMFFFCHUUTJ-ACZMJKKPSA-N Gln-Ser-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O JILRMFFFCHUUTJ-ACZMJKKPSA-N 0.000 description 9
- AAJHGGDRKHYSDH-GUBZILKMSA-N Glu-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O AAJHGGDRKHYSDH-GUBZILKMSA-N 0.000 description 9
- BFEZQZKEPRKKHV-SRVKXCTJSA-N Glu-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O BFEZQZKEPRKKHV-SRVKXCTJSA-N 0.000 description 9
- NNQDRRUXFJYCCJ-NHCYSSNCSA-N Glu-Pro-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O NNQDRRUXFJYCCJ-NHCYSSNCSA-N 0.000 description 9
- BPCLDCNZBUYGOD-BPUTZDHNSA-N Glu-Trp-Glu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 BPCLDCNZBUYGOD-BPUTZDHNSA-N 0.000 description 9
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 9
- IXKRSKPKSLXIHN-YUMQZZPRSA-N Gly-Cys-Leu Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O IXKRSKPKSLXIHN-YUMQZZPRSA-N 0.000 description 9
- AFWYPMDMDYCKMD-KBPBESRZSA-N Gly-Leu-Tyr Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 AFWYPMDMDYCKMD-KBPBESRZSA-N 0.000 description 9
- ALPXXNRQBMRCPZ-MEYUZBJRSA-N His-Thr-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ALPXXNRQBMRCPZ-MEYUZBJRSA-N 0.000 description 9
- UHNQRAFSEBGZFZ-YESZJQIVSA-N Leu-Phe-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N UHNQRAFSEBGZFZ-YESZJQIVSA-N 0.000 description 9
- VUBIPAHVHMZHCM-KKUMJFAQSA-N Leu-Tyr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 VUBIPAHVHMZHCM-KKUMJFAQSA-N 0.000 description 9
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 9
- GILLQRYAWOMHED-DCAQKATOSA-N Lys-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN GILLQRYAWOMHED-DCAQKATOSA-N 0.000 description 9
- RKIIYGUHIQJCBW-SRVKXCTJSA-N Met-His-Glu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RKIIYGUHIQJCBW-SRVKXCTJSA-N 0.000 description 9
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 9
- KHRLUIPIMIQFGT-AVGNSLFASA-N Pro-Val-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHRLUIPIMIQFGT-AVGNSLFASA-N 0.000 description 9
- MUJQWSAWLLRJCE-KATARQTJSA-N Ser-Leu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MUJQWSAWLLRJCE-KATARQTJSA-N 0.000 description 9
- RHAPJNVNWDBFQI-BQBZGAKWSA-N Ser-Pro-Gly Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O RHAPJNVNWDBFQI-BQBZGAKWSA-N 0.000 description 9
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 9
- HSWXBJCBYSWBPT-GUBZILKMSA-N Ser-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(O)=O HSWXBJCBYSWBPT-GUBZILKMSA-N 0.000 description 9
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 9
- SPVHQURZJCUDQC-VOAKCMCISA-N Thr-Lys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O SPVHQURZJCUDQC-VOAKCMCISA-N 0.000 description 9
- QNXZCKMXHPULME-ZNSHCXBVSA-N Thr-Val-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O QNXZCKMXHPULME-ZNSHCXBVSA-N 0.000 description 9
- WURLIFOWSMBUAR-SLFFLAALSA-N Tyr-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)C(=O)O WURLIFOWSMBUAR-SLFFLAALSA-N 0.000 description 9
- MDXLPNRXCFOBTL-BZSNNMDCSA-N Tyr-Ser-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MDXLPNRXCFOBTL-BZSNNMDCSA-N 0.000 description 9
- BMGOFDMKDVVGJG-NHCYSSNCSA-N Val-Asp-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BMGOFDMKDVVGJG-NHCYSSNCSA-N 0.000 description 9
- KTEZUXISLQTDDQ-NHCYSSNCSA-N Val-Lys-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KTEZUXISLQTDDQ-NHCYSSNCSA-N 0.000 description 9
- ZLNYBMWGPOKSLW-LSJOCFKGSA-N Val-Val-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLNYBMWGPOKSLW-LSJOCFKGSA-N 0.000 description 9
- 238000000684 flow cytometry Methods 0.000 description 9
- 108010073101 phenylalanylleucine Proteins 0.000 description 9
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 8
- KBQOUDLMWYWXNP-YDHLFZDLSA-N Asn-Val-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC(=O)N)N KBQOUDLMWYWXNP-YDHLFZDLSA-N 0.000 description 8
- YHOJJFFTSMWVGR-HJGDQZAQSA-N Glu-Met-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YHOJJFFTSMWVGR-HJGDQZAQSA-N 0.000 description 8
- POJJAZJHBGXEGM-YUMQZZPRSA-N Gly-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN POJJAZJHBGXEGM-YUMQZZPRSA-N 0.000 description 8
- SYOJVRNQCXYEOV-XVKPBYJWSA-N Gly-Val-Glu Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SYOJVRNQCXYEOV-XVKPBYJWSA-N 0.000 description 8
- MKWSZEHGHSLNPF-NAKRPEOUSA-N Ile-Ala-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)N MKWSZEHGHSLNPF-NAKRPEOUSA-N 0.000 description 8
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 8
- RKQAYOWLSFLJEE-SVSWQMSJSA-N Ile-Thr-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O)N RKQAYOWLSFLJEE-SVSWQMSJSA-N 0.000 description 8
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 8
- FAELBUXXFQLUAX-AJNGGQMLSA-N Leu-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C FAELBUXXFQLUAX-AJNGGQMLSA-N 0.000 description 8
- PRSBSVAVOQOAMI-BJDJZHNGSA-N Lys-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN PRSBSVAVOQOAMI-BJDJZHNGSA-N 0.000 description 8
- CRGKLOXHKICQOL-GARJFASQSA-N Met-Gln-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N CRGKLOXHKICQOL-GARJFASQSA-N 0.000 description 8
- ODGNUUUDJONJSC-UFYCRDLUSA-N Phe-Pro-Tyr Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O ODGNUUUDJONJSC-UFYCRDLUSA-N 0.000 description 8
- XQLBWXHVZVBNJM-FXQIFTODSA-N Pro-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 XQLBWXHVZVBNJM-FXQIFTODSA-N 0.000 description 8
- VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 description 8
- GMJDSFYVTAMIBF-FXQIFTODSA-N Pro-Ser-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GMJDSFYVTAMIBF-FXQIFTODSA-N 0.000 description 8
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 8
- WNDUPCKKKGSKIQ-CIUDSAMLSA-N Ser-Pro-Gln Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O WNDUPCKKKGSKIQ-CIUDSAMLSA-N 0.000 description 8
- LAFLAXHTDVNVEL-WDCWCFNPSA-N Thr-Gln-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O LAFLAXHTDVNVEL-WDCWCFNPSA-N 0.000 description 8
- OACSGBOREVRSME-NHCYSSNCSA-N Val-His-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(O)=O OACSGBOREVRSME-NHCYSSNCSA-N 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 230000001472 cytotoxic effect Effects 0.000 description 8
- 108010003700 lysyl aspartic acid Proteins 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 description 7
- HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 7
- AOHKLEBWKMKITA-IHRRRGAJSA-N Arg-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AOHKLEBWKMKITA-IHRRRGAJSA-N 0.000 description 7
- SRUUBQBAVNQZGJ-LAEOZQHASA-N Asn-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N SRUUBQBAVNQZGJ-LAEOZQHASA-N 0.000 description 7
- QNFRBNZGVVKBNJ-PEFMBERDSA-N Asp-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N QNFRBNZGVVKBNJ-PEFMBERDSA-N 0.000 description 7
- JSNWZMFSLIWAHS-HJGDQZAQSA-N Asp-Thr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O JSNWZMFSLIWAHS-HJGDQZAQSA-N 0.000 description 7
- BPAUXFVCSYQDQX-JRQIVUDYSA-N Asp-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)O)N)O BPAUXFVCSYQDQX-JRQIVUDYSA-N 0.000 description 7
- NDNZRWUDUMTITL-FXQIFTODSA-N Cys-Ser-Val Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NDNZRWUDUMTITL-FXQIFTODSA-N 0.000 description 7
- VLOLPWWCNKWRNB-LOKLDPHHSA-N Gln-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O VLOLPWWCNKWRNB-LOKLDPHHSA-N 0.000 description 7
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 7
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 7
- BUEFQXUHTUZXHR-LURJTMIESA-N Gly-Gly-Pro zwitterion Chemical compound NCC(=O)NCC(=O)N1CCC[C@H]1C(O)=O BUEFQXUHTUZXHR-LURJTMIESA-N 0.000 description 7
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 7
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 7
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 7
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 7
- OIQSIMFSVLLWBX-VOAKCMCISA-N Lys-Leu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OIQSIMFSVLLWBX-VOAKCMCISA-N 0.000 description 7
- FWAHLGXNBLWIKB-NAKRPEOUSA-N Met-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCSC FWAHLGXNBLWIKB-NAKRPEOUSA-N 0.000 description 7
- SPSSJSICDYYTQN-HJGDQZAQSA-N Met-Thr-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O SPSSJSICDYYTQN-HJGDQZAQSA-N 0.000 description 7
- JOXIIFVCSATTDH-IHPCNDPISA-N Phe-Asn-Trp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N JOXIIFVCSATTDH-IHPCNDPISA-N 0.000 description 7
- YUSRGTQIPCJNHQ-CIUDSAMLSA-N Ser-Arg-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O YUSRGTQIPCJNHQ-CIUDSAMLSA-N 0.000 description 7
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 7
- HJEBZBMOTCQYDN-ACZMJKKPSA-N Ser-Glu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HJEBZBMOTCQYDN-ACZMJKKPSA-N 0.000 description 7
- XUDRHBPSPAPDJP-SRVKXCTJSA-N Ser-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO XUDRHBPSPAPDJP-SRVKXCTJSA-N 0.000 description 7
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 7
- XGFGVFMXDXALEV-XIRDDKMYSA-N Trp-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N XGFGVFMXDXALEV-XIRDDKMYSA-N 0.000 description 7
- ANHVRCNNGJMJNG-BZSNNMDCSA-N Tyr-Tyr-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CS)C(=O)O)N)O ANHVRCNNGJMJNG-BZSNNMDCSA-N 0.000 description 7
- KRAHMIJVUPUOTQ-DCAQKATOSA-N Val-Ser-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KRAHMIJVUPUOTQ-DCAQKATOSA-N 0.000 description 7
- 239000012642 immune effector Substances 0.000 description 7
- 229940121354 immunomodulator Drugs 0.000 description 7
- 108010091871 leucylmethionine Proteins 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 7
- VGPWRRFOPXVGOH-BYPYZUCNSA-N Ala-Gly-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)NCC(O)=O VGPWRRFOPXVGOH-BYPYZUCNSA-N 0.000 description 6
- HYQYLOSCICEYTR-YUMQZZPRSA-N Asn-Gly-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O HYQYLOSCICEYTR-YUMQZZPRSA-N 0.000 description 6
- RCFGLXMZDYNRSC-CIUDSAMLSA-N Asn-Lys-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O RCFGLXMZDYNRSC-CIUDSAMLSA-N 0.000 description 6
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 6
- SMEYEQDCCBHTEF-FXQIFTODSA-N Cys-Pro-Ala Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O SMEYEQDCCBHTEF-FXQIFTODSA-N 0.000 description 6
- ALTQTAKGRFLRLR-GUBZILKMSA-N Cys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N ALTQTAKGRFLRLR-GUBZILKMSA-N 0.000 description 6
- RBWKVOSARCFSQQ-FXQIFTODSA-N Gln-Gln-Ser Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O RBWKVOSARCFSQQ-FXQIFTODSA-N 0.000 description 6
- SMLDOQHTOAAFJQ-WDSKDSINSA-N Gln-Gly-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SMLDOQHTOAAFJQ-WDSKDSINSA-N 0.000 description 6
- XFAUJGNLHIGXET-AVGNSLFASA-N Gln-Leu-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O XFAUJGNLHIGXET-AVGNSLFASA-N 0.000 description 6
- CKOFNWCLWRYUHK-XHNCKOQMSA-N Glu-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O CKOFNWCLWRYUHK-XHNCKOQMSA-N 0.000 description 6
- MFVQGXGQRIXBPK-WDSKDSINSA-N Gly-Ala-Glu Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFVQGXGQRIXBPK-WDSKDSINSA-N 0.000 description 6
- PMNHJLASAAWELO-FOHZUACHSA-N Gly-Asp-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PMNHJLASAAWELO-FOHZUACHSA-N 0.000 description 6
- IFHJOBKVXBESRE-YUMQZZPRSA-N Gly-Met-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)CN IFHJOBKVXBESRE-YUMQZZPRSA-N 0.000 description 6
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 6
- ZGKVPOSSTGHJAF-HJPIBITLSA-N Ile-Tyr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CO)C(=O)O)N ZGKVPOSSTGHJAF-HJPIBITLSA-N 0.000 description 6
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 6
- BKTXKJMNTSMJDQ-AVGNSLFASA-N Leu-His-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N BKTXKJMNTSMJDQ-AVGNSLFASA-N 0.000 description 6
- AUNMOHYWTAPQLA-XUXIUFHCSA-N Leu-Met-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AUNMOHYWTAPQLA-XUXIUFHCSA-N 0.000 description 6
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 6
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 6
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 6
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 6
- YKIRNDPUWONXQN-GUBZILKMSA-N Lys-Asn-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YKIRNDPUWONXQN-GUBZILKMSA-N 0.000 description 6
- GQFDWEDHOQRNLC-QWRGUYRKSA-N Lys-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN GQFDWEDHOQRNLC-QWRGUYRKSA-N 0.000 description 6
- AEIIJFBQVGYVEV-YESZJQIVSA-N Lys-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCCCN)N)C(=O)O AEIIJFBQVGYVEV-YESZJQIVSA-N 0.000 description 6
- LUTDBHBIHHREDC-IHRRRGAJSA-N Lys-Pro-Lys Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O LUTDBHBIHHREDC-IHRRRGAJSA-N 0.000 description 6
- WZVSHTFTCYOFPL-GARJFASQSA-N Lys-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N)C(=O)O WZVSHTFTCYOFPL-GARJFASQSA-N 0.000 description 6
- CAVRAQIDHUPECU-UVOCVTCTSA-N Lys-Thr-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAVRAQIDHUPECU-UVOCVTCTSA-N 0.000 description 6
- DXTOOBDIIAJZBJ-BQBZGAKWSA-N Pro-Gly-Ser Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O DXTOOBDIIAJZBJ-BQBZGAKWSA-N 0.000 description 6
- KWMUAKQOVYCQJQ-ZPFDUUQYSA-N Pro-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@@H]1CCCN1 KWMUAKQOVYCQJQ-ZPFDUUQYSA-N 0.000 description 6
- ULWBBFKQBDNGOY-RWMBFGLXSA-N Pro-Lys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)O ULWBBFKQBDNGOY-RWMBFGLXSA-N 0.000 description 6
- KBUAPZAZPWNYSW-SRVKXCTJSA-N Pro-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KBUAPZAZPWNYSW-SRVKXCTJSA-N 0.000 description 6
- QKWYXRPICJEQAJ-KJEVXHAQSA-N Pro-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@@H]2CCCN2)O QKWYXRPICJEQAJ-KJEVXHAQSA-N 0.000 description 6
- YDTUEBLEAVANFH-RCWTZXSCSA-N Pro-Val-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 YDTUEBLEAVANFH-RCWTZXSCSA-N 0.000 description 6
- UEJYSALTSUZXFV-SRVKXCTJSA-N Rigin Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O UEJYSALTSUZXFV-SRVKXCTJSA-N 0.000 description 6
- HBZBPFLJNDXRAY-FXQIFTODSA-N Ser-Ala-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O HBZBPFLJNDXRAY-FXQIFTODSA-N 0.000 description 6
- MOVJSUIKUNCVMG-ZLUOBGJFSA-N Ser-Cys-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N)O MOVJSUIKUNCVMG-ZLUOBGJFSA-N 0.000 description 6
- HMRAQFJFTOLDKW-GUBZILKMSA-N Ser-His-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O HMRAQFJFTOLDKW-GUBZILKMSA-N 0.000 description 6
- HDBOEVPDIDDEPC-CIUDSAMLSA-N Ser-Lys-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O HDBOEVPDIDDEPC-CIUDSAMLSA-N 0.000 description 6
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 6
- 210000001744 T-lymphocyte Anatomy 0.000 description 6
- DGDCHPCRMWEOJR-FQPOAREZSA-N Thr-Ala-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DGDCHPCRMWEOJR-FQPOAREZSA-N 0.000 description 6
- JMZKMSTYXHFYAK-VEVYYDQMSA-N Thr-Arg-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O JMZKMSTYXHFYAK-VEVYYDQMSA-N 0.000 description 6
- JKGGPMOUIAAJAA-YEPSODPASA-N Thr-Gly-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O JKGGPMOUIAAJAA-YEPSODPASA-N 0.000 description 6
- FYBFTPLPAXZBOY-KKHAAJSZSA-N Thr-Val-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O FYBFTPLPAXZBOY-KKHAAJSZSA-N 0.000 description 6
- SQUMHUZLJDUROQ-YDHLFZDLSA-N Tyr-Val-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O SQUMHUZLJDUROQ-YDHLFZDLSA-N 0.000 description 6
- PWRITNSESKQTPW-NRPADANISA-N Val-Gln-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N PWRITNSESKQTPW-NRPADANISA-N 0.000 description 6
- SBJCTAZFSZXWSR-AVGNSLFASA-N Val-Met-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N SBJCTAZFSZXWSR-AVGNSLFASA-N 0.000 description 6
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 6
- VVIZITNVZUAEMI-DLOVCJGASA-N Val-Val-Gln Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(N)=O VVIZITNVZUAEMI-DLOVCJGASA-N 0.000 description 6
- 230000001900 immune effect Effects 0.000 description 6
- 108010057821 leucylproline Proteins 0.000 description 6
- 210000004698 lymphocyte Anatomy 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 108010079317 prolyl-tyrosine Proteins 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- QAPSNMNOIOSXSQ-YNEHKIRRSA-N 1-[(2r,4s,5r)-4-[tert-butyl(dimethyl)silyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)C1 QAPSNMNOIOSXSQ-YNEHKIRRSA-N 0.000 description 5
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 5
- KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 5
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 5
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- ZEEPYMXTJWIMSN-GUBZILKMSA-N Gln-Lys-Ser Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@@H](N)CCC(N)=O ZEEPYMXTJWIMSN-GUBZILKMSA-N 0.000 description 5
- OSCLNNWLKKIQJM-WDSKDSINSA-N Gln-Ser-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O OSCLNNWLKKIQJM-WDSKDSINSA-N 0.000 description 5
- ZALGPUWUVHOGAE-GVXVVHGQSA-N Glu-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZALGPUWUVHOGAE-GVXVVHGQSA-N 0.000 description 5
- LURCIJSJAKFCRO-QWRGUYRKSA-N Gly-Asn-Tyr Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LURCIJSJAKFCRO-QWRGUYRKSA-N 0.000 description 5
- FYVHHKMHFPMBBG-GUBZILKMSA-N His-Gln-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N FYVHHKMHFPMBBG-GUBZILKMSA-N 0.000 description 5
- OIARJGNVARWKFP-YUMQZZPRSA-N Leu-Asn-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O OIARJGNVARWKFP-YUMQZZPRSA-N 0.000 description 5
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 5
- DAYQSYGBCUKVKT-VOAKCMCISA-N Leu-Thr-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DAYQSYGBCUKVKT-VOAKCMCISA-N 0.000 description 5
- ODTZHNZPINULEU-KKUMJFAQSA-N Lys-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N ODTZHNZPINULEU-KKUMJFAQSA-N 0.000 description 5
- ADJDNJCSPNFFPI-FXQIFTODSA-N Ser-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO ADJDNJCSPNFFPI-FXQIFTODSA-N 0.000 description 5
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 5
- SSSDKJMQMZTMJP-BVSLBCMMSA-N Trp-Tyr-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CC=C(O)C=C1 SSSDKJMQMZTMJP-BVSLBCMMSA-N 0.000 description 5
- KISFXYYRKKNLOP-IHRRRGAJSA-N Val-Phe-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)N KISFXYYRKKNLOP-IHRRRGAJSA-N 0.000 description 5
- 210000004899 c-terminal region Anatomy 0.000 description 5
- 230000006037 cell lysis Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000009089 cytolysis Effects 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 231100000221 frame shift mutation induction Toxicity 0.000 description 5
- 230000037433 frameshift Effects 0.000 description 5
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- GJLXVWOMRRWCIB-MERZOTPQSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanamide Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=C(O)C=C1 GJLXVWOMRRWCIB-MERZOTPQSA-N 0.000 description 4
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 4
- IORKCNUBHNIMKY-CIUDSAMLSA-N Ala-Pro-Glu Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O IORKCNUBHNIMKY-CIUDSAMLSA-N 0.000 description 4
- GMFAGHNRXPSSJS-SRVKXCTJSA-N Arg-Leu-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GMFAGHNRXPSSJS-SRVKXCTJSA-N 0.000 description 4
- FRBAHXABMQXSJQ-FXQIFTODSA-N Arg-Ser-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O FRBAHXABMQXSJQ-FXQIFTODSA-N 0.000 description 4
- HDHZCEDPLTVHFZ-GUBZILKMSA-N Asn-Leu-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O HDHZCEDPLTVHFZ-GUBZILKMSA-N 0.000 description 4
- MJIJBEYEHBKTIM-BYULHYEWSA-N Asn-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N MJIJBEYEHBKTIM-BYULHYEWSA-N 0.000 description 4
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 4
- YUELDQUPTAYEGM-XIRDDKMYSA-N Asp-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)O)N YUELDQUPTAYEGM-XIRDDKMYSA-N 0.000 description 4
- 101100505161 Caenorhabditis elegans mel-32 gene Proteins 0.000 description 4
- 101150117824 Calr gene Proteins 0.000 description 4
- OZHXXYOHPLLLMI-CIUDSAMLSA-N Cys-Lys-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OZHXXYOHPLLLMI-CIUDSAMLSA-N 0.000 description 4
- 206010064571 Gene mutation Diseases 0.000 description 4
- DHNWZLGBTPUTQQ-QEJZJMRPSA-N Gln-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N DHNWZLGBTPUTQQ-QEJZJMRPSA-N 0.000 description 4
- MADFVRSKEIEZHZ-DCAQKATOSA-N Gln-Gln-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N MADFVRSKEIEZHZ-DCAQKATOSA-N 0.000 description 4
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 4
- UQJNXZSSGQIPIQ-FBCQKBJTSA-N Gly-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)CN UQJNXZSSGQIPIQ-FBCQKBJTSA-N 0.000 description 4
- ULZCYBYDTUMHNF-IUCAKERBSA-N Gly-Leu-Glu Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ULZCYBYDTUMHNF-IUCAKERBSA-N 0.000 description 4
- TTYKEFZRLKQTHH-MELADBBJSA-N His-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O TTYKEFZRLKQTHH-MELADBBJSA-N 0.000 description 4
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 4
- KWUKZRFFKPLUPE-HJGDQZAQSA-N Lys-Asp-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWUKZRFFKPLUPE-HJGDQZAQSA-N 0.000 description 4
- NTBFKPBULZGXQL-KKUMJFAQSA-N Lys-Asp-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NTBFKPBULZGXQL-KKUMJFAQSA-N 0.000 description 4
- RFQATBGBLDAKGI-VHSXEESVSA-N Lys-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCCCN)N)C(=O)O RFQATBGBLDAKGI-VHSXEESVSA-N 0.000 description 4
- IOQWIOPSKJOEKI-SRVKXCTJSA-N Lys-Ser-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IOQWIOPSKJOEKI-SRVKXCTJSA-N 0.000 description 4
- UEHNWRNADDPYNK-DLOVCJGASA-N Phe-Cys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CC=CC=C1)N UEHNWRNADDPYNK-DLOVCJGASA-N 0.000 description 4
- QARPMYDMYVLFMW-KKUMJFAQSA-N Phe-Pro-Glu Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=CC=C1 QARPMYDMYVLFMW-KKUMJFAQSA-N 0.000 description 4
- IIEOLPMQYRBZCN-SRVKXCTJSA-N Phe-Ser-Cys Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O IIEOLPMQYRBZCN-SRVKXCTJSA-N 0.000 description 4
- GNRMAQSIROFNMI-IXOXFDKPSA-N Phe-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O GNRMAQSIROFNMI-IXOXFDKPSA-N 0.000 description 4
- 206010035226 Plasma cell myeloma Diseases 0.000 description 4
- UAYHMOIGIQZLFR-NHCYSSNCSA-N Pro-Gln-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O UAYHMOIGIQZLFR-NHCYSSNCSA-N 0.000 description 4
- LHALYDBUDCWMDY-CIUDSAMLSA-N Pro-Glu-Ala Chemical compound C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O LHALYDBUDCWMDY-CIUDSAMLSA-N 0.000 description 4
- FDMKYQQYJKYCLV-GUBZILKMSA-N Pro-Pro-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 FDMKYQQYJKYCLV-GUBZILKMSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- KNCJWSPMTFFJII-ZLUOBGJFSA-N Ser-Cys-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(O)=O KNCJWSPMTFFJII-ZLUOBGJFSA-N 0.000 description 4
- RNFKSBPHLTZHLU-WHFBIAKZSA-N Ser-Cys-Gly Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)O)N)O RNFKSBPHLTZHLU-WHFBIAKZSA-N 0.000 description 4
- OQPNSDWGAMFJNU-QWRGUYRKSA-N Ser-Gly-Tyr Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OQPNSDWGAMFJNU-QWRGUYRKSA-N 0.000 description 4
- FDALPRWYVKJCLL-PMVVWTBXSA-N Thr-His-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(O)=O FDALPRWYVKJCLL-PMVVWTBXSA-N 0.000 description 4
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 4
- BDGBHYCAZJPLHX-HJGDQZAQSA-N Thr-Lys-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BDGBHYCAZJPLHX-HJGDQZAQSA-N 0.000 description 4
- JMBRNXUOLJFURW-BEAPCOKYSA-N Thr-Phe-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N)O JMBRNXUOLJFURW-BEAPCOKYSA-N 0.000 description 4
- MROIJTGJGIDEEJ-RCWTZXSCSA-N Thr-Pro-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 MROIJTGJGIDEEJ-RCWTZXSCSA-N 0.000 description 4
- KIMOCKLJBXHFIN-YLVFBTJISA-N Trp-Ile-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O)=CNC2=C1 KIMOCKLJBXHFIN-YLVFBTJISA-N 0.000 description 4
- SINRIKQYQJRGDQ-MEYUZBJRSA-N Tyr-Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SINRIKQYQJRGDQ-MEYUZBJRSA-N 0.000 description 4
- NUQZCPSZHGIYTA-HKUYNNGSSA-N Tyr-Trp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N NUQZCPSZHGIYTA-HKUYNNGSSA-N 0.000 description 4
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 4
- SCBITHMBEJNRHC-LSJOCFKGSA-N Val-Asp-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N SCBITHMBEJNRHC-LSJOCFKGSA-N 0.000 description 4
- HGJRMXOWUWVUOA-GVXVVHGQSA-N Val-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N HGJRMXOWUWVUOA-GVXVVHGQSA-N 0.000 description 4
- XTDDIVQWDXMRJL-IHRRRGAJSA-N Val-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N XTDDIVQWDXMRJL-IHRRRGAJSA-N 0.000 description 4
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 4
- KSFXWENSJABBFI-ZKWXMUAHSA-N Val-Ser-Asn Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KSFXWENSJABBFI-ZKWXMUAHSA-N 0.000 description 4
- SDHZOOIGIUEPDY-JYJNAYRXSA-N Val-Ser-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 SDHZOOIGIUEPDY-JYJNAYRXSA-N 0.000 description 4
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 4
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 108010038633 aspartylglutamate Proteins 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 108010060199 cysteinylproline Proteins 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 108010087823 glycyltyrosine Proteins 0.000 description 4
- 210000004408 hybridoma Anatomy 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000002826 magnetic-activated cell sorting Methods 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 201000000050 myeloid neoplasm Diseases 0.000 description 4
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 4
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 108010080629 tryptophan-leucine Proteins 0.000 description 4
- IESDGNYHXIOKRW-YXMSTPNBSA-N (2s)-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s,3r)-2-amino-3-hydroxybutanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IESDGNYHXIOKRW-YXMSTPNBSA-N 0.000 description 3
- DIBLBAURNYJYBF-XLXZRNDBSA-N (2s)-2-[[(2s)-2-[[2-[[(2s)-6-amino-2-[[(2s)-2-amino-3-methylbutanoyl]amino]hexanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 DIBLBAURNYJYBF-XLXZRNDBSA-N 0.000 description 3
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 3
- OYJCVIGKMXUVKB-GARJFASQSA-N Ala-Leu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N OYJCVIGKMXUVKB-GARJFASQSA-N 0.000 description 3
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 3
- BTRULDJUUVGRNE-DCAQKATOSA-N Ala-Pro-Lys Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O BTRULDJUUVGRNE-DCAQKATOSA-N 0.000 description 3
- RTZCUEHYUQZIDE-WHFBIAKZSA-N Ala-Ser-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RTZCUEHYUQZIDE-WHFBIAKZSA-N 0.000 description 3
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 3
- MMGCRPZQZWTZTA-IHRRRGAJSA-N Arg-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N MMGCRPZQZWTZTA-IHRRRGAJSA-N 0.000 description 3
- POZKLUIXMHIULG-FDARSICLSA-N Arg-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCCN=C(N)N)N POZKLUIXMHIULG-FDARSICLSA-N 0.000 description 3
- IZSMEUDYADKZTJ-KJEVXHAQSA-N Arg-Tyr-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IZSMEUDYADKZTJ-KJEVXHAQSA-N 0.000 description 3
- SLKLLQWZQHXYSV-CIUDSAMLSA-N Asn-Ala-Lys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O SLKLLQWZQHXYSV-CIUDSAMLSA-N 0.000 description 3
- MVXJBVVLACEGCG-PCBIJLKTSA-N Asn-Phe-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MVXJBVVLACEGCG-PCBIJLKTSA-N 0.000 description 3
- SZNGQSBRHFMZLT-IHRRRGAJSA-N Asn-Pro-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SZNGQSBRHFMZLT-IHRRRGAJSA-N 0.000 description 3
- NSTBNYOKCZKOMI-AVGNSLFASA-N Asn-Tyr-Glu Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O NSTBNYOKCZKOMI-AVGNSLFASA-N 0.000 description 3
- PDECQIHABNQRHN-GUBZILKMSA-N Asp-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O PDECQIHABNQRHN-GUBZILKMSA-N 0.000 description 3
- VIRHEUMYXXLCBF-WDSKDSINSA-N Asp-Gly-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O VIRHEUMYXXLCBF-WDSKDSINSA-N 0.000 description 3
- SWTQDYFZVOJVLL-KKUMJFAQSA-N Asp-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)O)N)O SWTQDYFZVOJVLL-KKUMJFAQSA-N 0.000 description 3
- DPNWSMBUYCLEDG-CIUDSAMLSA-N Asp-Lys-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O DPNWSMBUYCLEDG-CIUDSAMLSA-N 0.000 description 3
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 3
- SQIARYGNVQWOSB-BZSNNMDCSA-N Asp-Tyr-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SQIARYGNVQWOSB-BZSNNMDCSA-N 0.000 description 3
- HKALUUKHYNEDRS-GUBZILKMSA-N Cys-Leu-Gln Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O HKALUUKHYNEDRS-GUBZILKMSA-N 0.000 description 3
- XKBASPWPBXNVLQ-WDSKDSINSA-N Gln-Gly-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XKBASPWPBXNVLQ-WDSKDSINSA-N 0.000 description 3
- JXFLPKSDLDEOQK-JHEQGTHGSA-N Gln-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O JXFLPKSDLDEOQK-JHEQGTHGSA-N 0.000 description 3
- XUMFMAVDHQDATI-DCAQKATOSA-N Gln-Pro-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O XUMFMAVDHQDATI-DCAQKATOSA-N 0.000 description 3
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 3
- GLWXKFRTOHKGIT-ACZMJKKPSA-N Glu-Asn-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GLWXKFRTOHKGIT-ACZMJKKPSA-N 0.000 description 3
- HNVFSTLPVJWIDV-CIUDSAMLSA-N Glu-Glu-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HNVFSTLPVJWIDV-CIUDSAMLSA-N 0.000 description 3
- ALMBZBOCGSVSAI-ACZMJKKPSA-N Glu-Ser-Asn Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ALMBZBOCGSVSAI-ACZMJKKPSA-N 0.000 description 3
- GRIRDMVMJJDZKV-RCOVLWMOSA-N Gly-Asn-Val Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O GRIRDMVMJJDZKV-RCOVLWMOSA-N 0.000 description 3
- PABFFPWEJMEVEC-JGVFFNPUSA-N Gly-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)CN)C(=O)O PABFFPWEJMEVEC-JGVFFNPUSA-N 0.000 description 3
- WMKXFMUJRCEGRP-SRVKXCTJSA-N His-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N WMKXFMUJRCEGRP-SRVKXCTJSA-N 0.000 description 3
- CSTDQOOBZBAJKE-BWAGICSOSA-N His-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CN=CN2)N)O CSTDQOOBZBAJKE-BWAGICSOSA-N 0.000 description 3
- QRTVJGKXFSYJGW-KBIXCLLPSA-N Ile-Glu-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N QRTVJGKXFSYJGW-KBIXCLLPSA-N 0.000 description 3
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 3
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 3
- CQGSYZCULZMEDE-SRVKXCTJSA-N Leu-Gln-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O CQGSYZCULZMEDE-SRVKXCTJSA-N 0.000 description 3
- XNKDCYABMBBEKN-IUCAKERBSA-N Lys-Gly-Gln Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O XNKDCYABMBBEKN-IUCAKERBSA-N 0.000 description 3
- WQDKIVRHTQYJSN-DCAQKATOSA-N Lys-Ser-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N WQDKIVRHTQYJSN-DCAQKATOSA-N 0.000 description 3
- IEVXCWPVBYCJRZ-IXOXFDKPSA-N Lys-Thr-His Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IEVXCWPVBYCJRZ-IXOXFDKPSA-N 0.000 description 3
- DLCAXBGXGOVUCD-PPCPHDFISA-N Lys-Thr-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DLCAXBGXGOVUCD-PPCPHDFISA-N 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- MSHZERMPZKCODG-ACRUOGEOSA-N Phe-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 MSHZERMPZKCODG-ACRUOGEOSA-N 0.000 description 3
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 3
- TUYWCHPXKQTISF-LPEHRKFASA-N Pro-Cys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CS)C(=O)N2CCC[C@@H]2C(=O)O TUYWCHPXKQTISF-LPEHRKFASA-N 0.000 description 3
- HJSCRFZVGXAGNG-SRVKXCTJSA-N Pro-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1 HJSCRFZVGXAGNG-SRVKXCTJSA-N 0.000 description 3
- KIPIKSXPPLABPN-CIUDSAMLSA-N Pro-Glu-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 KIPIKSXPPLABPN-CIUDSAMLSA-N 0.000 description 3
- ULIWFCCJIOEHMU-BQBZGAKWSA-N Pro-Gly-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 ULIWFCCJIOEHMU-BQBZGAKWSA-N 0.000 description 3
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 3
- MHHQQZIFLWFZGR-DCAQKATOSA-N Pro-Lys-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O MHHQQZIFLWFZGR-DCAQKATOSA-N 0.000 description 3
- HWLKHNDRXWTFTN-GUBZILKMSA-N Pro-Pro-Cys Chemical compound C1C[C@H](NC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CS)C(=O)O HWLKHNDRXWTFTN-GUBZILKMSA-N 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- OYEDZGNMSBZCIM-XGEHTFHBSA-N Ser-Arg-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OYEDZGNMSBZCIM-XGEHTFHBSA-N 0.000 description 3
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 3
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 3
- GZSZPKSBVAOGIE-CIUDSAMLSA-N Ser-Lys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O GZSZPKSBVAOGIE-CIUDSAMLSA-N 0.000 description 3
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 3
- ASJDFGOPDCVXTG-KATARQTJSA-N Thr-Cys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O ASJDFGOPDCVXTG-KATARQTJSA-N 0.000 description 3
- KWQBJOUOSNJDRR-XAVMHZPKSA-N Thr-Cys-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N)O KWQBJOUOSNJDRR-XAVMHZPKSA-N 0.000 description 3
- DSLHSTIUAPKERR-XGEHTFHBSA-N Thr-Cys-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(O)=O DSLHSTIUAPKERR-XGEHTFHBSA-N 0.000 description 3
- XXNLGZRRSKPSGF-HTUGSXCWSA-N Thr-Gln-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O XXNLGZRRSKPSGF-HTUGSXCWSA-N 0.000 description 3
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 3
- BEZTUFWTPVOROW-KJEVXHAQSA-N Thr-Tyr-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O BEZTUFWTPVOROW-KJEVXHAQSA-N 0.000 description 3
- JAWUQFCGNVEDRN-MEYUZBJRSA-N Thr-Tyr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N)O JAWUQFCGNVEDRN-MEYUZBJRSA-N 0.000 description 3
- DQDXHYIEITXNJY-BPUTZDHNSA-N Trp-Gln-Gln Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N DQDXHYIEITXNJY-BPUTZDHNSA-N 0.000 description 3
- BYSKNUASOAGJSS-NQCBNZPSSA-N Trp-Ile-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N BYSKNUASOAGJSS-NQCBNZPSSA-N 0.000 description 3
- ARKBYVBCEOWRNR-UBHSHLNASA-N Trp-Ser-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O ARKBYVBCEOWRNR-UBHSHLNASA-N 0.000 description 3
- SCCKSNREWHMKOJ-SRVKXCTJSA-N Tyr-Asn-Ser Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O SCCKSNREWHMKOJ-SRVKXCTJSA-N 0.000 description 3
- NXRGXTBPMOGFID-CFMVVWHZSA-N Tyr-Ile-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O NXRGXTBPMOGFID-CFMVVWHZSA-N 0.000 description 3
- LMKKMCGTDANZTR-BZSNNMDCSA-N Tyr-Phe-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LMKKMCGTDANZTR-BZSNNMDCSA-N 0.000 description 3
- NHOVZGFNTGMYMI-KKUMJFAQSA-N Tyr-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NHOVZGFNTGMYMI-KKUMJFAQSA-N 0.000 description 3
- RIVVDNTUSRVTQT-IRIUXVKKSA-N Tyr-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O RIVVDNTUSRVTQT-IRIUXVKKSA-N 0.000 description 3
- HPANGHISDXDUQY-ULQDDVLXSA-N Val-Lys-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N HPANGHISDXDUQY-ULQDDVLXSA-N 0.000 description 3
- HWNYVQMOLCYHEA-IHRRRGAJSA-N Val-Ser-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N HWNYVQMOLCYHEA-IHRRRGAJSA-N 0.000 description 3
- BZDGLJPROOOUOZ-XGEHTFHBSA-N Val-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N)O BZDGLJPROOOUOZ-XGEHTFHBSA-N 0.000 description 3
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 230000002072 anti-mutant effect Effects 0.000 description 3
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000012636 effector Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000001641 gel filtration chromatography Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000003119 immunoblot Methods 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 108010027345 wheylin-1 peptide Proteins 0.000 description 3
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- AAQGRPOPTAUUBM-ZLUOBGJFSA-N Ala-Ala-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O AAQGRPOPTAUUBM-ZLUOBGJFSA-N 0.000 description 2
- WCBVQNZTOKJWJS-ACZMJKKPSA-N Ala-Cys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O WCBVQNZTOKJWJS-ACZMJKKPSA-N 0.000 description 2
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 2
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 2
- WQLDNOCHHRISMS-NAKRPEOUSA-N Ala-Pro-Ile Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WQLDNOCHHRISMS-NAKRPEOUSA-N 0.000 description 2
- VNFSAYFQLXPHPY-CIQUZCHMSA-N Ala-Thr-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VNFSAYFQLXPHPY-CIQUZCHMSA-N 0.000 description 2
- XKXAZPSREVUCRT-BPNCWPANSA-N Ala-Tyr-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=C(O)C=C1 XKXAZPSREVUCRT-BPNCWPANSA-N 0.000 description 2
- ZDILXFDENZVOTL-BPNCWPANSA-N Ala-Val-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZDILXFDENZVOTL-BPNCWPANSA-N 0.000 description 2
- KWTVWJPNHAOREN-IHRRRGAJSA-N Arg-Asn-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O KWTVWJPNHAOREN-IHRRRGAJSA-N 0.000 description 2
- OZNSCVPYWZRQPY-CIUDSAMLSA-N Arg-Asp-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OZNSCVPYWZRQPY-CIUDSAMLSA-N 0.000 description 2
- SQKPKIJVWHAWNF-DCAQKATOSA-N Arg-Asp-Lys Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O SQKPKIJVWHAWNF-DCAQKATOSA-N 0.000 description 2
- FEZJJKXNPSEYEV-CIUDSAMLSA-N Arg-Gln-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O FEZJJKXNPSEYEV-CIUDSAMLSA-N 0.000 description 2
- GOWZVQXTHUCNSQ-NHCYSSNCSA-N Arg-Glu-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GOWZVQXTHUCNSQ-NHCYSSNCSA-N 0.000 description 2
- PNIGSVZJNVUVJA-BQBZGAKWSA-N Arg-Gly-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O PNIGSVZJNVUVJA-BQBZGAKWSA-N 0.000 description 2
- COXMUHNBYCVVRG-DCAQKATOSA-N Arg-Leu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O COXMUHNBYCVVRG-DCAQKATOSA-N 0.000 description 2
- CNBIWSCSSCAINS-UFYCRDLUSA-N Arg-Tyr-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CNBIWSCSSCAINS-UFYCRDLUSA-N 0.000 description 2
- QLSRIZIDQXDQHK-RCWTZXSCSA-N Arg-Val-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QLSRIZIDQXDQHK-RCWTZXSCSA-N 0.000 description 2
- HUZGPXBILPMCHM-IHRRRGAJSA-N Asn-Arg-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HUZGPXBILPMCHM-IHRRRGAJSA-N 0.000 description 2
- RDLYUKRPEJERMM-XIRDDKMYSA-N Asn-Trp-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(O)=O RDLYUKRPEJERMM-XIRDDKMYSA-N 0.000 description 2
- LRCIOEVFVGXZKB-BZSNNMDCSA-N Asn-Tyr-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LRCIOEVFVGXZKB-BZSNNMDCSA-N 0.000 description 2
- ZVTDYGWRRPMFCL-WFBYXXMGSA-N Asp-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N ZVTDYGWRRPMFCL-WFBYXXMGSA-N 0.000 description 2
- MRQQMVZUHXUPEV-IHRRRGAJSA-N Asp-Arg-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O MRQQMVZUHXUPEV-IHRRRGAJSA-N 0.000 description 2
- YNQIDCRRTWGHJD-ZLUOBGJFSA-N Asp-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(O)=O YNQIDCRRTWGHJD-ZLUOBGJFSA-N 0.000 description 2
- KNMRXHIAVXHCLW-ZLUOBGJFSA-N Asp-Asn-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N)C(=O)O KNMRXHIAVXHCLW-ZLUOBGJFSA-N 0.000 description 2
- YNCHFVRXEQFPBY-BQBZGAKWSA-N Asp-Gly-Arg Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N YNCHFVRXEQFPBY-BQBZGAKWSA-N 0.000 description 2
- QCVXMEHGFUMKCO-YUMQZZPRSA-N Asp-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O QCVXMEHGFUMKCO-YUMQZZPRSA-N 0.000 description 2
- AYFVRYXNDHBECD-YUMQZZPRSA-N Asp-Leu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O AYFVRYXNDHBECD-YUMQZZPRSA-N 0.000 description 2
- VNXQRBXEQXLERQ-CIUDSAMLSA-N Asp-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N VNXQRBXEQXLERQ-CIUDSAMLSA-N 0.000 description 2
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 2
- ZUNMTUPRQMWMHX-LSJOCFKGSA-N Asp-Val-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O ZUNMTUPRQMWMHX-LSJOCFKGSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- AMRLSQGGERHDHJ-FXQIFTODSA-N Cys-Ala-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AMRLSQGGERHDHJ-FXQIFTODSA-N 0.000 description 2
- GEEXORWTBTUOHC-FXQIFTODSA-N Cys-Arg-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N)CN=C(N)N GEEXORWTBTUOHC-FXQIFTODSA-N 0.000 description 2
- OWAFTBLVZNSIFO-SRVKXCTJSA-N Cys-His-His Chemical compound N[C@@H](CS)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O OWAFTBLVZNSIFO-SRVKXCTJSA-N 0.000 description 2
- ZXCAQANTQWBICD-DCAQKATOSA-N Cys-Lys-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N ZXCAQANTQWBICD-DCAQKATOSA-N 0.000 description 2
- PGBLJHDDKCVSTC-CIUDSAMLSA-N Cys-Met-Gln Chemical compound CSCC[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O PGBLJHDDKCVSTC-CIUDSAMLSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VSXBYIJUAXPAAL-WDSKDSINSA-N Gln-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O VSXBYIJUAXPAAL-WDSKDSINSA-N 0.000 description 2
- FGYPOQPQTUNESW-IUCAKERBSA-N Gln-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N FGYPOQPQTUNESW-IUCAKERBSA-N 0.000 description 2
- ORYMMTRPKVTGSJ-XVKPBYJWSA-N Gln-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O ORYMMTRPKVTGSJ-XVKPBYJWSA-N 0.000 description 2
- YPMDZWPZFOZYFG-GUBZILKMSA-N Gln-Leu-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YPMDZWPZFOZYFG-GUBZILKMSA-N 0.000 description 2
- XZLLTYBONVKGLO-SDDRHHMPSA-N Gln-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N)C(=O)O XZLLTYBONVKGLO-SDDRHHMPSA-N 0.000 description 2
- XBWGJWXGUNSZAT-CIUDSAMLSA-N Gln-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N XBWGJWXGUNSZAT-CIUDSAMLSA-N 0.000 description 2
- UESYBOXFJWJVSB-AVGNSLFASA-N Gln-Phe-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O UESYBOXFJWJVSB-AVGNSLFASA-N 0.000 description 2
- LPIKVBWNNVFHCQ-GUBZILKMSA-N Gln-Ser-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LPIKVBWNNVFHCQ-GUBZILKMSA-N 0.000 description 2
- SYZZMPFLOLSMHL-XHNCKOQMSA-N Gln-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N)C(=O)O SYZZMPFLOLSMHL-XHNCKOQMSA-N 0.000 description 2
- OTQSTOXRUBVWAP-NRPADANISA-N Gln-Ser-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OTQSTOXRUBVWAP-NRPADANISA-N 0.000 description 2
- FITIQFSXXBKFFM-NRPADANISA-N Gln-Val-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FITIQFSXXBKFFM-NRPADANISA-N 0.000 description 2
- CSMHMEATMDCQNY-DZKIICNBSA-N Gln-Val-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CSMHMEATMDCQNY-DZKIICNBSA-N 0.000 description 2
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 2
- JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 description 2
- SBCYJMOOHUDWDA-NUMRIWBASA-N Glu-Asp-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SBCYJMOOHUDWDA-NUMRIWBASA-N 0.000 description 2
- RQNYYRHRKSVKAB-GUBZILKMSA-N Glu-Cys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O RQNYYRHRKSVKAB-GUBZILKMSA-N 0.000 description 2
- DMYACXMQUABZIQ-NRPADANISA-N Glu-Ser-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O DMYACXMQUABZIQ-NRPADANISA-N 0.000 description 2
- MFYLRRCYBBJYPI-JYJNAYRXSA-N Glu-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O MFYLRRCYBBJYPI-JYJNAYRXSA-N 0.000 description 2
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 2
- NTNUEBVGKMVANB-NHCYSSNCSA-N Glu-Val-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O NTNUEBVGKMVANB-NHCYSSNCSA-N 0.000 description 2
- GWCRIHNSVMOBEQ-BQBZGAKWSA-N Gly-Arg-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O GWCRIHNSVMOBEQ-BQBZGAKWSA-N 0.000 description 2
- BIRKKBCSAIHDDF-WDSKDSINSA-N Gly-Glu-Cys Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(O)=O BIRKKBCSAIHDDF-WDSKDSINSA-N 0.000 description 2
- MBOAPAXLTUSMQI-JHEQGTHGSA-N Gly-Glu-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MBOAPAXLTUSMQI-JHEQGTHGSA-N 0.000 description 2
- QPTNELDXWKRIFX-YFKPBYRVSA-N Gly-Gly-Gln Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O QPTNELDXWKRIFX-YFKPBYRVSA-N 0.000 description 2
- OLPPXYMMIARYAL-QMMMGPOBSA-N Gly-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)CN OLPPXYMMIARYAL-QMMMGPOBSA-N 0.000 description 2
- QAMMIGULQSIRCD-IRXDYDNUSA-N Gly-Phe-Tyr Chemical compound C([C@H](NC(=O)C[NH3+])C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C([O-])=O)C1=CC=CC=C1 QAMMIGULQSIRCD-IRXDYDNUSA-N 0.000 description 2
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 2
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 2
- MUGLKCQHTUFLGF-WPRPVWTQSA-N Gly-Val-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)CN MUGLKCQHTUFLGF-WPRPVWTQSA-N 0.000 description 2
- IZVICCORZOSGPT-JSGCOSHPSA-N Gly-Val-Tyr Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IZVICCORZOSGPT-JSGCOSHPSA-N 0.000 description 2
- SDTPKSOWFXBACN-GUBZILKMSA-N His-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O SDTPKSOWFXBACN-GUBZILKMSA-N 0.000 description 2
- CSRRMQFXMBPSIL-SIXJUCDHSA-N His-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CN=CN3)N CSRRMQFXMBPSIL-SIXJUCDHSA-N 0.000 description 2
- RWYCOSAAAJBJQL-KCTSRDHCSA-N Ile-Gly-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N RWYCOSAAAJBJQL-KCTSRDHCSA-N 0.000 description 2
- GTSAALPQZASLPW-KJYZGMDISA-N Ile-His-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N GTSAALPQZASLPW-KJYZGMDISA-N 0.000 description 2
- FHPZJWJWTWZKNA-LLLHUVSDSA-N Ile-Phe-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N FHPZJWJWTWZKNA-LLLHUVSDSA-N 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 2
- IBMVEYRWAWIOTN-RWMBFGLXSA-N Leu-Arg-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(O)=O IBMVEYRWAWIOTN-RWMBFGLXSA-N 0.000 description 2
- VPKIQULSKFVCSM-SRVKXCTJSA-N Leu-Gln-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VPKIQULSKFVCSM-SRVKXCTJSA-N 0.000 description 2
- ZYLJULGXQDNXDK-GUBZILKMSA-N Leu-Gln-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ZYLJULGXQDNXDK-GUBZILKMSA-N 0.000 description 2
- DPWGZWUMUUJQDT-IUCAKERBSA-N Leu-Gln-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O DPWGZWUMUUJQDT-IUCAKERBSA-N 0.000 description 2
- NRFGTHFONZYFNY-MGHWNKPDSA-N Leu-Ile-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NRFGTHFONZYFNY-MGHWNKPDSA-N 0.000 description 2
- IAJFFZORSWOZPQ-SRVKXCTJSA-N Leu-Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IAJFFZORSWOZPQ-SRVKXCTJSA-N 0.000 description 2
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 2
- LCNASHSOFMRYFO-WDCWCFNPSA-N Leu-Thr-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O LCNASHSOFMRYFO-WDCWCFNPSA-N 0.000 description 2
- ILDSIMPXNFWKLH-KATARQTJSA-N Leu-Thr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ILDSIMPXNFWKLH-KATARQTJSA-N 0.000 description 2
- MPGHETGWWWUHPY-CIUDSAMLSA-N Lys-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN MPGHETGWWWUHPY-CIUDSAMLSA-N 0.000 description 2
- KNKHAVVBVXKOGX-JXUBOQSCSA-N Lys-Ala-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KNKHAVVBVXKOGX-JXUBOQSCSA-N 0.000 description 2
- QUCDKEKDPYISNX-HJGDQZAQSA-N Lys-Asn-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QUCDKEKDPYISNX-HJGDQZAQSA-N 0.000 description 2
- MWVUEPNEPWMFBD-SRVKXCTJSA-N Lys-Cys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCCCN MWVUEPNEPWMFBD-SRVKXCTJSA-N 0.000 description 2
- MRWXLRGAFDOILG-DCAQKATOSA-N Lys-Gln-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MRWXLRGAFDOILG-DCAQKATOSA-N 0.000 description 2
- ODUQLUADRKMHOZ-JYJNAYRXSA-N Lys-Glu-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N)O ODUQLUADRKMHOZ-JYJNAYRXSA-N 0.000 description 2
- ISHNZELVUVPCHY-ZETCQYMHSA-N Lys-Gly-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O ISHNZELVUVPCHY-ZETCQYMHSA-N 0.000 description 2
- ONPDTSFZAIWMDI-AVGNSLFASA-N Lys-Leu-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ONPDTSFZAIWMDI-AVGNSLFASA-N 0.000 description 2
- CTJUSALVKAWFFU-CIUDSAMLSA-N Lys-Ser-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N CTJUSALVKAWFFU-CIUDSAMLSA-N 0.000 description 2
- XABXVVSWUVCZST-GVXVVHGQSA-N Lys-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN XABXVVSWUVCZST-GVXVVHGQSA-N 0.000 description 2
- NYTDJEZBAAFLLG-IHRRRGAJSA-N Lys-Val-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O NYTDJEZBAAFLLG-IHRRRGAJSA-N 0.000 description 2
- QWTGQXGNNMIUCW-BPUTZDHNSA-N Met-Asn-Trp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O QWTGQXGNNMIUCW-BPUTZDHNSA-N 0.000 description 2
- UZVWDRPUTHXQAM-FXQIFTODSA-N Met-Asp-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O UZVWDRPUTHXQAM-FXQIFTODSA-N 0.000 description 2
- ABHVWYPPHDYFNY-WDSOQIARSA-N Met-His-Trp Chemical compound C([C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CN=CN1 ABHVWYPPHDYFNY-WDSOQIARSA-N 0.000 description 2
- IIHMNTBFPMRJCN-RCWTZXSCSA-N Met-Val-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IIHMNTBFPMRJCN-RCWTZXSCSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 2
- 108010079364 N-glycylalanine Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- HXSUFWQYLPKEHF-IHRRRGAJSA-N Phe-Asn-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N HXSUFWQYLPKEHF-IHRRRGAJSA-N 0.000 description 2
- HHOOEUSPFGPZFP-QWRGUYRKSA-N Phe-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HHOOEUSPFGPZFP-QWRGUYRKSA-N 0.000 description 2
- LLGTYVHITPVGKR-RYUDHWBXSA-N Phe-Gln-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O LLGTYVHITPVGKR-RYUDHWBXSA-N 0.000 description 2
- JJHVFCUWLSKADD-ONGXEEELSA-N Phe-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O JJHVFCUWLSKADD-ONGXEEELSA-N 0.000 description 2
- FXEKNHAJIMHRFJ-ULQDDVLXSA-N Phe-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N FXEKNHAJIMHRFJ-ULQDDVLXSA-N 0.000 description 2
- XKHCJJPNXFBADI-DCAQKATOSA-N Pro-Asp-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O XKHCJJPNXFBADI-DCAQKATOSA-N 0.000 description 2
- MGDFPGCFVJFITQ-CIUDSAMLSA-N Pro-Glu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MGDFPGCFVJFITQ-CIUDSAMLSA-N 0.000 description 2
- UUHXBJHVTVGSKM-BQBZGAKWSA-N Pro-Gly-Asn Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UUHXBJHVTVGSKM-BQBZGAKWSA-N 0.000 description 2
- JMVQDLDPDBXAAX-YUMQZZPRSA-N Pro-Gly-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 JMVQDLDPDBXAAX-YUMQZZPRSA-N 0.000 description 2
- PCWLNNZTBJTZRN-AVGNSLFASA-N Pro-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 PCWLNNZTBJTZRN-AVGNSLFASA-N 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- HQTKVSCNCDLXSX-BQBZGAKWSA-N Ser-Arg-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O HQTKVSCNCDLXSX-BQBZGAKWSA-N 0.000 description 2
- VGNYHOBZJKWRGI-CIUDSAMLSA-N Ser-Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO VGNYHOBZJKWRGI-CIUDSAMLSA-N 0.000 description 2
- FMDHKPRACUXATF-ACZMJKKPSA-N Ser-Gln-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O FMDHKPRACUXATF-ACZMJKKPSA-N 0.000 description 2
- UAJAYRMZGNQILN-BQBZGAKWSA-N Ser-Gly-Met Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O UAJAYRMZGNQILN-BQBZGAKWSA-N 0.000 description 2
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 2
- UIPXCLNLUUAMJU-JBDRJPRFSA-N Ser-Ile-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UIPXCLNLUUAMJU-JBDRJPRFSA-N 0.000 description 2
- WGDYNRCOQRERLZ-KKUMJFAQSA-N Ser-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N WGDYNRCOQRERLZ-KKUMJFAQSA-N 0.000 description 2
- RRVFEDGUXSYWOW-BZSNNMDCSA-N Ser-Phe-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RRVFEDGUXSYWOW-BZSNNMDCSA-N 0.000 description 2
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 2
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 2
- ZKOKTQPHFMRSJP-YJRXYDGGSA-N Ser-Thr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKOKTQPHFMRSJP-YJRXYDGGSA-N 0.000 description 2
- RCOUFINCYASMDN-GUBZILKMSA-N Ser-Val-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O RCOUFINCYASMDN-GUBZILKMSA-N 0.000 description 2
- SIEBDTCABMZCLF-XGEHTFHBSA-N Ser-Val-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SIEBDTCABMZCLF-XGEHTFHBSA-N 0.000 description 2
- 108091008874 T cell receptors Proteins 0.000 description 2
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
- DWYAUVCQDTZIJI-VZFHVOOUSA-N Thr-Ala-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DWYAUVCQDTZIJI-VZFHVOOUSA-N 0.000 description 2
- KRPKYGOFYUNIGM-XVSYOHENSA-N Thr-Asp-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O KRPKYGOFYUNIGM-XVSYOHENSA-N 0.000 description 2
- MMTOHPRBJKEZHT-BWBBJGPYSA-N Thr-Cys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O MMTOHPRBJKEZHT-BWBBJGPYSA-N 0.000 description 2
- GKWNLDNXMMLRMC-GLLZPBPUSA-N Thr-Glu-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O GKWNLDNXMMLRMC-GLLZPBPUSA-N 0.000 description 2
- MECLEFZMPPOEAC-VOAKCMCISA-N Thr-Leu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O MECLEFZMPPOEAC-VOAKCMCISA-N 0.000 description 2
- FIFDDJFLNVAVMS-RHYQMDGZSA-N Thr-Leu-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O FIFDDJFLNVAVMS-RHYQMDGZSA-N 0.000 description 2
- MXDOAJQRJBMGMO-FJXKBIBVSA-N Thr-Pro-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O MXDOAJQRJBMGMO-FJXKBIBVSA-N 0.000 description 2
- BKVICMPZWRNWOC-RHYQMDGZSA-N Thr-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O BKVICMPZWRNWOC-RHYQMDGZSA-N 0.000 description 2
- NLWCSMOXNKBRLC-WDSOQIARSA-N Trp-Lys-Val Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O NLWCSMOXNKBRLC-WDSOQIARSA-N 0.000 description 2
- MBFJIHUHHCJBSN-AVGNSLFASA-N Tyr-Asn-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MBFJIHUHHCJBSN-AVGNSLFASA-N 0.000 description 2
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 2
- QOIKZODVIPOPDD-AVGNSLFASA-N Tyr-Cys-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O QOIKZODVIPOPDD-AVGNSLFASA-N 0.000 description 2
- QPBJXNYYQTUTDD-KKUMJFAQSA-N Tyr-Met-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QPBJXNYYQTUTDD-KKUMJFAQSA-N 0.000 description 2
- FGVFBDZSGQTYQX-UFYCRDLUSA-N Tyr-Phe-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O FGVFBDZSGQTYQX-UFYCRDLUSA-N 0.000 description 2
- SZEIFUXUTBBQFQ-STQMWFEESA-N Tyr-Pro-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SZEIFUXUTBBQFQ-STQMWFEESA-N 0.000 description 2
- BIVIUZRBCAUNPW-JRQIVUDYSA-N Tyr-Thr-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O BIVIUZRBCAUNPW-JRQIVUDYSA-N 0.000 description 2
- PWKMJDQXKCENMF-MEYUZBJRSA-N Tyr-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O PWKMJDQXKCENMF-MEYUZBJRSA-N 0.000 description 2
- AGKDVLSDNSTLFA-UMNHJUIQSA-N Val-Gln-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N AGKDVLSDNSTLFA-UMNHJUIQSA-N 0.000 description 2
- RKIGNDAHUOOIMJ-BQFCYCMXSA-N Val-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 RKIGNDAHUOOIMJ-BQFCYCMXSA-N 0.000 description 2
- UEHRGZCNLSWGHK-DLOVCJGASA-N Val-Glu-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UEHRGZCNLSWGHK-DLOVCJGASA-N 0.000 description 2
- QRVPEKJBBRYISE-XUXIUFHCSA-N Val-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N QRVPEKJBBRYISE-XUXIUFHCSA-N 0.000 description 2
- CXWJFWAZIVWBOS-XQQFMLRXSA-N Val-Lys-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N CXWJFWAZIVWBOS-XQQFMLRXSA-N 0.000 description 2
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 2
- TVGWMCTYUFBXAP-QTKMDUPCSA-N Val-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N)O TVGWMCTYUFBXAP-QTKMDUPCSA-N 0.000 description 2
- OWFGFHQMSBTKLX-UFYCRDLUSA-N Val-Tyr-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N OWFGFHQMSBTKLX-UFYCRDLUSA-N 0.000 description 2
- ZHWZDZFWBXWPDW-GUBZILKMSA-N Val-Val-Cys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(O)=O ZHWZDZFWBXWPDW-GUBZILKMSA-N 0.000 description 2
- 108010081404 acein-2 Proteins 0.000 description 2
- 108010070783 alanyltyrosine Proteins 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 229940125644 antibody drug Drugs 0.000 description 2
- 239000000611 antibody drug conjugate Substances 0.000 description 2
- 229940049595 antibody-drug conjugate Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 108010013835 arginine glutamate Proteins 0.000 description 2
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 2
- 108010060035 arginylproline Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 2
- 108010084389 glycyltryptophan Proteins 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 108010028295 histidylhistidine Proteins 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 238000002823 phage display Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 108010091078 rigin Proteins 0.000 description 2
- 230000001235 sensitizing effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 108010048818 seryl-histidine Proteins 0.000 description 2
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 108010020532 tyrosyl-proline Proteins 0.000 description 2
- 108010071635 tyrosyl-prolyl-arginine Proteins 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IGXNPQWXIRIGBF-KEOOTSPTSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoic acid Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 IGXNPQWXIRIGBF-KEOOTSPTSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- QMOQBVOBWVNSNO-UHFFFAOYSA-N 2-[[2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]acetyl]amino]acetate Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(O)=O QMOQBVOBWVNSNO-UHFFFAOYSA-N 0.000 description 1
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- CXRCVCURMBFFOL-FXQIFTODSA-N Ala-Ala-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CXRCVCURMBFFOL-FXQIFTODSA-N 0.000 description 1
- XEXJJJRVTFGWIC-FXQIFTODSA-N Ala-Asn-Arg Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XEXJJJRVTFGWIC-FXQIFTODSA-N 0.000 description 1
- LSLIRHLIUDVNBN-CIUDSAMLSA-N Ala-Asp-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LSLIRHLIUDVNBN-CIUDSAMLSA-N 0.000 description 1
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 1
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 1
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 1
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 1
- CREYEAPXISDKSB-FQPOAREZSA-N Ala-Thr-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CREYEAPXISDKSB-FQPOAREZSA-N 0.000 description 1
- QDGMZAOSMNGBLP-MRFFXTKBSA-N Ala-Trp-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N QDGMZAOSMNGBLP-MRFFXTKBSA-N 0.000 description 1
- XCIGOVDXZULBBV-DCAQKATOSA-N Ala-Val-Lys Chemical compound CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(O)=O XCIGOVDXZULBBV-DCAQKATOSA-N 0.000 description 1
- HJWQFFYRVFEWRM-SRVKXCTJSA-N Arg-Arg-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O HJWQFFYRVFEWRM-SRVKXCTJSA-N 0.000 description 1
- HPKSHFSEXICTLI-CIUDSAMLSA-N Arg-Glu-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HPKSHFSEXICTLI-CIUDSAMLSA-N 0.000 description 1
- PNQWAUXQDBIJDY-GUBZILKMSA-N Arg-Glu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNQWAUXQDBIJDY-GUBZILKMSA-N 0.000 description 1
- HPSVTWMFWCHKFN-GARJFASQSA-N Arg-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O HPSVTWMFWCHKFN-GARJFASQSA-N 0.000 description 1
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 1
- ZUVMUOOHJYNJPP-XIRDDKMYSA-N Arg-Trp-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZUVMUOOHJYNJPP-XIRDDKMYSA-N 0.000 description 1
- ULBHWNVWSCJLCO-NHCYSSNCSA-N Arg-Val-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N ULBHWNVWSCJLCO-NHCYSSNCSA-N 0.000 description 1
- GOVUDFOGXOONFT-VEVYYDQMSA-N Asn-Arg-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GOVUDFOGXOONFT-VEVYYDQMSA-N 0.000 description 1
- QISZHYWZHJRDAO-CIUDSAMLSA-N Asn-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N QISZHYWZHJRDAO-CIUDSAMLSA-N 0.000 description 1
- WONGRTVAMHFGBE-WDSKDSINSA-N Asn-Gly-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N WONGRTVAMHFGBE-WDSKDSINSA-N 0.000 description 1
- ZTRJUKDEALVRMW-SRVKXCTJSA-N Asn-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC(=O)N)N ZTRJUKDEALVRMW-SRVKXCTJSA-N 0.000 description 1
- RBOBTTLFPRSXKZ-BZSNNMDCSA-N Asn-Phe-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RBOBTTLFPRSXKZ-BZSNNMDCSA-N 0.000 description 1
- JWQWPRCDYWNVNM-ACZMJKKPSA-N Asn-Ser-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N JWQWPRCDYWNVNM-ACZMJKKPSA-N 0.000 description 1
- HSWYMWGDMPLTTH-FXQIFTODSA-N Asp-Glu-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HSWYMWGDMPLTTH-FXQIFTODSA-N 0.000 description 1
- VFUXXFVCYZPOQG-WDSKDSINSA-N Asp-Glu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VFUXXFVCYZPOQG-WDSKDSINSA-N 0.000 description 1
- RTXQQDVBACBSCW-CFMVVWHZSA-N Asp-Ile-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RTXQQDVBACBSCW-CFMVVWHZSA-N 0.000 description 1
- DONWIPDSZZJHHK-HJGDQZAQSA-N Asp-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N)O DONWIPDSZZJHHK-HJGDQZAQSA-N 0.000 description 1
- YIDFBWRHIYOYAA-LKXGYXEUSA-N Asp-Ser-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YIDFBWRHIYOYAA-LKXGYXEUSA-N 0.000 description 1
- 102100021277 Beta-secretase 2 Human genes 0.000 description 1
- 101710150190 Beta-secretase 2 Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101100512078 Caenorhabditis elegans lys-1 gene Proteins 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 101800004419 Cleaved form Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- RRIJEABIXPKSGP-FXQIFTODSA-N Cys-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CS RRIJEABIXPKSGP-FXQIFTODSA-N 0.000 description 1
- CLDCTNHPILWQCW-CIUDSAMLSA-N Cys-Arg-Glu Chemical compound C(C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)N)CN=C(N)N CLDCTNHPILWQCW-CIUDSAMLSA-N 0.000 description 1
- YMBAVNPKBWHDAW-CIUDSAMLSA-N Cys-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N YMBAVNPKBWHDAW-CIUDSAMLSA-N 0.000 description 1
- SAEVTQWAYDPXMU-KATARQTJSA-N Cys-Thr-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O SAEVTQWAYDPXMU-KATARQTJSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- CVRUVYDNRPSKBM-QEJZJMRPSA-N Gln-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)N)N CVRUVYDNRPSKBM-QEJZJMRPSA-N 0.000 description 1
- WPJDPEOQUIXXOY-AVGNSLFASA-N Gln-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O WPJDPEOQUIXXOY-AVGNSLFASA-N 0.000 description 1
- PVBBEKPHARMPHX-DCAQKATOSA-N Glu-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O PVBBEKPHARMPHX-DCAQKATOSA-N 0.000 description 1
- MTAOBYXRYJZRGQ-WDSKDSINSA-N Glu-Gly-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MTAOBYXRYJZRGQ-WDSKDSINSA-N 0.000 description 1
- VMKCPNBBPGGQBJ-GUBZILKMSA-N Glu-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N VMKCPNBBPGGQBJ-GUBZILKMSA-N 0.000 description 1
- YGLCLCMAYUYZSG-AVGNSLFASA-N Glu-Lys-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 YGLCLCMAYUYZSG-AVGNSLFASA-N 0.000 description 1
- QDMVXRNLOPTPIE-WDCWCFNPSA-N Glu-Lys-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QDMVXRNLOPTPIE-WDCWCFNPSA-N 0.000 description 1
- PMSDOVISAARGAV-FHWLQOOXSA-N Glu-Tyr-Phe Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 PMSDOVISAARGAV-FHWLQOOXSA-N 0.000 description 1
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 1
- IWAXHBCACVWNHT-BQBZGAKWSA-N Gly-Asp-Arg Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IWAXHBCACVWNHT-BQBZGAKWSA-N 0.000 description 1
- IKAIKUBBJHFNBZ-LURJTMIESA-N Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CN IKAIKUBBJHFNBZ-LURJTMIESA-N 0.000 description 1
- NTBOEZICHOSJEE-YUMQZZPRSA-N Gly-Lys-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NTBOEZICHOSJEE-YUMQZZPRSA-N 0.000 description 1
- WDXLKVQATNEAJQ-BQBZGAKWSA-N Gly-Pro-Asp Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WDXLKVQATNEAJQ-BQBZGAKWSA-N 0.000 description 1
- NSVOVKWEKGEOQB-LURJTMIESA-N Gly-Pro-Gly Chemical compound NCC(=O)N1CCC[C@H]1C(=O)NCC(O)=O NSVOVKWEKGEOQB-LURJTMIESA-N 0.000 description 1
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 1
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 1
- FULZDMOZUZKGQU-ONGXEEELSA-N Gly-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN FULZDMOZUZKGQU-ONGXEEELSA-N 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- MAABHGXCIBEYQR-XVYDVKMFSA-N His-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N MAABHGXCIBEYQR-XVYDVKMFSA-N 0.000 description 1
- HIAHVKLTHNOENC-HGNGGELXSA-N His-Glu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HIAHVKLTHNOENC-HGNGGELXSA-N 0.000 description 1
- STOOMQFEJUVAKR-KKUMJFAQSA-N His-His-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CNC=N1 STOOMQFEJUVAKR-KKUMJFAQSA-N 0.000 description 1
- IGBBXBFSLKRHJB-BZSNNMDCSA-N His-Lys-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 IGBBXBFSLKRHJB-BZSNNMDCSA-N 0.000 description 1
- TVMNTHXFRSXZGR-IHRRRGAJSA-N His-Lys-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O TVMNTHXFRSXZGR-IHRRRGAJSA-N 0.000 description 1
- HZWWOGWOBQBETJ-CUJWVEQBSA-N His-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N)O HZWWOGWOBQBETJ-CUJWVEQBSA-N 0.000 description 1
- 101100383038 Homo sapiens CD19 gene Proteins 0.000 description 1
- CYHYBSGMHMHKOA-CIQUZCHMSA-N Ile-Ala-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CYHYBSGMHMHKOA-CIQUZCHMSA-N 0.000 description 1
- HQEPKOFULQTSFV-JURCDPSOSA-N Ile-Phe-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)O)N HQEPKOFULQTSFV-JURCDPSOSA-N 0.000 description 1
- QQFSKBMCAKWHLG-UHFFFAOYSA-N Ile-Phe-Pro-Pro Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(NC(=O)C(N)C(C)CC)CC1=CC=CC=C1 QQFSKBMCAKWHLG-UHFFFAOYSA-N 0.000 description 1
- VGSPNSSCMOHRRR-BJDJZHNGSA-N Ile-Ser-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N VGSPNSSCMOHRRR-BJDJZHNGSA-N 0.000 description 1
- PZWBBXHHUSIGKH-OSUNSFLBSA-N Ile-Thr-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PZWBBXHHUSIGKH-OSUNSFLBSA-N 0.000 description 1
- OMDWJWGZGMCQND-CFMVVWHZSA-N Ile-Tyr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OMDWJWGZGMCQND-CFMVVWHZSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- IGUOAYLTQJLPPD-DCAQKATOSA-N Leu-Asn-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IGUOAYLTQJLPPD-DCAQKATOSA-N 0.000 description 1
- VCSBGUACOYUIGD-CIUDSAMLSA-N Leu-Asn-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VCSBGUACOYUIGD-CIUDSAMLSA-N 0.000 description 1
- GPICTNQYKHHHTH-GUBZILKMSA-N Leu-Gln-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O GPICTNQYKHHHTH-GUBZILKMSA-N 0.000 description 1
- KGCLIYGPQXUNLO-IUCAKERBSA-N Leu-Gly-Glu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O KGCLIYGPQXUNLO-IUCAKERBSA-N 0.000 description 1
- BTNXKBVLWJBTNR-SRVKXCTJSA-N Leu-His-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O BTNXKBVLWJBTNR-SRVKXCTJSA-N 0.000 description 1
- QLDHBYRUNQZIJQ-DKIMLUQUSA-N Leu-Ile-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QLDHBYRUNQZIJQ-DKIMLUQUSA-N 0.000 description 1
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 1
- FKQPWMZLIIATBA-AJNGGQMLSA-N Leu-Lys-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FKQPWMZLIIATBA-AJNGGQMLSA-N 0.000 description 1
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 1
- KQFZKDITNUEVFJ-JYJNAYRXSA-N Leu-Phe-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CC=CC=C1 KQFZKDITNUEVFJ-JYJNAYRXSA-N 0.000 description 1
- IXHKPDJKKCUKHS-GARJFASQSA-N Lys-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IXHKPDJKKCUKHS-GARJFASQSA-N 0.000 description 1
- NLOZZWJNIKKYSC-WDSOQIARSA-N Lys-Arg-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCCN)C(O)=O)=CNC2=C1 NLOZZWJNIKKYSC-WDSOQIARSA-N 0.000 description 1
- URBJRJKWSUFCKS-AVGNSLFASA-N Lys-Met-Arg Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCCCN)N URBJRJKWSUFCKS-AVGNSLFASA-N 0.000 description 1
- SBQDRNOLGSYHQA-YUMQZZPRSA-N Lys-Ser-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SBQDRNOLGSYHQA-YUMQZZPRSA-N 0.000 description 1
- YKBSXQFZWFXFIB-VOAKCMCISA-N Lys-Thr-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCCN)C(O)=O YKBSXQFZWFXFIB-VOAKCMCISA-N 0.000 description 1
- HMZPYMSEAALNAE-ULQDDVLXSA-N Lys-Val-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMZPYMSEAALNAE-ULQDDVLXSA-N 0.000 description 1
- JQEBITVYKUCBMC-SRVKXCTJSA-N Met-Arg-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JQEBITVYKUCBMC-SRVKXCTJSA-N 0.000 description 1
- NKDSBBBPGIVWEI-RCWTZXSCSA-N Met-Arg-Thr Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NKDSBBBPGIVWEI-RCWTZXSCSA-N 0.000 description 1
- YLLWCSDBVGZLOW-CIUDSAMLSA-N Met-Gln-Ala Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O YLLWCSDBVGZLOW-CIUDSAMLSA-N 0.000 description 1
- UOENBSHXYCHSAU-YUMQZZPRSA-N Met-Gln-Gly Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O UOENBSHXYCHSAU-YUMQZZPRSA-N 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- 239000012124 Opti-MEM Substances 0.000 description 1
- NPLGQVKZFGJWAI-QWHCGFSZSA-N Phe-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O NPLGQVKZFGJWAI-QWHCGFSZSA-N 0.000 description 1
- BWTKUQPNOMMKMA-FIRPJDEBSA-N Phe-Ile-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BWTKUQPNOMMKMA-FIRPJDEBSA-N 0.000 description 1
- INHMISZWLJZQGH-ULQDDVLXSA-N Phe-Leu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 INHMISZWLJZQGH-ULQDDVLXSA-N 0.000 description 1
- AXIOGMQCDYVTNY-ACRUOGEOSA-N Phe-Phe-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 AXIOGMQCDYVTNY-ACRUOGEOSA-N 0.000 description 1
- BPIMVBKDLSBKIJ-FCLVOEFKSA-N Phe-Thr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 BPIMVBKDLSBKIJ-FCLVOEFKSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- DKKGAAJTDKHWOD-BIIVOSGPSA-N Ser-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)C(=O)O DKKGAAJTDKHWOD-BIIVOSGPSA-N 0.000 description 1
- BYIROAKULFFTEK-CIUDSAMLSA-N Ser-Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO BYIROAKULFFTEK-CIUDSAMLSA-N 0.000 description 1
- COLJZWUVZIXSSS-CIUDSAMLSA-N Ser-Cys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)N COLJZWUVZIXSSS-CIUDSAMLSA-N 0.000 description 1
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 1
- CKDXFSPMIDSMGV-GUBZILKMSA-N Ser-Pro-Val Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O CKDXFSPMIDSMGV-GUBZILKMSA-N 0.000 description 1
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 1
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 1
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 1
- LDEBVRIURYMKQS-WISUUJSJSA-N Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO LDEBVRIURYMKQS-WISUUJSJSA-N 0.000 description 1
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 1
- PLQWGQUNUPMNOD-KKUMJFAQSA-N Ser-Tyr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O PLQWGQUNUPMNOD-KKUMJFAQSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- TWLMXDWFVNEFFK-FJXKBIBVSA-N Thr-Arg-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O TWLMXDWFVNEFFK-FJXKBIBVSA-N 0.000 description 1
- VFEHSAJCWWHDBH-RHYQMDGZSA-N Thr-Arg-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VFEHSAJCWWHDBH-RHYQMDGZSA-N 0.000 description 1
- XSEPSRUDSPHMPX-KATARQTJSA-N Thr-Lys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O XSEPSRUDSPHMPX-KATARQTJSA-N 0.000 description 1
- XKWABWFMQXMUMT-HJGDQZAQSA-N Thr-Pro-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XKWABWFMQXMUMT-HJGDQZAQSA-N 0.000 description 1
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 1
- OGOYMQWIWHGTGH-KZVJFYERSA-N Thr-Val-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O OGOYMQWIWHGTGH-KZVJFYERSA-N 0.000 description 1
- UDCHKDYNMRJYMI-QEJZJMRPSA-N Trp-Glu-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UDCHKDYNMRJYMI-QEJZJMRPSA-N 0.000 description 1
- PKZIWSHDJYIPRH-JBACZVJFSA-N Trp-Tyr-Gln Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PKZIWSHDJYIPRH-JBACZVJFSA-N 0.000 description 1
- MNMYOSZWCKYEDI-JRQIVUDYSA-N Tyr-Asp-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MNMYOSZWCKYEDI-JRQIVUDYSA-N 0.000 description 1
- SLCSPPCQWUHPPO-JYJNAYRXSA-N Tyr-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SLCSPPCQWUHPPO-JYJNAYRXSA-N 0.000 description 1
- JJNXZIPLIXIGBX-HJPIBITLSA-N Tyr-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N JJNXZIPLIXIGBX-HJPIBITLSA-N 0.000 description 1
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 1
- MVFQLSPDMMFCMW-KKUMJFAQSA-N Tyr-Leu-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O MVFQLSPDMMFCMW-KKUMJFAQSA-N 0.000 description 1
- MQGGXGKQSVEQHR-KKUMJFAQSA-N Tyr-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MQGGXGKQSVEQHR-KKUMJFAQSA-N 0.000 description 1
- OJCISMMNNUNNJA-BZSNNMDCSA-N Tyr-Tyr-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 OJCISMMNNUNNJA-BZSNNMDCSA-N 0.000 description 1
- IRLYZKKNBFPQBW-XGEHTFHBSA-N Val-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)N)O IRLYZKKNBFPQBW-XGEHTFHBSA-N 0.000 description 1
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 1
- HJSLDXZAZGFPDK-ULQDDVLXSA-N Val-Phe-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N HJSLDXZAZGFPDK-ULQDDVLXSA-N 0.000 description 1
- PGQUDQYHWICSAB-NAKRPEOUSA-N Val-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N PGQUDQYHWICSAB-NAKRPEOUSA-N 0.000 description 1
- QTPQHINADBYBNA-DCAQKATOSA-N Val-Ser-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN QTPQHINADBYBNA-DCAQKATOSA-N 0.000 description 1
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 1
- GVNLOVJNNDZUHS-RHYQMDGZSA-N Val-Thr-Lys Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O GVNLOVJNNDZUHS-RHYQMDGZSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
- 210000000628 antibody-producing cell Anatomy 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000012575 bio-layer interferometry Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000000375 direct analysis in real time Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000012063 dual-affinity re-targeting Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- -1 inhalants Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000012482 interaction analysis Methods 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 108010053037 kyotorphin Proteins 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 108010085203 methionylmethionine Proteins 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 108010024607 phenylalanylalanine Proteins 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000007026 protein scission Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 108010079202 tyrosyl-alanyl-cysteine Proteins 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4727—Calcium binding proteins, e.g. calmodulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Optics & Photonics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
본 발명은, 변이형 칼레티큘린 단백질에 특이적으로 결합하는, 보다 고성능인 이중 특이성 및 해당 항체를 함유하는 의약 조성물을 제공하는 것이다. 변이형 칼레티큘린 단백질에 특이적으로 결합하는 제1 도메인 및 CD3 항원에 특이적으로 결합하는 제2 도메인을 갖는 이중특이성 항체를 제공한다.
Description
본 발명은 변이형 CALR 단백질에 대한 특이성을 갖는 이중특이성 항체 및 그 치료 및 진단 용도에 대한 이용 분야에 관한 것이다.
필라델피아 염색체 음성 골수 증식성 종양(Philadelphia-negative myeloproliferative neoplasms; MPNs) 환자의 일부에서는 Calreticulin(CALR) 유전자의 제9 엑손에, 염기 결실이나 삽입이 발견된다(비특허문헌 1, 2). CALR 변이 유전자로부터 생산되는 변이형 CALR 단백질은, 트롬보포이에틴(Thrombopoietin; TPO) 수용체를 항상적으로 활성화함으로써, 단독으로 골수 증식성 종양(MPN)을 일으키는 종양원성을 가지고 있음이 이미 밝혀져 있다(비특허문헌 3 내지 6).
MPN 환자에서 발견되는 CALR 유전자 변이는, 반드시 최종 엑손의 국한된 장소에서의 프레임 시프트 변이이며, 프레임 시프트 변이에 의한 아미노산의 판독 프레임의 어긋남은, 반드시 +1이다. 이러한 점에서 변이형 CALR 단백질의 C 말단에는, 야생형에 존재하지 않는 서열이 존재하며, 특히 그 C 말단의 44 아미노산은, 거의 모든 변이형 CALR 단백질에 공통되어 있다. 그 예로서, MPN 환자에서 발견되는 CALR 유전자 변이 중에서도 가장 빈도가 높은 52 염기 결실형(Del 52), 그 다음으로 빈도가 높은 5 염기 삽입형(Ins 5)의 C 말단 서열을 야생형 CALR 단백질의 해당 영역과 비교한 것을 도 1 [a]에 나타내었다.
MPN을 일으키는 원인인 변이형 CALR 단백질은 종양 세포에 발현되어 있으므로, 프레임 시프트 변이에 의해 생긴 변이형 CALR 단백질에 특이적인 서열은 네오 항원으로서, 진단 시의 마커나 치료 표적이 될 가능성이 시사되어 있었다(특허문헌 1 내지 2).
그러나, 상기 프레임 시프트 변이에 의해 출현하는 변이형 CALR 단백질에 특이적인 서열(네오 항원)을 단순히 인식하는 항체로는, 세포 추출액이나 세포 표면에서의 변이형 CALR 단백질을 정확하게 검출할 수 없는 것으로 판명되었다. 변이형 CALR 단백질의 기능 해석 결과, 종양 세포에 발현되어 있는 변이형 CALR 단백질의 대부분이, 변이형 CALR 단백질에 특이적인 서열 중에서 절단되고, 네오 항원으로 여겨졌던 서열의 대부분이 상실된 절단형의 변이형 CALR 단백질이 많이 발현되어 있었다. 이에, 네오 항원 중의, 절단 부위보다 N 말단 측에 위치하는 매우 짧은 아미노산 서열을 특이적으로 인식하는 항체를 제작했더니(도 1 [b]), 우수한 MPN 치료 효과가 얻어진다는 것이 밝혀졌다. 이러한 점에서, CALR 유전자 변이를 가진 MPN 환자의 진단이나 치료에서는, 전장형(미절단형) 뿐만 아니라, 절단형을 포함하는 변이형 CALR 단백질을 검출 또는 표적으로 함으로써, 보다 고성능의 의약품을 개발할 수 있다는 것이 시사되었다.
나아가 최근, 항암 활성의 증강을 목적으로 2종의 항원에 대해 특이적으로 결합하는 것이 가능한 항체의 특성을 살려, 특이적인 항종양 효과를 가진, 보다 효과적인 치료제로서의 연구가 활발히 진행되고 있다. 한쪽 부위가 표적 세포 상의 표면 항원에, 다른 쪽 부위가 이펙터 세포 상의 표면 항원에 결합할 수 있는 이중특이성 항체가 주목받고 있다. 이펙터 세포에는 T 세포를 비롯한 면역 이펙터 세포가 이용되는 경우가 많으며, 이중특이성 항체가 표적 세포와 면역 이펙터 세포와의 사이에 일시적인 상호 작용을 가져오는 것을 목적으로 하고 있다. 예를 들어, T 세포 표면 항원 중 T 세포 수용체(TCR) 단백질 복합체에서 유래하는 CD3 입실론 서브유닛에 대한 결합 부위를 갖는 항체는, 주로 T 세포에 의한 표적 세포 용해를 일으키는, 즉, T 세포 리다이렉트 킬링을 하는 것이 가능하다. 이와 같이, 이중특이성 항체는 표적 세포 및 T 세포에 특이적으로 결합하고, T 세포가 표적 세포에 직접 작용을 초래하기 때문에, 암세포에서 비정상적으로 발현되고 있는 물질 또는 암화에 따라 변화가 일어나는 물질을 표적으로 하는 연구가 진행되고 있다.
예를 들어, 특허문헌 3에는 인간 CD19에 대한 제1 특이성 및 인간 CD3 항원에 대한 제2 특이성을 갖는 이중특이성 항체가, 특허문헌 4에는 CALR과 면역 세포에 관한 이중특이성 항체가 기재되어 있다.
Klampfl T, Gisslinger H, Harutyunyan AS, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. The New England journal of medicine. 2013; 369: 2379-90.
Nangalia J, Massie CE, Baxter EJ, et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. The New England journal of medicine. 2013; 369: 2391-405.
Araki M, Yang Y, Masubuchi N, et al. Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms. Blood. 2016; 127: 1307-16.
Elf S, Abdelfattah NS, Chen E, et al. Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation. Cancer Discov. 2016; 6: 368-81.
Marty C, Pecquet C, Nivarthi H, et al. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis. Blood. 2016; 127: 1317-24.
Vainchenker W, Kralovics R. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood. 2017; 129: 667-79.
변이형 CALR 단백질은 MPN 환자 세포에 특이적으로 발현되고 있는데, 변이형 CALR 단백질의 대부분이, 절단형의 변이형 CALR 단백질이었다. 따라서, 본 발명의 과제는, 전장형 및 절단형의 변이형 CALR 단백질을 정확하게 검출하여, 치료 응용 가능한 항체 또는 기능성 단편을 함유하는 의약 조성물을 제공하는 것에 있다.
절단 부위보다 N 말단측에 위치하는 매우 짧은 아미노산 서열을 특이적으로 인식하는 항체를 이용함으로써, 절단형의 변이형 CALR 단백질이 배양 세포뿐만 아니라, 환자 말초혈 세포, 환자 혈소판, 환자 골수 세포 등에서도 발현이 확인되었다. 이 항절단형 변이 CALR 항체를 이용하면, 세포 표면에서의 변이형 CALR 단백질의 검출 감도가 비약적으로 향상되었다. 나아가 절단형의 변이형 CALR 단백질과 CD3 항원과 결합하는 단백질로 이루어지는 이중특이성 항체(항절단형 변이 CALR-CD3 이중특이성 항체)를 제작하였더니, 우수한 MPN 치료 효과를 얻을 수 있는 것으로 밝혀졌다. 종래 네오 항원으로 여겨졌던 서열에 대한 항체를 바탕으로 한 이중특이성 항체로는, 충분한 치료 효과가 얻어지지 않는다는 것이 판명되었으므로, 전장형 및 절단형의 변이형 CALR 단백질과 특이적으로 결합하는, 보다 고성능인 이중특이성 항체 및 해당 항체를 함유하는 의약 조성물을 제공하는 것이 중요하다는 것이 강력히 시사되어, 본 발명을 완성하였다.
즉, 본 발명은 다음의 (1) 내지 (22)를 제공하는 것이다.
(1) 변이형 칼레티큘린 단백질에 특이적으로 결합하는 제1 도메인 및 CD3 항원에 특이적으로 결합하는 제2 도메인을 갖는 이중특이성 항체.
(2) 상기 제1 도메인이, 서열 번호 1의 변이형 칼레티큘린 단백질의 에피토프에 결합하는 항체와 경쟁하는, (1)에 기재된 이중특이성 항체.
(3) 변이형 칼레티큘린 단백질이 서열 번호 1로 표시되는 아미노산 서열로 이루어지는 폴리펩티드쇄 중, 또는 서열 번호 1에서 1개 또는 수개의 아미노산이 결실, 치환 또는 부가된 아미노산 서열로 이루어지는 폴리펩티드쇄 중에 항원 인식 부위를 갖는, (1) 또는 (2)에 기재된 이중특이성 항체.
(4) 제1 도메인이 야생형 칼레티큘린 단백질에 결합하지 않고, 변이형 칼레티큘린 단백질에 대해 높은 친화성을 갖는, (1) 내지 (3) 중 어느 한 항에 기재된 이중특이성 항체.
(5) 제1 도메인이, 절단 후의 변이형 칼레티큘린 단백질에 대해 높은 친화성을 갖는, (1) 내지 (4) 중 어느 한 항에 기재된 이중특이성 항체.
(6) 제1 도메인과 변이형 칼레티큘린 단백질 간의 결합은, KD가 10-7 M 이하인, (1) 내지 (5) 중 어느 한 항에 기재된 이중특이성 항체.
(7) 제1 도메인의 CDR이, (a) 서열 번호 10, 서열 번호 11 또는 126, 및 서열 번호 12(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 13, 서열 번호 14 또는 127, 및 서열 번호 15(VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖거나, (b) 서열 번호 16-18(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 19-21(VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖거나, 또는 (c) 서열 번호 22-24(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 25-27(VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는, (1) 내지 (6) 중 어느 한 항에 기재된 이중특이성 항체.
(8) 제1 도메인이, (d) 서열 번호 2, 90, 91, 92, 93, 94, 133, 134, 135 및 136으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 3, 95, 96, 97, 98, 99, 137, 138, 139, 140 및 141로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖거나, (e) 서열 번호 4로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 5로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖거나, 또는 (f) 서열 번호 6으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 7로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖는, (1) 내지 (7) 중 어느 한 항에 기재된 이중특이성 항체.
(9) 제2 도메인의 CDR이, 서열 번호 28, 서열 번호 29 또는 128, 및 서열 번호 30, 129 또는 130(VHCDR)으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 31 또는 131, 서열 번호 32 또는 132, 및 서열 번호 33(VLCDR)으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는, (1) 내지 (8) 중 어느 한 항에 기재된 이중특이성 항체.
(10) 제2 도메인이, 서열 번호 8, 204, 205 및 206으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 9, 207 및 208로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖는, (1) 내지 (9) 중 어느 한 항에 기재된 이중특이성 항체.
(11) 이량체화 모듈이 한 개 또는 복수개의 노브 인투 홀 구조를 갖는 헤테로 H쇄이며, H쇄의 정상 영역의 349, 354, 366, 368 및 407번째로부터 선택되는 하나 이상의 위치의 아미노산을 각각 Y349C, T366S, L368A, Y407V(홀 또는 공동) S354C, 또는 T366W(노브 또는 돌기)로 치환한 서열 번호 209 또는 210의 Fc 영역을 포함하는, (1) 내지 (10) 중 어느 한 항에 기재된 이중특이성 항체.
(12) H쇄 Fc 영역의 234 및 235로부터 선택되는 하나 이상의 위치의 아미노산을 각각 L234A 또는 L235A로 치환한 변이를 포함하는 서열 번호 211의 변이 Fc 영역을 포함하는, (1) 내지 (11) 중 어느 한 항에 기재된 이중특이성 항체.
(13) 인간 항체, 인간화 항체, 동물 유래 항체와 인간 항체의 키메라 항체 또는 합성 항체인, (1) 내지 (12) 중 어느 한 항에 기재된 이중특이성 항체.
(14) (1) 내지 (13) 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능성 단편을 함유하는 의약 조성물.
(15) 골수 증식성 종양 치료 또는 진단용 의약 조성물인 (14)에 기재된 의약 조성물.
(16) (1) 내지 (13) 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능적 단편을 이용하여, 생체 시료 중의 다음의 (A) 또는 (B)의 폴리펩티드를 검출하는 것을 특징으로 하는 변이형 칼레티큘린 단백질의 검출 방법.
(A) 서열 번호 1로 표시되는 아미노산 서열로 이루어지는 폴리펩티드
(B) 서열 번호 1에서 1개 또는 수개의 아미노산이 결실, 치환 또는 부가된 아미노산 서열로 이루어지는 폴리펩티드
(17) 변이형 칼레티큘린 단백질의 검출에 이용하기 위한, (1) 내지 (13) 중 어느 한 항에 기재된 이중특이성 항체 또는 그 기능적 단편.
(18) (1) 내지 (13) 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능적 단편을 이용하여, 생체 시료 중의 다음의 (A) 또는 (B)의 폴리펩티드를 검출하는 것을 특징으로 하는 골수 증식성 종양의 진단 방법.
(A) 서열 번호 1로 표시되는 아미노산 서열로 이루어지는 폴리펩티드
(B) 서열 번호 1에서 1개 또는 수개의 아미노산이 결실, 치환 또는 부가된 아미노산 서열로 이루어지는 폴리펩티드
(19) 골수 증식성 종양의 치료 또는 진단에 이용하기 위한, (1) 내지 (13) 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능적 단편.
(20) (1) 내지 (13) 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능적 단편의 골수 증식성 종양 치료약 또는 진단약 제조를 위한 사용.
(21) 제1항 내지 제13항 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능적 단편을 투여하는 것을 특징으로 하는 종양의 예방 또는 치료 방법.
(22) 종양이 혈액 종양, 바람직하게는 골수 증식성 종양, 골수성 백혈병, 혈소판 증가증, 적혈구 증가증, 원발성 골수 섬유증, 또는 이차성 골수성 섬유증인 (21)에 기재된 방법.
본 발명의 이중특이성 항체는 상기 (A) 또는 (B)의 폴리펩티드쇄 중에 항원 인식 부위(에피토프)를 가지며, 이를 이용하면, 변이형 CALR 단백질의 절단에 의해 생긴 절단형의 변이형 CALR 단백질을 검출할 수 있어, 세포 표면에서의 변이형 CALR 단백질의 검출 감도가 비약적으로 향상된다. 또한 절단형의 변이형 CALR 단백질의 에피토프와 결합하는 제1 특이성, 및 CD3 항원과 결합하는 제2 특이성을 갖는 항절단형 변이 CALR-CD3 이중특이성 항체를 개발함으로써, 변이형 CALR 양성 세포에 특이적인 강한 세포 상해 활성을 갖는 항체를 얻을 수 있다. 따라서, 본 발명의 이중특이성 항체를 이용하면, 변이형 CALR을 발현하는 질환을 특이적으로 예방 또는 치료할 수 있다.
도 1은 변이형 CALR 단백질의 특징을 나타내는 도면이다. [a] MPN 환자의 발병 원인인 CALR 유전자 변이는, +1 프레임 시프트 변이이며, 그 결과 생기는 변이형 CALR 단백질의 C 말단에는, 변이형 단백질에 공통된 아미노산 서열이 발견된다. SP: 시그널 서열, N: N 도메인, P: P 도메인. 화살표는, 야생형(WT)과 다른 아미노산 서열이 시작되는 부분을 나타내고 있다. [b] 변이형 CALR 단백질 특이적 서열(흑색) 내에 생기는 단백질의 절단 부위보다도 N 말단 측에 있는, 변이형 특이적 서열을 인식하는 항체를 나타낸다.
도 2는 클론 B3, C6, 및 G1 항체가 모두 전장형과 절단형의 변이형 CALR 단백질을 인식하는 것을 나타낸다. 상세하게는, UT-7/TPO 세포로부터 분비된 단백질을, 클론 B3, C6 및 G1 항체를 이용하여 면역 블롯 해석한 결과를 나타낸다. N 말단 시그널 서열의 하류에 FLAG 태그를 부가한 Del 52형과 Ins 5형의 전장형과, 보다 저분자량의 절단형 CALR 단백질 모두가, 항 FLAG 항체와 마찬가지로 B3, C6, G1 중 어느 항체를 이용해도 검출된다.
도 3은 서열 번호 2의 VH쇄, 서열 번호 3의 VL쇄, 서열 번호 8의 VH쇄 및 서열 번호 9의 VL쇄를 이용하여 제작한 항절단형 변이 CALR-CD3 이중특이성 항체를 이용하여, [a] 변이형 CALR을 발현하지 않은 UT-7/TPO vec 세포, [b] Ins 5 변이형 CALR을 발현시킨 세포(UT-7/TPO CALR Ins 5 세포), 또는 [c] Del 52 변이형 CALR을 발현시킨 세포(UT-7/TPO CALR Del 52 세포)를 플로우 사이토메트리 해석한 결과를 나타낸다.
도 4는 도 3에 기재된 항절단형 변이 CALR-CD3 이중특이성 항체를 이용하여 CD3 발현 세포(T-LAK 세포)를 플로우 사이토메트리 해석한 결과를 나타낸다.
도 5는 도 3에 기재된 항절단형 변이 CALR-CD3 이중특이성 항체와 항체의 제작에 이용한 항원에 대한 결합 강도를, 표면 플라즈몬 공명 해석법에 의해 평가한 결과를 나타낸다.
도 6은 항절단형 CALR-CD3 이중특이성 항체의 개략도를 나타낸다.
도 2는 클론 B3, C6, 및 G1 항체가 모두 전장형과 절단형의 변이형 CALR 단백질을 인식하는 것을 나타낸다. 상세하게는, UT-7/TPO 세포로부터 분비된 단백질을, 클론 B3, C6 및 G1 항체를 이용하여 면역 블롯 해석한 결과를 나타낸다. N 말단 시그널 서열의 하류에 FLAG 태그를 부가한 Del 52형과 Ins 5형의 전장형과, 보다 저분자량의 절단형 CALR 단백질 모두가, 항 FLAG 항체와 마찬가지로 B3, C6, G1 중 어느 항체를 이용해도 검출된다.
도 3은 서열 번호 2의 VH쇄, 서열 번호 3의 VL쇄, 서열 번호 8의 VH쇄 및 서열 번호 9의 VL쇄를 이용하여 제작한 항절단형 변이 CALR-CD3 이중특이성 항체를 이용하여, [a] 변이형 CALR을 발현하지 않은 UT-7/TPO vec 세포, [b] Ins 5 변이형 CALR을 발현시킨 세포(UT-7/TPO CALR Ins 5 세포), 또는 [c] Del 52 변이형 CALR을 발현시킨 세포(UT-7/TPO CALR Del 52 세포)를 플로우 사이토메트리 해석한 결과를 나타낸다.
도 4는 도 3에 기재된 항절단형 변이 CALR-CD3 이중특이성 항체를 이용하여 CD3 발현 세포(T-LAK 세포)를 플로우 사이토메트리 해석한 결과를 나타낸다.
도 5는 도 3에 기재된 항절단형 변이 CALR-CD3 이중특이성 항체와 항체의 제작에 이용한 항원에 대한 결합 강도를, 표면 플라즈몬 공명 해석법에 의해 평가한 결과를 나타낸다.
도 6은 항절단형 CALR-CD3 이중특이성 항체의 개략도를 나타낸다.
본 발명은 MPN과 관련된 변이형 CALR 단백질의 검출 및 진단 방법 및 MPN의 예방 또는 치료로서 이용할 수 있는 변이형 CALR 단백질에 특이적인 서열 중에서 절단되어 잔존하는 C 말단측 폴리펩티드(도 1[a]) 중의 불과 13 아미노산(서열 번호 1:RRMMRTKMRMRRM)을 인식하는 이중특이성 항체이며, 변이형 CALR 단백질의 C 말단측이 절단되어 절단형의 변이형 CALR 단백질이 생기는 것, 변이형 CALR 단백질의 공통 영역 대부분이 변이형 CALR 단백질로부터 소실되는 것은, 본 발명자가 처음 발견한 것이다. 나아가 절단형의 변이형 CALR 단백질과 결합하는 제1 도메인과, CD3 항원에 결합하는 제2 도메인을 갖는 이중특이성 항체로 함으로써, 효과적으로 종양을 치료, 예방, 검출 또는 진단할 수 있음을 발견하였다.
즉, 본 발명은, 절단형의 변이형 CALR 단백질과 CD3 항원을 특이적으로 인식하는 이중특이성 항체, 및 해당 이중특이성 항체를 포함하는 의약 조성물, 특히 MPN을 치료 또는 예방하기 위한 의약 조성물을 제공한다.
본 명세서에서, "이중특이성 항체"란, 다른 항원과 결합 가능한 적어도 2개의 항원 결합 부위를 갖는 모노클로날 항체를 가리킨다. 구체적으로, "이중특이성 항체"란, 예를 들어 제1 항체의 중쇄 가변 영역과 제1 항체의 경쇄 가변 영역으로 형성되는 제1 항원 결합 부위(제1 도메인)와, 제2 항체의 중쇄 가변 영역과 제2 항체의 경쇄 가변 영역으로 형성되는 제2 항원 결합 부위(제2 도메인)를 적어도 하나씩 포함하고, 다른 2종의 항원 인식능을 갖는 단백질을 의미한다.
이중특이성 항체의 형태로서는, 특별히 한정되지 않고, 해당 기술 분야에서 공지된 형태 중 어느 것이어도 좋으며, 2종의 항원에 대한 특이성을 유지하고 있는 한, 그 이외의 형태이어도 좋다. 이중특이성 항체의 형태는, IgG 유사형과 저분자형으로 대별된다. IgG 유사형이란, Fc 영역을 유지한 형태이다. IgG 유사형 항체의 형태로서는, 이것으로 한정되는 것은 아니지만, CrossMab, DAF(two-in-one), DAF(four-in-one), DutaMab, DT-IgG, knobs-into-holes, knobs-into-holes common LC, SEEDbody, Triomab, κλ-body, DVD-Ig, IgG-scFv, DuoBody 등을 들 수 있다. IgG 유사형 항체에서는, Fc 영역을 유지하고 있기 때문에, ADCC나 CDC와 같은 이펙터 기능의 발휘, 정제의 용이화, 안정성의 개선, 혈중 반감기의 연장 등이 기대된다. 한편, 저분자형이란, 통상, 중쇄 가변 영역과 경쇄 가변 영역으로 이루어지는 Fv 영역을 기본 구성 요소로 한 형태이다. 저분자형 항체의 형태로서는, 이것으로 한정되는 것은 아니지만, Diabody(Db), BiTE, DART, TandAb, scDb, triple body, miniantibody, minibody, scFv, tandem scFv, F(ab')2 등을 들 수 있다. 저분자형에서는, 그 크기로부터, 조직 투과성의 향상이나 생산성의 고양 등이 기대된다. 그 밖에, 항원과의 결합능을 유지한 채 아미노산 서열을 결실, 치환 또는 부가시킨 것, 당쇄의 일부 또는 전부를 결실 또는 부가시킨 것, 링커 등이 부가된 것, 다른 단백질과 융합시킨 것, 항체와 저분자 의약을 링커를 통해 결합한 항체 약물 복합체(ADC) 등의 개질 항체도 포함된다.
본 발명의 이중특이성 항체는, 변이형 칼레티큘린 단백질에 특이적으로 결합하는 제1 도메인 및 CD3 항원에 특이적으로 결합하는 제2 도메인을 갖는다.
상기 제1 도메인은, 서열 번호 1의 변이형 칼레티큘린 단백질의 에피토프에 결합하는 항체와 경쟁한다. 여기서, 변이형 칼레티큘린 단백질은, 서열 번호 1로 표시되는 아미노산 서열로 이루어지는 폴리펩티드쇄 중, 또는 서열 번호 1에서 1개 또는 수개의 아미노산이 결실, 치환 또는 부가된 아미노산 서열로 이루어지는 폴리펩티드쇄 중에 항원 인식 부위를 갖는 것이 바람직하다.
상기 제1 도메인은, 야생형 칼레티큘린 단백질에 결합하지 않고, 변이형 칼레티큘린 단백질에 대해 높은 친화성을 가지며, 특히 절단 후의 변이형 칼레티큘린 단백질에 대해 높은 친화성을 갖는다.
절단형 CALR 단백질로서는, 서열 번호 1로 표시되는 아미노산 서열로 이루어지는 폴리펩티드 (A) 및 서열 번호 1에서 1개 또는 수개의 아미노산이 결실, 치환 또는 부가된 아미노산 서열로 이루어지는 폴리펩티드 (B)를 들 수 있다. (B)에서는, 1 내지 4개의 아미노산이 결실, 치환 또는 부가된 아미노산 서열이 바람직하며, 1 내지 3개의 아미노산이 결실, 치환 또는 부가된 아미노산 서열이 보다 바람직하다. 보다 바람직하게는, 서열 번호 1의 C 말단측으로부터 3 아미노산이 결실된 아미노산 서열이 보다 바람직하다. 또한, 폴리펩티드 (B)의 아미노산 서열과 서열 번호 1의 아미노산 서열의 동일성은 80% 이상이 바람직하고, 85% 이상이 보다 바람직하며, 90% 이상이 더욱 바람직하다.
제1 도메인으로서는, (A) 또는 (B)의 폴리펩티드쇄 중에 항원 인식 부위(에피토프)를 갖는 항체이면 좋으나, 절단형의 변이형 CALR 단백질에만 결합하는 것이어도, 절단형의 변이형 CALR 단백질과 전장형의 변이형 CALR 단백질 모두에 결합하는 것이어도 좋으며, 절단형의 변이형 CALR 단백질과 전장형의 변이형 CALR 단백질 모두에 결합하는 "변이형 CALR 단백질"에 특이적인 항체인 것이 바람직하다.
이러한 제1 도메인은, 본 발명자들이 발견한 항변이 CALR 항체(클론 B3, C6 및 G1 항체)의 중쇄 가변 영역 및 경쇄 가변 영역, 나아가 중쇄 상보성 결정 영역(CDR-H1, CDR-H2 및 CDR-H3) 및 경쇄 상보성 결정 영역(CDR-L1, CDR-L2 및 CDR-L3) 혹은 그 변이체인 것이 바람직하다.
제2 도메인은, CD3 항원에 특이적으로 결합하는 도메인이면 되며, 기존의 항CD3 항체 유래의 중쇄 가변 영역 및 경쇄 가변 영역, 나아가 종래 알려진 항CD3 항체 유래의 중쇄 상보성 결정 영역(CDR-H1, CDR-H2 및 CDR-H3) 및 경쇄 상보성 결정 영역(CDR-L1, CDR-L2 및 CDR-L3) 혹은 그 변이체인 것이 바람직하다. 기존의 항CD3 항체로서는, OKT3을 들 수 있다.
제1 도메인 및 제2 도메인의 바람직한 예로서, 항변이 CALR 항체(클론 B3, C6 및 G1 항체)와 그 변이체 및 항CD3 항체(OKT3)와 그 변이체의 중쇄 가변 영역 및 경쇄 가변 영역, 나아가 중쇄 상보성 결정 영역(CDR-H1, CDR-H2 및 CDR-H3) 및 경쇄 상보성 결정 영역(CDR-L1, CDR-L2 및 CDR-L3)의 아미노산 서열을 표 1-1 내지 1-4에 나타낸다.
[표 1-1]
[표 1-2]
[표 1-3]
[표 1-4]
이들 영역은, 절단형의 변이형 CALR 단백질의 일부 또는 전장을 동물에게 면역 또는 림프구를 in vitro에서 감작하여 미에로마와 융합시킴으로써 얻은 항체나 파지 디스플레이 등의 항체 라이브러리 등에 의해 얻어진 항체의 서열 정보를 바탕으로 유전자 공학적 기법으로 재조합 항체로서 제작할 수 있다. 항CD3 항체에 관한 서열 정보는 기존 정보로부터 얻을 수 있다. 즉, 얻어진 유전자 정보로부터 항체의 중쇄 및 경쇄 유전자를 합성하고, 이를 벡터(예를 들어, 플라스미드)에 삽입한 후, 숙주 세포(예를 들어, CHO 세포, HEK 세포 등)에 도입하여, 숙주 세포를 배양함으로써, 배양물로부터 재조합 항체를 채취할 수 있다. 항체의 중쇄 및 경쇄의 유전자를 합성함에 있어서는, 코돈을 최적화하는 것이 바람직하다.
본 발명의 바람직한 이중특이성 항체로서는, 제1 도메인의 CDR이, (a) 서열 번호 10, 서열 번호 11 또는 126, 및 서열 번호 12(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 13, 서열 번호 14 또는 127, 및 서열 번호 15(VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖거나, (b) 서열 번호 16-18(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 19-21(VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖거나, 또는 (c) 서열 번호 22-24(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열번호 25-27(VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는, 이중특이성 항체를 들 수 있다.
또한, 제1 도메인이, (d) 서열 번호 2, 90, 91, 92, 93, 94, 133, 134, 135 및 136으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 3, 95, 96, 97, 98, 99, 137, 138, 139, 140 및 141로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖거나, (e) 서열 번호 4로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 5로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖거나, 또는 (f) 서열 번호 6으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 7로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖는, 이중특이성 항체를 들 수 있다.
또한, 제2 도메인의 CDR이, 서열 번호 28, 서열 번호 29 또는 128, 및 서열 번호 30, 129 또는 130(VHCDR)으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 31 또는 131, 서열 번호 32 또는 132, 및 서열 번호 33(VLCDR)으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는, 이중특이성 항체가 바람직하다.
또한, 제2 도메인이, 서열 번호 8, 204, 205 및 206으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 9, 서열 번호 207 및 208로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖는, 이중특이성 항체가 바람직하다.
본 발명의 보다 바람직한 이중특이성 항체로서는, 제1 도메인의 CDR이, (a) 서열 번호 10, 서열 번호 11 또는 126, 및 서열 번호 12(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 13, 서열 번호 14 또는 127, 및 서열 번호 15(VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖거나, (b) 서열 번호 16-18(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 19-21 (VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖거나, 또는 (c) 서열 번호 22-24(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열번호 25-27(VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 것이며; 제2 도메인의 CDR이, 서열번호 28, 서열번호 29 또는 128, 및 서열번호 30, 서열번호 129 또는 130(VHCDR)으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열번호 31 또는 131, 서열번호 32 또는 132, 및 서열번호 33(VLCDR)으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 것인 이중특이성 항체를 들 수 있다.
더욱 바람직한 이중특이성 항체로서는, 제1 도메인이, (d) 서열 번호 2, 90, 91, 92, 93, 94, 133, 134, 135 및 136으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 3, 95, 96, 97, 98, 99, 137, 138, 139, 140 및 141로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖거나, (e) 서열 번호 4로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 5로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖거나, 또는 (f) 서열 번호 6으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 7로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖는 것이며, 제2 도메인이, 서열 번호 8, 서열 번호 204, 서열 번호 205 및 206으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 9, 서열 번호 207 및 208로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖는 이중특이성 항체를 들 수 있다.
상기와 같이, 본 발명의 이중특이성 항체의 형태로서는, 상기 2종의 항원에 대한 특이성을 유지하고 있는 한, 어떠한 형태이어도 좋으며, IgG 유사형이어도 저분자형이어도 좋다. 구체적으로는, Fc 영역 또는 헤테로 H쇄 등을 가지고 있어도 좋다.
상기 이중특이성 항체의 구체예로서는, 다음의 (I) 내지 (XXVII)로부터 선택되는 항체를 들 수 있다.
(I) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-A, VL-A, VH-B, VL-B의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 1: 서열번호 34).
(II) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VL-A, VH-A, VH-B, VL-B의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체.
(III) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-B, VL-B, VH-A, VL-A의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 3: 서열번호 36).
(IV) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-B, VL-B, VL-A, VH-A의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 4: 서열번호 37).
(V) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-B, VL-A, VH-A, VL-B의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체.
(VI) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VL-B, VH-A, VL-A, VH-B의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 6: 서열번호 39).
(VII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-A, VL-B, VH-B, VL-A의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체.
(VIII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VL-A, VH-B, VL-B, VH-A의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체.
(IX) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-A, VL-A, VH-B, VL-B 순서로 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 9: 서열 번호 42).
(X) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VL-A, VH-A, VH-B, VL-B 순서로 펩티드 링커를 통해 융합되어 있는 이중특이성 항체.
(XI) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-B, VL-B, VH-A, VL-A의 순서로 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 11: 서열 번호 44).
(XII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A) 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B) 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-B, VL-B, VL-A, VH-A의 순서로 펩티드 링커를 통해 융합되어 있는 이중특이성 항체.
(XIII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 IgG 항체와, 상기 IgG 항체의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv가 펩티드 링커를 통해 융합되어 있는 항체가 노브-인투-홀법에 따라 한쪽 Fc 도메인이 노브를 포함하고, 다른쪽 Fc 도메인이 홀을 포함함으로써 헤테로 회합하고 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 13: 서열번호 46, 서열번호 47, 서열 48).
(XIV) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 IgG 항체의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv가 펩티드 링커를 통해 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 14: 서열번호 48, 서열번호 49).
(XV) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 IgG 항체와, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv가 펩티드 링커를 통해 Fc와 융합되어 있는 scFv-Fc가 노브-인투-홀법에 따라 한쪽 Fc 도메인이 노브를 포함하고, 다른쪽 Fc 도메인이 홀을 포함함으로써 헤테로 회합하고 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 15: 서열번호 46, 서열번호 48, 서열번호 50).
(XVI) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 단쇄 Fv가 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 16: 서열 번호 48, 서열 번호 51).
(XVII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 C 말단에 CD3 항원에 특이적으로 결합하는 단쇄 Fv가 펩티드 링커를 통해 융합된 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 17: 서열번호 48, 서열번호 52).
(XVIII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 단쇄 Fv가 펩티드 링커를 통해 융합된 폴리펩티드에 추가로 펩티드 링커를 통해 CH3 도메인이 융합되어 있는 이중특이성 항체(항체 18: 서열 번호 48, 서열 번호 53).
(XIX) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 단쇄 Fv가 펩티드 링커를 통해 융합되고, 추가로 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 N 말단이 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 19: 서열 번호 48, 서열 번호 54).
(XX) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 N 말단이 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 20: 서열 번호 48, 서열 번호 55).
(XXI) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 IgG 항체이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 IgG의 중쇄 N 말단이 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(서열 번호 48, 서열 번호 56).
(XXII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 N 말단이 펩티드 링커를 통해 융합된 폴리펩티드에 추가로 펩티드 링커를 통해 CH3 도메인이 융합되어 있는 이중특이성 항체(항체 22: 서열 번호 48, 서열 번호 57).
(XXIII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 경쇄 N 말단이 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 23: 서열 번호 58, 서열 번호 59).
(XXIV) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 IgG 항체이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 IgG의 경쇄 N 말단이 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 24: 서열 번호 59, 서열 번호 60).
(XXV) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 경쇄 N 말단이 펩티드 링커를 통해 융합된 폴리펩티드와 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 C 말단에 추가로 펩티드 링커를 통해 CH3 도메인이 융합되어 있는 폴리펩티드로 이루어지는 이중특이성 항체(항체 25: 서열 번호 59, 서열 번호 61).
(XXVI) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 N 말단이 펩티드 링커를 통해 융합된 폴리펩티드와 CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 경쇄 N 말단이 펩티드 링커를 통해 융합된 폴리펩티드로 이루어지는 이중특이성 항체(항체 26: 서열번호 55, 서열번호 59).
(XXVII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 11 및 12로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 13, 14 및 15로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 29 및 30으로 표시되는 아미노산 서열을 포함하는 VH 도메인 및 서열 번호 31, 32 및 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인으로 이루어지는 단쇄 Fv이며, 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 단쇄 Fv가 펩티드 링커를 통해 융합된 폴리펩티드와 CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 경쇄 N 말단이 펩티드 링커를 통해 융합된 폴리펩티드로 이루어지는 이중특이성 항체(항체 27: 서열번호 51, 서열번호 59).
[표 2]
[표 3]
[표 4]
[표 5]
[표 6]
[표 7]
[표 8]
또한 상기 이중특이성 항체로서는, 또한 다음의 (XXVIII) 내지 (LIV)로부터 선택되는 항체인 것이 바람직하다.
(XXVIII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-A, VL-A, VH-B, VL-B의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 1: 서열번호 34).
(XXIX) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VL-A, VH-A, VH-B, VL-B의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체.
(XXX) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-B, VL-B, VH-A, VL-A의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 3: 서열 번호 36).
(XXXI) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-B, VL-B, VL-A, VH-A의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 4: 서열 번호 37).
(XXXII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-B, VL-A, VH-A, VL-B의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체.
(XXXIII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VL-B, VH-A, VL-A, VH-B의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 6: 서열 번호 39).
(XXXIV) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-A, VL-B, VH-B, VL-A의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체.
(XXXV) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VL-A, VH-B, VL-B, VH-A의 순서로 펩티드 링커를 통해 융합되어 있는 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체.
(XXXVI) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-A, VL-A, VH-B, VL-B의 순서로 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 9: 서열 번호 42).
(XXXVII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VL-A, VH-A, VH-B, VL-B의 순서로 펩티드 링커를 통해 융합되어 있는 이중특이성 항체.
(XXXVIII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-B, VL-B, VH-A, VL-A의 순서로 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 11: 서열 번호 44).
(XXXIX) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인(VH-A) 및 서열 번호 3으로 표시되는 VL 도메인(VL-A)으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인(VH-B) 및 서열 번호 9로 표시되는 VL 도메인(VL-B)으로 이루어지는 단쇄 Fv이며, N 말단측으로부터 VH-B, VL-B, VL-A, VH-A의 순서로 펩티드 링커를 통해 융합되어 있는 이중특이성 항체.
(XL) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 IgG 항체와, 상기 IgG 항체의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv가 펩티드 링커를 통해 융합되어 있는 항체가 노브-인투-홀법에 따라 한쪽 Fc 도메인이 노브를 포함하고 다른 쪽 Fc 도메인이 홀을 포함함으로써 헤테로 회합하고 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 13: 서열 번호 46, 서열 번호 47, 서열 번호 48).
(XLI) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 IgG 항체의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv가 펩티드 링커를 통해 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 14: 서열 번호 48, 서열 번호 49).
(XLII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 IgG 항체와, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv가 펩티드 링커를 통해 Fc에 융합되어 있는 scFv-Fc가 노브-인투-홀법에 따라 한쪽 Fc 도메인이 노브를 포함하고 다른 쪽 Fc 도메인이 홀을 포함함으로써 헤테로 회합하고 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 15: 서열 번호 46, 서열 번호 50).
(XLIII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 단쇄 Fv가 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 16: 서열 번호 48, 서열 번호 51).
(XLIV) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 단쇄 Fv가 펩티드 링커를 통해 융합된 폴리펩티드에 추가로 Fc가 융합되어 있는 이중특이성 항체. 경우에 따라서는 Fc 도메인이 Fc 수용체에 대한 결합을 저하시키는 한 개 또는 복수개의 아미노산 치환을 포함하는 Fc 도메인인 이중특이성 항체(항체 17: 서열 번호 48, 서열 번호 52).
(XLV) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 단쇄 Fv가 펩티드 링커를 통해 융합된 폴리펩티드에 추가로 펩티드 링커를 통해 CH3 도메인이 융합되어 있는 이중특이성 항체(항체 18: 서열 번호 48, 서열 번호 53).
(XLVI) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 단쇄 Fv가 펩티드 링커를 통해 융합되고, 추가로 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 N 말단이 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 19: 서열 번호 48, 서열 번호 54).
(XLVII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 N 말단이 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 20: 서열 번호 48, 서열 번호 55).
(XLVIII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 IgG 항체이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 IgG의 중쇄 N 말단이 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(서열 번호 48, 서열 번호 56).
(XLIX) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 N 말단이 펩티드 링커를 통해 융합된 폴리펩티드에 추가로 펩티드 링커를 통해 CH3 도메인이 융합되어 있는 이중특이성 항체(항체 22: 서열 번호 48, 서열 번호 57).
(L) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 경쇄 N 말단이 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 23: 서열 번호 58, 서열 번호 59).
(LI) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 IgG 항체이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 IgG의 경쇄 N 말단이 펩티드 링커를 통해 융합되어 있는 이중특이성 항체(항체 24: 서열 번호 59, 서열 번호 60).
(LII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 경쇄 N 말단이 펩티드 링커를 통해 융합된 폴리펩티드와 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 C 말단에 추가로 펩티드 링커를 통해 CH3 도메인이 융합되어 있는 폴리펩티드로 이루어지는 이중특이성 항체(항체 25: 서열 번호 59, 서열 번호 61).
(LIII) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 N 말단이 펩티드 링커를 통해 융합된 폴리펩티드와 CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 경쇄 N 말단이 펩티드 링커를 통해 융합된 폴리펩티드로 이루어지는 이중특이성 항체(항체 26: 서열 번호 59).
(LIV) 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 2로 표시되는 VH 도메인 및 서열 번호 3으로 표시되는 VL 도메인으로 이루어지는 Fab 단편이며, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 8로 표시되는 VH 도메인 및 서열 번호 9로 표시되는 VL 도메인으로 이루어지는 단쇄 Fv이며, 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 중쇄 C 말단에 CD3 항원에 특이적으로 결합하는 단쇄 Fv가 펩티드 링커를 통해 융합된 폴리펩티드와 CD3 항원에 특이적으로 결합하는 단쇄 Fv의 C 말단에 변이형 CALR 단백질에 특이적으로 결합하는 Fab 단편의 경쇄 N 말단이 펩티드 링커를 통해 융합된 폴리펩티드로 이루어지는 이중특이성 항체(항체 27: 서열 번호 51, 서열 번호 59).
[표 9]
본 발명의 이중특이성 항체의 바람직한 구체예는, 상기 (I) 내지 (XXVII)의 각 서열 또는 (XXVIII) 내지 (LIV)의 각 서열을 갖는 것으로서, 이들 영역 이외의 영역의 아미노산 서열은 특별히 제한되지 않는다. 또한, 본 발명의 항체는 인간화 항체 및 인간 이외의 포유 동물 항체이어도 좋다. 보다 구체적으로는, 인간 이외의 포유 동물, 예를 들어 랫트 항체의 중쇄, 경쇄의 가변 영역과 인간 항체의 중쇄, 경쇄의 정상 영역으로 이루어진 키메라 항체이어도 좋고, 이러한 항체는 랫트 항체의 가변 영역을 코딩하는 DNA를 인간 항체의 정상 영역을 코딩하는 DNA와 연결하고, 이것을 발현 벡터에 삽입하고 숙주에 도입하여 생산함으로써 얻을 수 있다. 인간화 항체의 일례로서, 이하에 VH1 내지 8 및 VL1 내지 7을 나타낸다(표 10-1 내지 10-2 및 표 11).
[표 10-1]
[표 10-2]
[표 11]
또한, 인간화 항체를 이용한 이중특이성 항체의 구체예로서는, 이하의 서열 등이 있지만, 이것으로 한정되는 것은 아니다(표 12).
[표 12]
또한, 인간화된 이중특이성 항체의 구체예로서 이하와 같은 항체를 들 수 있다(표 13-1 내지 13-2).
[A] 도 6 구조 1을 갖는 것으로서, 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 서열 번호 11 또는 126, 및 서열 번호 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A), 및 서열 번호 13, 서열 번호 14 또는 127, 및 서열 번호 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지고, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 서열 번호 29 또는 128, 및 서열 번호 30, 129 또는 130으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B), 및 서열 번호 31 또는 131, 서열 번호 32 또는 132, 및 서열 번호 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 이중특이성 항체(항체 56-99).
[B] 도 6 구조 2를 갖는 것으로서, 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 서열 번호 11 또는 126, 및 서열 번호 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A), 및 서열 번호 13, 서열 번호 14 또는 127, 및 서열 번호 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지고, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 서열 번호 29 또는 128, 및 서열 번호 30, 129 또는 130으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B), 및 서열 번호 31 또는 131, 서열 번호 32 또는 132, 및 서열 번호 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 이중특이성 항체(항체 100-104).
[C] 도 6 구조 3을 갖는 것으로서, 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 서열 번호 11 또는 126, 및 서열 번호 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A), 및 서열 번호 13, 서열 번호 14 또는 127, 및 서열 번호 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지고, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 서열 번호 29 또는 128, 및 서열 번호 30, 129 또는 130으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B), 및 서열 번호 31 또는 131, 서열 번호 32 또는 132, 및 서열 번호 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 이중특이성 항체(항체 105).
[D] 도 6 구조 4를 갖는 것으로서, 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 서열 번호 11 또는 126, 및 서열 번호 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A), 및 서열 번호 13, 서열 번호 14 또는 127, 및 서열 번호 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지고, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 서열 번호 29 또는 128, 및 서열 번호 30, 129 또는 130으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B), 및 서열 번호 31 또는 131, 서열 번호 32 또는 132, 및 서열 번호 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 이중특이성 항체(항체 106).
[E] 도 6 구조 5를 갖는 것으로서, 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 서열 번호 11 또는 126, 및 서열 번호 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A), 및 서열 번호 13, 서열 번호 14 또는 127, 및 서열 번호 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지고, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 서열 번호 29 또는 128, 및 서열 번호 30, 129 또는 130으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B), 및 서열 번호 31 또는 131, 서열 번호 32 또는 132, 및 서열 번호 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 이중특이성 항체(항체 107, 109-111).
[F] 도 6 구조 6을 갖는 것으로서, 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 서열 번호 11 또는 126, 및 서열 번호 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A), 및 서열 번호 13, 서열 번호 14 또는 127, 및 서열 번호 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지고, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 서열 번호 29 또는 128, 및 서열 번호 30, 129 또는 130으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B), 및 서열 번호 31 또는 131, 서열 번호 32 또는 132, 및 서열 번호 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 이중특이성 항체(항체 112, 113).
[G] 도 6 구조 7을 갖는 것으로서, 변이형 CALR 단백질에 특이적으로 결합하는 도메인이 서열 번호 10, 서열 번호 11 또는 126, 및 서열 번호 12로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-A), 및 서열 번호 13, 서열 번호 14 또는 127, 및 서열 번호 15로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-A)으로 이루어지고, CD3 항원에 특이적으로 결합하는 도메인이 서열 번호 28, 서열 번호 29 또는 128, 및 서열 번호 30, 129 또는 130으로 표시되는 아미노산 서열을 포함하는 VH 도메인(VH-B), 및 서열 번호 31 또는 131, 서열 번호 32 또는 132, 및 서열 번호 33으로 표시되는 아미노산 서열을 포함하는 VL 도메인(VL-B)으로 이루어지는 이중특이성 항체(항체 114).
[표 13-1]
[표 13-2]
또한, 다른 인간 항체 취득 방법도 알려져 있다. 예를 들어 인간 림프구를 in vitro에서 목적하는 항원 또는 목적하는 항원을 발현하는 세포로 감작하고, 감작 림프구를 인간 미에로마 세포, 예를 들어 U266과 융합시켜, 항원에 대한 결합 활성을 갖는 목적하는 인간 항체를 얻을 수도 있다(일본 특공평1-59878 참조). 또한, 인간 항체 유전자의 모든 레퍼토리를 갖는 트랜스제닉 동물을 목적하는 항원으로 면역함으로써 목적하는 인간 항체를 취득할 수 있다(WO93/12227, WO92/03918, WO94/02602, WO94/25585, WO96/34096, WO96/33735 참조). 또한, 인간 항체 라이브러리를 사용하여 패닝에 의해 인간 항체를 취득하는 기술도 알려져 있다. 예를 들어, 인간 항체의 가변 영역을 단쇄 항체(scFv)로서 파지 디스플레이법에 의해 파지의 표면에 발현시켜, 항원과 결합하는 파지를 선택할 수 있다. 선택된 파지의 유전자를 해석하면, 항원에 결합하는 인간 항체의 가변 영역을 코딩하는 DNA 서열을 결정할 수 있다. 항원에 결합하는 scFv의 DNA 서열이 밝혀지면, 해당 서열을 적당한 발현 벡터를 제작하여, 인간 항체를 취득할 수 있다. 이러한 방법은 이미 잘 알려져 있으며, WO92/01047, WO92/20791, WO93/06213, WO93/11236, WO93/19172, WO95/01438, WO95/15388을 참고할 수 있다.
이중특이성 항체는, 예를 들어 항변이 CALR 항체 및 항CD3 항체를 코딩하는 DNA와 발현 벡터를 이용하여 이중특이성 항체 발현 벡터를 구축하고, 발현 벡터를 CHO 세포 또는 HEK293 세포에 도입하여, 형질전환 세포를 얻을 수 있다. 이 형질전환 세포를 배양한 배양액을 크로마토그래피에 의해 정제하여 얻을 수 있다. 이중특이성 항체의 제작 방법은 이미 알려져 있으며, JP2019022497, JP2017137329, JP2015110628을 참고할 수 있다.
항체의 클래스는 특별히 한정되지 않으며, IgG, IgM, IgA, IgD 혹은 IgE 등 중 어느 아이소 타입을 갖는 항체를 포함한다. 정제의 용이성 등을 고려하면, 바람직하게는 IgG이다.
도메인 구조로서는, 항체 단편(플래그먼트) 등의 저분자화 항체나 항체 수식물을 들 수 있다. 항체 단편의 구체예로서는, 예를 들어, Fab, Fab', F(ab')2, Fv, scFv, Diabody 등을 들 수 있지만, 이것으로 한정되는 것은 아니다. 후술하는 실시예에서는, Fc 수용체에 대한 결합 친화성을 억제하는 것으로 여겨지는 228, 233-238, 265, 268, 309, 318, 328-331의 아미노산 변이를 갖는 인간 IgG의 H쇄 정상 영역이나 헤테로 H쇄를 위한 349, 354, 366, 368, 407 아미노산 변이를 나타내지만, 이것으로 한정되는 것은 아니다.
또한, 본 발명의 항체 중, 상기 (A) 또는 (B)의 폴리펩티드의 검출에 이용하는 항체는 이러한 폴리펩티드에 결합하면 된다. 한편, MPN의 예방 또는 치료에 사용하는 항체는, 상기 (A) 또는 (B)의 폴리펩티드에 결합하여, 세포 상해 활성을 갖는 항체가 바람직하다.
절단형의 변이형 CALR 단백질에 결합하는 항체로서는, 서열 번호 1로 표시되는 서열을 갖는 폴리펩티드쇄에 결합하는 항체이면 좋으나, 절단형의 변이형 CALR 단백질 중의 서열 번호 1로 표시되는 아미노산 서열 부분으로의 결합에서, 적어도 상기 항체 또는 그 기능적 단편 중 어느 하나와 경쟁하는 항체인 것이 바람직하다.
변이형 CALR-CD3 이중특이성 항체의 변이형 CALR 단백질에 대한 친화성은, 결합 상수(KD)가 10-7 M 이하이면 좋으며, 바람직하게는, 10-8 M 이하이다. 결합 상수는, 표면 플라즈몬 공명(SPR)법에 의해 측정하는 것이 바람직하지만, 간이적으로는 변이형 CALR 발현 세포에 대한 결합의 농도 의존성으로부터 플로우 사이토메트리 해석에 의해 구할 수도 있다.
여기서, 상기 검출에 이용되는 생체 시료로서는, 예를 들어 피험자로부터 채취된 생체 시료로서, (A) 또는 (B)의 폴리펩티드가 포함되는 시료를 들 수 있다. 구체적으로는, 전혈, 혈장, 혈청, 림프구, 림프액, 혈소판, 단핵구, 과립구, 타액이나 뇨 등의 체액, 골수 생검에 의해 얻어지는 조직 표본(골수액, 골수 조직) 등을 들 수 있다.
(A) 또는 (B)의 폴리펩티드의 검출 수단으로서는 액체 크로마토그래피 질량 분석법, 면역학적 방법, 특이적 결합능을 갖는 저/중분자나 핵산 혹은 핵산 유도체를 이용한 방법 등을 들 수 있는데, 간편하고 측정 감도가 높은 면역학적 방법이 바람직하다.
면역학적 방법으로서는, (A) 또는 (B)의 폴리펩티드쇄 중에 항원 인식 부위(에피토프)를 갖는 항체, 또는 그 기능적 단편을 이용하는 면역학적 방법이 바람직하다. (A) 또는 (B)의 폴리펩티드쇄 중의 에피토프로서는, (A) 또는 (B)의 폴리펩티드쇄 중에 존재하는 서열이면 좋으며, (A) 또는 (B)의 폴리펩티드쇄 중의 연속되는 3 아미노산 이상의 아미노산을 갖는 펩티드가 바람직하고, (A) 또는 (B)의 폴리펩티드쇄 중의 연속하는 5 아미노산 이상의 아미노산을 갖는 펩티드가 보다 바람직하다.
면역학적 방법에 이용하는 항체는, 예를 들어 (A) 또는 (B)의 폴리펩티드쇄 중의 연속하는 3 아미노산 이상의 아미노산을 갖는 펩티드를 항원으로서 이용하여 얻어지는 항체이면 되고, 폴리클로날 항체, 모노클로날 항체 혹은 이중특이성 항체이어도 좋으나, 이중특이성 항체가 바람직하다. 여기서 모노클로날 항체는, 예를 들어 (A) 또는 (B)의 폴리펩티드쇄 중의 연속하는 3 아미노산 이상의 아미노산을 갖는 펩티드를 감작함으로써 얻어진 항체 생산 세포와 골수종 세포를 세포 융합시켜 하이브리도마를 제작하고, 목적하는 항체를 생산하는 클론을 선택하고, 이 세포를 증식시켜 제조할 수 있다. 이중특이성 항체는, 항체를 코딩하는 DNA와 발현 벡터를 이용하여 이중특이성 항체 발현 벡터를 구축하고, 이것에 의해 형질전환시킨 세포를 증식시켜 제조할 수 있다.
면역학적 방법으로서는, 면역 크로마토그래피법, 효소 표지 면역학적 측정법(EIA), 방사 면역 측정법(RIA), 응집법, 비탁법, 플로우 사이토메트리법, 조직 면역 염색법, 웨스턴블롯 등의 면역 블롯법 등의 어느 것이든 이용할 수 있다. 여기서 면역 블롯법은, 폴리펩티드를 멤브레인에 전사하고, 멤브레인 상의 폴리펩티드를 항체로 검출하는 방법이다. 항체의 검출에는, 효소 표지, 형광 표지 등이 이용된다.
생체 시료 중에 (A) 또는 (B)의 폴리펩티드가 검출되면, 해당 생체 시료는 MPN 환자 유래의 생체 시료라고 판정할 수 있다.
본 발명의 MPN 진단약은, 상기 (A) 또는 (B)의 폴리펩티드쇄 중에 항원 인식부(에피토프)를 갖는 항체를 함유한다. 이 항체는 전술한 항체인 것이 바람직하다.
또한, 본 발명의 MPN 진단약에는, 상기 항체 외에 완충액, 측정 실시 프로토콜 등이 포함되어 있어도 좋다.
본 발명의 MPN 예방 또는 치료제 등의 의약 조성물은, 상기 항체를 함유하면 되는데, 약학적으로 허용할 수 있는 담체와 함께 혼합, 용해, 유화, 캡슐 봉입 또는 동결 건조 등에 의해 제제화하여 제조할 수 있다.
본 발명의 의약 조성물의 예방 또는 치료 대상이 되는 MPN은, 변이형 CALR이 검출되는 MPN인 것이 바람직하다.
경구 투여용의 바람직한 제제는, 본 발명 항체를, 물 혹은 생리 식염수와 같은 희석제에 유효량을 용해시킨 액제, 유효량을 고체나 과립으로서 포함하고 있는 캡슐제, 과립제, 산제, 또는 정제, 적당한 분산매 중에 유효량을 현탁시킨 현탁액제, 유효량을 용해시킨 용액을 적당한 분산매 중에 분산시켜 유화시킨 유제 등이다.
비경구 투여용으로는, 본 발명 항체를, 약학적으로 허용할 수 있는 용매, 부형제, 결합제, 안정화제, 분산제 등과 함께 주사용 용액, 현탁액, 유제, 크림제, 연고제, 흡입제, 좌제 등의 제형으로 제제화할 수 있다. 주사용 처방에서는, 본 발명의 항체를 수성 용액, 바람직하게는 행크스 용액, 링겔 용액, 또는 생리적 식염 완충액 등의 생리학적으로 적합성인 완충액 중에 용해할 수 있다. 또한, 본 발명의 의약은 유성 또는 수성 비히클 중에서 현탁액, 용액, 또는 유탁액 등의 형상을 취할 수 있다. 혹은, 본 발명 항체를 분체 형태로 제조하고, 사용 전에 멸균수 등을 이용하여 수용액 또는 현탁액을 조제해도 된다. 흡입에 의한 투여용으로는, 본 발명 항체를 분말화하여, 락토스 또는 전분 등의 적당한 기제와 함께 분말 혼합물로 만들 수 있다. 좌제 처방은, 본 발명 항체를 카카오버터 등 관용의 좌제 기제와 혼합함으로써 제조할 수 있다. 또한, 본 발명의 치료제는, 폴리머 매트릭스 등에 봉입하여 지속 방출용 제제로서 처방할 수 있다.
본 발명의 MPN 치료약의 스크리닝 방법은, 상기 (A) 또는 (B)의 폴리펩티드를 인식하는 항체나 단백질, 저/중분자, 핵산 혹은 핵산 유도체를 스크리닝하는 것을 특징으로 한다. 구체적으로는, (A) 또는 (B)의 폴리펩티드를 인식하는 항체를 이용한, 항체 의존성 세포 상해 활성이나 보체 의존성 세포 상해 활성을 갖는 항체 의약의 개발을 들 수 있다. 상기 본 발명의 항체가, 본 발명의 스크리닝법에 의해 얻어진 항체 의약의 예이다. 이 밖에도, (A) 또는 (B)의 폴리펩티드에 특이적으로 결합하는 저분자 혹은 중분자 화합물, 핵산 혹은 핵산 유도체, 단백질 등을 만들어 살세포 효과를 갖는 저분자 혹은 중분자 화합물, 핵산 혹은 핵산 유도체, 단백질 등을 종양 세포 특이적으로 송달하는 항종양약의 개발을 들 수 있다.
실시예
다음에 실시예를 들어 본 발명을 더욱 상세하게 설명하겠지만, 본 발명은 이들 실시예로 전혀 한정되지 않는다.
[시험예 1] 절단형을 포함하는 변이형 CALR 단백질을 인식하는 항체의 제작
서열 번호 1에 포함되는 아미노산 서열(RRMMRTKMR)의 C 말단 혹은 N 말단에 시스테인을 부가한 펩티드를 합성하고, 캐리어 단백질 키홀 림펫 헤모시아닌(Keyhole Limpet Hemocyanin; KLH)과 결합시킨 후, 8주령의 암컷 WKY/Izm 랫트에게 면역하고, 추가 면역 후에 림프구를 회수하였다. 림프구를 마우스 미에로마 SP2 세포와 PEG법에 의해 세포 융합시킨 후, 선택 배지에서 배양하여 하이브리도마를 취득하였다. 배양 상청 중의 항체의 특이성을, 면역한 펩티드나 정제 단백질을 이용한 ELISA법에 의해 스크리닝함으로써, 절단형을 포함하는 변이형 CALR 단백질에 결합하는 항체를 생산하는 하이브리도마(클론 B3, C6 및 G1)를 취득하였다. 이러한 하이브리드마에서 생산된 항체를 정제하여 시험에 이용하였다(클론 B3 항체, C6 항체 및 G1 항체).
[시험예 2] 변이형 CALR 발현 세포의 제작
인간 거핵아구성 백혈병 세포주 UT-7/TPO 세포에 Del 52 혹은 Ins 5형의 변이형 CALR 단백질을 발현시킴으로써 종양성으로 증식하는 UT-7/TPO CALR Del 52 세포 및 UT-7/TPO CALR Ins 5 세포와, 컨트롤로서 유전자 도입에 사용한 벡터만을 도입한 UT-7/TPO vec 세포를, 6.0×105개/mL의 밀도로 OptiMEM 배지(Thermo Fisher)에 파종하고, 5% CO2 존재 하에 37℃에서 32시간 배양하였다. 이 때, UT-7/TPO vec 세포는, 10ng/mL TPO를 함유하는 배지에서 배양하였다.
[시험예 3] 변이형 CALR 단백질을 인식하는 것의 확인
N 말단의 시그널 서열 하류에 FLAG 태그를 삽입한 Del 52형 혹은 Ins 5형의 변이형 CALR을 발현하는 UT-7/TPO 세포를 배양하고, 분비된 변이형 CALR 단백질을 포함한 배양 상청을 원심 분리(1,600gХ5분, 4℃)에 의해 제조하였다. 얻어진 배양 상청을 SDS와 환원제 존재 하에서 가열 처리한 후, SDS 폴리아크릴아미드 전기 영동법에 의해 겔 상에 전개한 후, 폴리비닐리덴디플루오라이드(PVDF)막에 전기적으로 전사하고, 5% 스킴 밀크를 포함하는 TBS-T 용액과 실온에서 1시간 반응시킨 후, 랫트 클론 B3, C6, G1 항체, 혹은 마우스 항DYKDDDDK tag 항체(후지필름 와코준야쿠)를 포함하는 5% BSA/TBS-T 용액과 4℃에서 하룻밤 반응시켰다. TBS-T 용액에 의한 세정을 실시한 후, 각각, 퍼옥시다제 표지된 염소 항랫트 IgG 항체(Jackson Immuno Research Inc.), 혹은 퍼옥시다제 표지된 염소 항마우스 IgG 항체(Jackson Immuno Research Inc.)를 포함하는 5% 스킴 밀크/TBS-T 용액과 실온에서 1시간 반응을 실시하였다. PVDF막을 TBS-T 용액으로 세정한 후에, 퍼옥시다아제 발광 시약과 반응시켜 얻어진 시그널을, FUSION 촬상 장치를 사용하여 검출하였다.
그 결과, 도 2에 나타내는 바와 같이 클론 B3, C6 및 G1 항체는 모두 전장형과 절단형의 변이형 CALR 단백질을 인식하는 것으로 확인되었다.
[시험예 4] 본 발명 항체의 서열 정보의 결정
본 발명의 항체 중쇄 및 경쇄 서열 정보를, 항체를 생산하는 세포로부터, PureLinc RNA Mini 키트(Thermo Fisher)를 사용하여, mRNA를 제조하였다. 얻어진 mRNA를 주형으로, 중쇄 혹은 경쇄 특이적인 역전사 프라이머를 이용하여 Rapid amplification of cDNA ends법에 의해 cDNA를 합성한 후, 플라스미드에 클로닝하였다. 얻어진 플라스미드를 생어 시퀀스 해석함으로써, 중쇄와 경쇄의 cDNA의 전장 서열을 결정하였다.
[실시예 1] 이중특이성 항체의 제조
재료 및 시험 방법
클론 B3, C6, G1 항체 및 항CD3 항체의 서열 정보(표 1-1 내지 1-4)를 바탕으로 한 이중특이성 항체를 코딩하는 DNA와 발현 벡터(pcDNA 3.4, Thermo Fisher)를 이용하여 이중특이성 항체 발현 벡터를 구축하였다. 상기 발현 벡터를 CHO 세포 또는 HEK293 세포에 ExpiFectamine CHO Transfection Kit(Thermo Fisher) 또는 ExpiFectamine 293 Transfection Kit(Thermo Fisher)에 의해 도입하고, 형질전환 세포를 배양한 후 원심 분리 및 필트레이션에 의해 세포를 제거하고, 배양액을 회수하였다. 항체의 정제는 니켈 결합 아가로스를 이용한 어피니티 크로마토그래피와 겔 여과 크로마토그래피의 조합, ProteinA 어피니티 크로마토그래피와 겔 여과 크로마토그래피의 조합 또는 CaptureSelect kappa XL 레진(Thermo Fisher)을 이용한 어피니티 크로마토그래피와 겔 여과 크로마토그래피의 조합으로 실시하였다. 또한, 상기와 같은 방법에 의해 특허문헌 4 및 특허문헌 2에 기재된 서열 정보를 바탕으로 한 이중특이성 항체(항체 28: 서열 번호 110 및 서열 번호 111, 항체 29: 서열 번호 112 및 서열 번호 113, 항체 30: 서열 번호 114 및 서열 번호 115) 및 B3 키메라 항체(서열 번호 48 및 서열 번호 60)를 제조하였다.
[실시예 2] 플로우 사이토메트리 해석에 의한 세포 표면의 변이형 CALR 단백질을 인식하는 것의 확인
재료 및 시험 방법
컨트롤로서 유전자 도입에 사용한 벡터만을 도입한 UT-7/TPO vec 세포, 변이형 CALR을 발현하는 UT-7/TPO CALR Ins 5 세포 및 UT-7/TPO CALR Del 52 세포를 소 태아 비동화 혈청(FBS) 10%를 포함하는 IMDM 배지를 이용하여 5% CO2 존재 하에서 37℃에서 배양하였다. 증식기 세포 5Х104개를 원심 분리(400gХ5분, 4℃) 후, FBS/PBS 용액 중에서 각종 항체를 5μg/mL의 농도로 제조하고, 빙상에서 30분간 반응시켰다. 반응 후, MACS buffer를 이용하여 2회 세포를 세정한 후 2차 항체로서 항인간 Fc 항체를 FBS/PBS 용액 중에서 2.5μg/mL의 농도로 제조하고, 빙상에서 30분간 반응시켰다. 반응 종료 후에 MACS buffer를 첨가하여 원심 분리(400gХ5분, 4℃)하고, 상청을 폐기함으로써 세포를 2회 세정하고, BD LSRFortessa X-20(BD Biosciences)을 이용하여 플로우 사이토메트리 해석에 의해 시그널을 정량하였다.
서열 번호 2의 VH쇄, 서열 번호 3의 VL쇄, 서열 번호 8의 VH쇄 및 서열 번호 9의 VL쇄를 이용하여 제작한 대표적인 항절단형 변이 CALR-CD3 이중특이성 항체를 이용하여, [a] UT-7/TPO vec 세포, [b] UT-7/TPO CALR Ins 5 세포 및 [c] UT-7/TPO CALR Del 52 세포를 플로우 사이토메트리 해석한 결과를 나타낸다.
그 결과, 도 3에 나타내는 바와 같이, 평가한 이중특이성 항체는, 변이형 CALR 단백질을 세포 표면 상에 발현하는 세포를 특이적으로 인식하는 것으로 확인되었다.
[실시예 3] 플로우 사이토메트리 해석에 의한 세포 표면의 CD3 항원을 인식하는 것의 확인
재료 및 시험 방법
건강한 인간 기증자로부터 단리된 말초혈 단핵 세포(PBMC)를 항CD3 항체(타카라바이오)로 4 내지 24시간 코팅한 플레이트에서 이틀간 배양한 후, IL-2와 10% FBS를 포함하는 RPMI-1640 배지(Sigma-Aldrich)에서 추가로 10 내지 21일간 배양하여 T-LAK 세포를 유도하였다. T-LAK 세포 5Х105개를 원심 분리(400gХ5분, 4℃) 후, FBS/PBS 용액 중에서 서열 번호 2의 VH쇄, 서열 번호 3의 VL쇄, 서열 번호 8의 VH쇄 및 서열 번호 9의 VL쇄를 이용하여 제작한 항절단형 변이 CALR-CD3 이중특이성 항체를 5μg/mL의 농도로 제조하고, 빙상에서 30분간 반응시켰다. 반응 후, MACS buffer를 이용하여 2회 세포를 세정한 후, 2차 항체로서 항인간 Fc 항체를 FBS/PBS 용액 중에서 5μg/mL 농도로 제조하고, 빙상에서 30분간 반응시켰다. 반응 종료 후 MACS buffer를 첨가하여 원심 분리(400gХ5분, 4℃)하고 상청을 폐기함으로써 세포를 2회 세정하고, BD LSRFortessa X-20(BD Biosciences)을 이용하여 플로우 사이토메트리 해석에 의해 시그널을 정량하였다.
그 결과, 도 4에 나타내는 바와 같이, 본 발명의 이중특이성 항체는 T-LAK 세포 표면에 발현되는 CD3 항원을 특이적으로 인식하는 것이 확인되었다.
[실시예 4] 표면 플라즈몬 공명 해석에 의한 항원 결합력의 평가
재료 및 시험 방법
표면 플라즈몬 공명 해석 장치 Biacore T200(GE 헬스케어)에 표면 플라즈몬 공명 해석용 센서 칩(GE 헬스케어)을 장진한 후, HBS-EP 버퍼(GE 헬스케어)로 평형화하였다. Acetate 5.5(GE 헬스케어)로 1μg/mL의 농도로 제조한, 서열 번호 2의 VH쇄, 서열 번호 3의 VL쇄, 서열 번호 8의 VH쇄 및 서열 번호 9의 VL쇄를 이용하여 제작한 항절단형 변이 CALR-CD3 이중특이성 항체를, Amine coupling kit(GE 헬스케어)를 이용하여 고정화량이 200RU가 되도록 고정화하였다. 이어서, HBS-EP 버퍼에 의해 20, 10, 5, 2.5, 1.25nM의 농도로 제조한, 서열 번호 1에 포함되는 아미노산 서열(RRMMRTKMR)의 N 말단에 시스테인을 부가한 펩티드를 이용하여, 표면 플라즈몬 공명을 측정하고, BiacoreT200 Evaluation Software에 의해 해리 상수를 취득하였다.
또 다른 방법으로서, Biolayer Interferometry 기술 및 표면 플라즈몬 공명 기술을 응용한 분자간 상호 작용 해석 시스템 BLItz(Fortebio사)를 이용하여 측정하였다. 구체적으로는, Anti-Penta-HIS 혹은 ProteinA의 바이오센서(Fortebio사)를 이용하여, 서열 번호 1의 N 말단에 Fc 영역 및 His 태그를 부가한 단백질을 0.1mg/mL의 농도로 고상화하였다. 이어서, 제작한 항체 1-114를 500, 100, 50nM의 농도로 제조하여 반응시켜, 해리 상수를 취득하였다.
그 결과, 도 5, 표 14 및 표 16-1 내지 16-2에 나타내는 바와 같이, 본 발명의 이중특이성 항체는 변이형 CALR 단백질과 강력하게 결합한다는 것을 알 수 있다.
[표 14]
[실시예 5] in vitro 세포 상해 활성 평가
재료 및 시험 방법
이중특이성 항체의 세포 상해 활성은 형광 색소 방출을 기반으로 한 세포 용해 어세이에서 측정되었다. 본 발명의 항체가 in vitro에서 면역 이펙터 세포에 의한 표적 세포의 세포 용해를 유도하는지를 확인하였다. 면역 이펙터 세포는 T-LAK 세포를 사용했는데, NK 세포, 마크로파지, 단구, 수상 세포, 또는 PBMC 등인 경우에도 매우 유사한 어세이를 사용할 수 있다.
변이형 CALR을 발현시킨 UT-7/TPO CALR Ins 5 세포를 약 10μM Calcein-AM(PromoKine)을 이용하여 37℃에서 30분간 표지하고, HBSS로 3회 세정하였다. 적절한 수의 표지 표적 세포를 카운트 후, 96웰 환저 배양 플레이트에 넣고 다양한 농도의 이중특이성 항체, 대조 단백질의 존재 하 또는 비존재 하, 또는 항체 미첨가에서 37℃에서 2시간 인큐베이션하였다. T-LAK 세포는 건강한 인간 기증자로부터 단리된 PBMC를 항CD3 항체(타카라바이오)로 4 내지 24시간 코팅한 플레이트에서 이틀간 배양한 후, IL-2와 10% FBS를 포함하는 RPMI-1640 배지에서 추가로 10 내지 21일간 배양하여 유도하였다. 면역 이펙터 세포와 표지 표적 세포의 비율을 10:1로 첨가하였다. 다른 면역 이펙터 세포: 표지 표적 세포비도 적절하다. 표지 표적 세포, 이중특이성 항체 및 면역 이펙터 세포를 함유하는 플레이트를, 5% CO2로 1 내지 6시간 동안 37℃에서 배양하였다. 1 내지 6시간 반응 후, 세포를 원심 분리(125rpm X 5분)하여 상청을 회수하였다. 그 후, 상청을 96웰 평저 배양 플레이트에 넣고 인큐베이션 배지에서의 방출된 색소를 형광 판독 장치(SynergyH1M, 바이오텍 재팬)로 485/526nm으로 흡광도를 측정하였다. 정규화를 위해서 표지 표적 세포의 최대 용해율(=100 %)은, 10ХLysis Solution의 첨가에 의해 얻어졌다. 최소 용해율(=0%)은 임의의 구축물 또는 항체를 포함하지 않고 표지 표적 세포를 인큐베이팅한 웰로부터 산출하였다. 다음 식을 이용하여 세포 용해율을 계산하였다: [(이중특이성 항체 존재 하에서의 종양 세포 용해율) - (이중특이성 항체 비존재 하에서의 종양 세포 용해율)] / [(최대 용해율) - (최소 용해율)]. S자형 용량 응답 곡선은 Prism Software(GraphPad Software Inc., San Diego)에 의해 계산되었으며, EC50값 (50% 효과 농도)이 산출되었다.
표 15에 나타내는 바와 같이, 본 발명의 이중특이성 항체는 변이형 CALR을 발현시킨 UT-7/TPO CALR Ins 5 세포에 대하여 세포 상해 활성을 나타냈다.
[표 15]
인간화된 항체(항체 56 내지 항체 114)에 대해서는 표 16-1 내지 16-2에 나타내는 바와 같이 변이형 CALR 단백질과 강력하게 결합하여, 변이형 CALR을 발현시킨 UT-7/TPO CALR Ins 5 세포에 대하여 세포 상해 활성을 나타냈다.
[표 16-1]
[표 16-2]
SEQUENCE LISTING
<110> JUNTENDO EDUCATIONAL FOUNDATION
Meiji Seika Pharma Co. Ltd.
<120> Bispecific antibodies that bind to cleaved form of mutant CALR-CD3 , and Pharmaceutical composition
<130> JUSM0030
<150> JP 2020-143551
<151> 2020-08-27
<160> 212
<170> PatentIn version 3.5
<210> 1
<211> 13
<212> PRT
<213> Homo sapiens
<400> 1
Arg Arg Met Met Arg Thr Lys Met Arg Met Arg Arg Met
1 5 10
<210> 2
<211> 119
<212> PRT
<213> Rattus norvegicus
<400> 2
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser
115
<210> 3
<211> 107
<212> PRT
<213> Rattus norvegicus
<400> 3
Asp Ile Gln Met Thr Gln Ser Pro Ala Ser Leu Ser Ala Ser Leu Gly
1 5 10 15
Glu Thr Val Ser Ile Glu Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ser Pro Gln Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Gln Phe Ser Leu Lys Ile Ser Gly Met Gln Pro
65 70 75 80
Glu Asp Glu Gly Asp Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu Asn
100 105
<210> 4
<211> 121
<212> PRT
<213> Rattus norvegicus
<400> 4
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
20 25 30
Phe Val His Trp Ile Lys Gln Gln Pro Gly Asp Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Tyr Pro Gly Asp Gly Asp Thr Glu Tyr Asn His Lys Phe
50 55 60
Asn Gly Lys Ser Thr Leu Thr Ala Asp Arg Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Tyr Asp Gly Arg Glu Val Met Asp Ala Trp Gly
100 105 110
Gln Gly Ala Ser Val Thr Val Ser Ser
115 120
<210> 5
<211> 112
<212> PRT
<213> Rattus norvegicus
<400> 5
Asp Val Val Leu Thr Gln Thr Pro Pro Thr Leu Ser Ala Thr Ile Gly
1 5 10 15
Gln Ser Val Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu Asp Ser
20 25 30
Asp Gly Glu Thr Tyr Leu Asn Trp Leu Leu Gln Arg Pro Gly Gln Ser
35 40 45
Pro Gln Leu Leu Ile Tyr Ser Val Ser Asn Leu Glu Ser Gly Val Pro
50 55 60
Asn Arg Phe Ser Gly Ser Gly Ser Glu Thr Asp Phe Thr Leu Lys Ile
65 70 75 80
Ser Gly Met Glu Ala Glu Asp Leu Gly Val Tyr Tyr Cys Met Gln Ala
85 90 95
Thr His Gly Pro Tyr Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys
100 105 110
<210> 6
<211> 121
<212> PRT
<213> Rattus norvegicus
<400> 6
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
20 25 30
Phe Val His Trp Ile Lys Gln Gln Pro Gly Asp Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Tyr Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Arg Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Tyr Asp Gly Arg Glu Val Met Asp Ala Trp Gly
100 105 110
Gln Gly Ala Ser Val Thr Val Ser Ser
115 120
<210> 7
<211> 112
<212> PRT
<213> Rattus norvegicus
<400> 7
Asp Val Val Leu Thr Gln Thr Pro Pro Thr Leu Ser Ala Thr Ile Gly
1 5 10 15
Gln Ser Val Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu Asp Ser
20 25 30
Asp Gly Glu Thr Tyr Leu Asn Trp Leu Leu Gln Arg Pro Gly Gln Cys
35 40 45
Pro Gln Leu Leu Ile Tyr Ser Val Ser Asn Leu Glu Ser Gly Val Pro
50 55 60
Asn Arg Phe Ser Gly Ser Gly Ser Glu Thr Asp Phe Thr Leu Lys Ile
65 70 75 80
Ser Gly Val Glu Ala Glu Asp Leu Gly Val Tyr Tyr Cys Met Gln Gly
85 90 95
Thr His Gly Pro Tyr Thr Phe Gly Ala Gly Thr Lys Leu Glu Leu Lys
100 105 110
<210> 8
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 8
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser
115
<210> 9
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 9
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met
20 25 30
Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr
35 40 45
Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser
50 55 60
Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu
65 70 75 80
Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr
85 90 95
Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr Arg
100 105
<210> 10
<211> 10
<212> PRT
<213> Rattus norvegicus
<400> 10
Gly Tyr Thr Phe Thr Arg Asn Phe Ile His
1 5 10
<210> 11
<211> 17
<212> PRT
<213> Rattus norvegicus
<400> 11
Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe Asn
1 5 10 15
Gly
<210> 12
<211> 10
<212> PRT
<213> Rattus norvegicus
<400> 12
Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr
1 5 10
<210> 13
<211> 11
<212> PRT
<213> Rattus norvegicus
<400> 13
Leu Ala Ser Glu Asp Ile Tyr Ser Tyr Leu Ala
1 5 10
<210> 14
<211> 7
<212> PRT
<213> Rattus norvegicus
<400> 14
Ala Ala Asn Arg Leu Gln Asp
1 5
<210> 15
<211> 9
<212> PRT
<213> Rattus norvegicus
<400> 15
Leu Gln Gly Ser Lys Phe Pro Tyr Thr
1 5
<210> 16
<211> 10
<212> PRT
<213> Rattus norvegicus
<400> 16
Gly Tyr Thr Phe Thr Ser Tyr Phe Val His
1 5 10
<210> 17
<211> 17
<212> PRT
<213> Rattus norvegicus
<400> 17
Trp Ile Tyr Pro Gly Asp Gly Asp Thr Glu Tyr Asn His Lys Phe Asn
1 5 10 15
Gly
<210> 18
<211> 12
<212> PRT
<213> Rattus norvegicus
<400> 18
Gly Asn Tyr Tyr Asp Gly Arg Glu Val Met Asp Ala
1 5 10
<210> 19
<211> 16
<212> PRT
<213> Rattus norvegicus
<400> 19
Arg Ser Ser Gln Ser Leu Leu Asp Ser Asp Gly Glu Thr Tyr Leu Asn
1 5 10 15
<210> 20
<211> 7
<212> PRT
<213> Rattus norvegicus
<400> 20
Ser Val Ser Asn Leu Glu Ser
1 5
<210> 21
<211> 9
<212> PRT
<213> Rattus norvegicus
<400> 21
Met Gln Ala Thr His Gly Pro Tyr Thr
1 5
<210> 22
<211> 10
<212> PRT
<213> Rattus norvegicus
<400> 22
Gly Tyr Thr Phe Thr Ser Tyr Phe Val His
1 5 10
<210> 23
<211> 17
<212> PRT
<213> Rattus norvegicus
<400> 23
Trp Ile Tyr Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe Asn
1 5 10 15
Gly
<210> 24
<211> 12
<212> PRT
<213> Rattus norvegicus
<400> 24
Gly Asn Tyr Tyr Asp Gly Arg Glu Val Met Asp Ala
1 5 10
<210> 25
<211> 16
<212> PRT
<213> Rattus norvegicus
<400> 25
Arg Ser Ser Gln Ser Leu Leu Asp Ser Asp Gly Glu Thr Tyr Leu Asn
1 5 10 15
<210> 26
<211> 7
<212> PRT
<213> Rattus norvegicus
<400> 26
Ser Val Ser Asn Leu Glu Ser
1 5
<210> 27
<211> 9
<212> PRT
<213> Rattus norvegicus
<400> 27
Met Gln Gly Thr His Gly Pro Tyr Thr
1 5
<210> 28
<211> 5
<212> PRT
<213> Mus musculus
<400> 28
Arg Tyr Thr Met His
1 5
<210> 29
<211> 17
<212> PRT
<213> Mus musculus
<400> 29
Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val Lys
1 5 10 15
Asp
<210> 30
<211> 10
<212> PRT
<213> Mus musculus
<400> 30
Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr
1 5 10
<210> 31
<211> 10
<212> PRT
<213> Mus musculus
<400> 31
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn
1 5 10
<210> 32
<211> 7
<212> PRT
<213> Mus musculus
<400> 32
Asp Thr Ser Lys Leu Ala Ser
1 5
<210> 33
<211> 9
<212> PRT
<213> Mus musculus
<400> 33
Gln Gln Trp Ser Ser Asn Pro Phe Thr
1 5
<210> 34
<211> 714
<212> PRT
<213> Artificial Sequence
<400> 34
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ala Ser
130 135 140
Leu Ser Ala Ser Leu Gly Glu Thr Val Ser Ile Glu Cys Leu Ala Ser
145 150 155 160
Glu Asp Ile Tyr Ser Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys
165 170 175
Ser Pro Gln Leu Leu Ile Phe Ala Ala Asn Arg Leu Gln Asp Gly Val
180 185 190
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Gln Phe Ser Leu Lys
195 200 205
Ile Ser Gly Met Gln Pro Glu Asp Glu Gly Asp Tyr Phe Cys Leu Gln
210 215 220
Gly Ser Lys Phe Pro Tyr Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu
225 230 235 240
Asn Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly
245 250 255
Val Val Gln Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly
260 265 270
Tyr Thr Phe Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly
275 280 285
Lys Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr
290 295 300
Asn Tyr Asn Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn
305 310 315 320
Ser Lys Asn Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp
325 330 335
Thr Gly Val Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu
340 345 350
Asp Tyr Trp Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly
355 360 365
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
370 375 380
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
385 390 395 400
Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln
405 410 415
Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys
420 425 430
Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr
435 440 445
Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr
450 455 460
Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly
465 470 475 480
Thr Lys Leu Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys
485 490 495
Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro
500 505 510
Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys
515 520 525
Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp
530 535 540
Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu
545 550 555 560
Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu
565 570 575
His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn
580 585 590
Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly
595 600 605
Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu
610 615 620
Leu Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr
625 630 635 640
Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn
645 650 655
Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe
660 665 670
Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn
675 680 685
Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr
690 695 700
Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
705 710
<210> 35
<211> 722
<212> PRT
<213> Artificial Sequence
<400> 35
Asp Ile Gln Met Thr Gln Ser Pro Ala Ser Leu Ser Ala Ser Leu Gly
1 5 10 15
Glu Thr Val Ser Ile Glu Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ser Pro Gln Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Gln Phe Ser Leu Lys Ile Ser Gly Met Gln Pro
65 70 75 80
Glu Asp Glu Gly Asp Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu Asn Gly Gly Gly Gly Ser
100 105 110
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Gln
115 120 125
Ser Gly Ala Glu Leu Val Lys Pro Gly Ser Ser Val Lys Ile Ser Cys
130 135 140
Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile Lys
145 150 155 160
Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro Gly
165 170 175
Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe Asn Gly Lys Ala Thr Leu
180 185 190
Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu
195 200 205
Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys Ala Arg Gly Asn Tyr Asn
210 215 220
Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly Val Met Val Thr Val Ser
225 230 235 240
Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly
245 250 255
Val Val Gln Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly
260 265 270
Tyr Thr Phe Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly
275 280 285
Lys Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr
290 295 300
Asn Tyr Asn Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn
305 310 315 320
Ser Lys Asn Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp
325 330 335
Thr Gly Val Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu
340 345 350
Asp Tyr Trp Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly
355 360 365
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
370 375 380
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
385 390 395 400
Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln
405 410 415
Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys
420 425 430
Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr
435 440 445
Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr
450 455 460
Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly
465 470 475 480
Thr Lys Leu Gln Ile Thr Arg Leu Glu Val Leu Phe Gln Gly Pro Asp
485 490 495
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
500 505 510
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
515 520 525
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
530 535 540
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
545 550 555 560
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
565 570 575
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
580 585 590
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
595 600 605
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
610 615 620
Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu
625 630 635 640
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
645 650 655
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
660 665 670
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
675 680 685
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
690 695 700
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
705 710 715 720
Gly Lys
<210> 36
<211> 714
<212> PRT
<213> Artificial Sequence
<400> 36
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
225 230 235 240
Arg Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Gln Ser Gly Ala Glu
245 250 255
Leu Val Lys Pro Gly Ser Ser Val Lys Ile Ser Cys Lys Ala Ser Gly
260 265 270
Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile Lys Gln Gln Pro Gly
275 280 285
Asn Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr
290 295 300
Glu Tyr Asn Gln Lys Phe Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys
305 310 315 320
Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp
325 330 335
Ser Ala Val Tyr Phe Cys Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe
340 345 350
Asp Tyr Trp Gly Gln Gly Val Met Val Thr Val Ser Ser Gly Gly Gly
355 360 365
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
370 375 380
Thr Gln Ser Pro Ala Ser Leu Ser Ala Ser Leu Gly Glu Thr Val Ser
385 390 395 400
Ile Glu Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr Leu Ala Trp Tyr
405 410 415
Gln Gln Lys Pro Gly Lys Ser Pro Gln Leu Leu Ile Phe Ala Ala Asn
420 425 430
Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly
435 440 445
Thr Gln Phe Ser Leu Lys Ile Ser Gly Met Gln Pro Glu Asp Glu Gly
450 455 460
Asp Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr Thr Phe Gly Pro
465 470 475 480
Gly Thr Lys Leu Glu Leu Asn Asp Lys Thr His Thr Cys Pro Pro Cys
485 490 495
Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro
500 505 510
Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys
515 520 525
Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp
530 535 540
Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu
545 550 555 560
Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu
565 570 575
His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn
580 585 590
Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly
595 600 605
Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu
610 615 620
Leu Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr
625 630 635 640
Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn
645 650 655
Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe
660 665 670
Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn
675 680 685
Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr
690 695 700
Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
705 710
<210> 37
<211> 714
<212> PRT
<213> Artificial Sequence
<400> 37
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
225 230 235 240
Arg Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ala Ser
245 250 255
Leu Ser Ala Ser Leu Gly Glu Thr Val Ser Ile Glu Cys Leu Ala Ser
260 265 270
Glu Asp Ile Tyr Ser Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys
275 280 285
Ser Pro Gln Leu Leu Ile Phe Ala Ala Asn Arg Leu Gln Asp Gly Val
290 295 300
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Gln Phe Ser Leu Lys
305 310 315 320
Ile Ser Gly Met Gln Pro Glu Asp Glu Gly Asp Tyr Phe Cys Leu Gln
325 330 335
Gly Ser Lys Phe Pro Tyr Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu
340 345 350
Asn Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
355 360 365
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
370 375 380
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
385 390 395 400
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
405 410 415
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
420 425 430
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
435 440 445
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
450 455 460
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
465 470 475 480
Val Met Val Thr Val Ser Ser Asp Lys Thr His Thr Cys Pro Pro Cys
485 490 495
Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro
500 505 510
Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys
515 520 525
Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp
530 535 540
Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu
545 550 555 560
Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu
565 570 575
His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn
580 585 590
Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly
595 600 605
Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu
610 615 620
Leu Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr
625 630 635 640
Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn
645 650 655
Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe
660 665 670
Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn
675 680 685
Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr
690 695 700
Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
705 710
<210> 38
<211> 717
<212> PRT
<213> Artificial Sequence
<400> 38
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
115 120 125
Thr Gln Ser Pro Ala Ser Leu Ser Ala Ser Leu Gly Glu Thr Val Ser
130 135 140
Ile Glu Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr Leu Ala Trp Tyr
145 150 155 160
Gln Gln Lys Pro Gly Lys Ser Pro Gln Leu Leu Ile Phe Ala Ala Asn
165 170 175
Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly
180 185 190
Thr Gln Phe Ser Leu Lys Ile Ser Gly Met Gln Pro Glu Asp Glu Gly
195 200 205
Asp Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr Thr Phe Gly Pro
210 215 220
Gly Thr Lys Leu Glu Leu Asn Gly Gly Gly Gly Ser Gly Gly Gly Gly
225 230 235 240
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Gln
245 250 255
Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser Ser Val Lys Ile Ser
260 265 270
Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile
275 280 285
Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro
290 295 300
Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe Asn Gly Lys Ala Thr
305 310 315 320
Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser
325 330 335
Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys Ala Arg Gly Asn Tyr
340 345 350
Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly Val Met Val Thr Val
355 360 365
Ser Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
370 375 380
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala
385 390 395 400
Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys
405 410 415
Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val
420 425 430
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr
435 440 445
Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln
450 455 460
Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile
465 470 475 480
Thr Arg Leu Glu Val Leu Phe Gln Gly Pro Asp Lys Thr His Thr Cys
485 490 495
Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu
500 505 510
Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu
515 520 525
Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys
530 535 540
Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys
545 550 555 560
Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu
565 570 575
Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys
580 585 590
Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys
595 600 605
Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser
610 615 620
Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys
625 630 635 640
Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln
645 650 655
Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly
660 665 670
Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln
675 680 685
Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn
690 695 700
His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
705 710 715
<210> 39
<211> 709
<212> PRT
<213> Artificial Sequence
<400> 39
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met
20 25 30
Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr
35 40 45
Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser
50 55 60
Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu
65 70 75 80
Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr
85 90 95
Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr Arg Gly Gly Gly Gly Ser
100 105 110
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
115 120 125
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
130 135 140
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
145 150 155 160
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
165 170 175
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
180 185 190
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
195 200 205
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
210 215 220
Val Met Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
225 230 235 240
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr
245 250 255
Gln Ser Pro Ala Ser Leu Ser Ala Ser Leu Gly Glu Thr Val Ser Ile
260 265 270
Glu Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr Leu Ala Trp Tyr Gln
275 280 285
Gln Lys Pro Gly Lys Ser Pro Gln Leu Leu Ile Phe Ala Ala Asn Arg
290 295 300
Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr
305 310 315 320
Gln Phe Ser Leu Lys Ile Ser Gly Met Gln Pro Glu Asp Glu Gly Asp
325 330 335
Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr Thr Phe Gly Pro Gly
340 345 350
Thr Lys Leu Glu Leu Asn Gly Gly Gly Gly Ser Gln Val Gln Leu Val
355 360 365
Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg Ser Leu Arg Leu Ser
370 375 380
Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr Thr Met His Trp Val
385 390 395 400
Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro
405 410 415
Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val Lys Asp Arg Phe Thr
420 425 430
Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe Leu Gln Met Asp Ser
435 440 445
Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys Ala Arg Tyr Tyr Asp
450 455 460
Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly Thr Pro Val Thr Val
465 470 475 480
Ser Ser Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala
485 490 495
Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr
500 505 510
Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val
515 520 525
Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val
530 535 540
Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser
545 550 555 560
Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu
565 570 575
Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala
580 585 590
Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro
595 600 605
Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln
610 615 620
Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala
625 630 635 640
Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr
645 650 655
Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu
660 665 670
Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser
675 680 685
Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser
690 695 700
Leu Ser Pro Gly Lys
705
<210> 40
<211> 709
<212> PRT
<213> Artificial Sequence
<400> 40
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
115 120 125
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
130 135 140
Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln
145 150 155 160
Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys
165 170 175
Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr
180 185 190
Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr
195 200 205
Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly
210 215 220
Thr Lys Leu Gln Ile Thr Arg Gly Gly Gly Gly Ser Gly Gly Gly Gly
225 230 235 240
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val
245 250 255
Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg Ser Leu Arg Leu Ser
260 265 270
Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr Thr Met His Trp Val
275 280 285
Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro
290 295 300
Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val Lys Asp Arg Phe Thr
305 310 315 320
Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe Leu Gln Met Asp Ser
325 330 335
Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys Ala Arg Tyr Tyr Asp
340 345 350
Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly Thr Pro Val Thr Val
355 360 365
Ser Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ala
370 375 380
Ser Leu Ser Ala Ser Leu Gly Glu Thr Val Ser Ile Glu Cys Leu Ala
385 390 395 400
Ser Glu Asp Ile Tyr Ser Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly
405 410 415
Lys Ser Pro Gln Leu Leu Ile Phe Ala Ala Asn Arg Leu Gln Asp Gly
420 425 430
Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Gln Phe Ser Leu
435 440 445
Lys Ile Ser Gly Met Gln Pro Glu Asp Glu Gly Asp Tyr Phe Cys Leu
450 455 460
Gln Gly Ser Lys Phe Pro Tyr Thr Phe Gly Pro Gly Thr Lys Leu Glu
465 470 475 480
Leu Asn Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala
485 490 495
Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr
500 505 510
Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val
515 520 525
Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val
530 535 540
Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser
545 550 555 560
Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu
565 570 575
Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala
580 585 590
Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro
595 600 605
Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln
610 615 620
Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala
625 630 635 640
Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr
645 650 655
Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu
660 665 670
Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser
675 680 685
Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser
690 695 700
Leu Ser Pro Gly Lys
705
<210> 41
<211> 717
<212> PRT
<213> Artificial Sequence
<400> 41
Asp Ile Gln Met Thr Gln Ser Pro Ala Ser Leu Ser Ala Ser Leu Gly
1 5 10 15
Glu Thr Val Ser Ile Glu Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ser Pro Gln Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Gln Phe Ser Leu Lys Ile Ser Gly Met Gln Pro
65 70 75 80
Glu Asp Glu Gly Asp Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu Asn Gly Gly Gly Gly Ser
100 105 110
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
115 120 125
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
130 135 140
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
145 150 155 160
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
165 170 175
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
180 185 190
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
195 200 205
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
210 215 220
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
225 230 235 240
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr
245 250 255
Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile
260 265 270
Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln
275 280 285
Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu
290 295 300
Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp
305 310 315 320
Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr
325 330 335
Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr
340 345 350
Lys Leu Gln Ile Thr Arg Gly Gly Gly Gly Ser Gln Val Gln Leu Gln
355 360 365
Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser Ser Val Lys Ile Ser
370 375 380
Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile
385 390 395 400
Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro
405 410 415
Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe Asn Gly Lys Ala Thr
420 425 430
Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser
435 440 445
Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys Ala Arg Gly Asn Tyr
450 455 460
Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly Val Met Val Thr Val
465 470 475 480
Ser Ser Leu Glu Val Leu Phe Gln Gly Pro Asp Lys Thr His Thr Cys
485 490 495
Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu
500 505 510
Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu
515 520 525
Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys
530 535 540
Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys
545 550 555 560
Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu
565 570 575
Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys
580 585 590
Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys
595 600 605
Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser
610 615 620
Arg Asp Glu Leu Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys
625 630 635 640
Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln
645 650 655
Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly
660 665 670
Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln
675 680 685
Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn
690 695 700
His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
705 710 715
<210> 42
<211> 493
<212> PRT
<213> Artificial Sequence
<400> 42
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ala Ser
130 135 140
Leu Ser Ala Ser Leu Gly Glu Thr Val Ser Ile Glu Cys Leu Ala Ser
145 150 155 160
Glu Asp Ile Tyr Ser Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys
165 170 175
Ser Pro Gln Leu Leu Ile Phe Ala Ala Asn Arg Leu Gln Asp Gly Val
180 185 190
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Gln Phe Ser Leu Lys
195 200 205
Ile Ser Gly Met Gln Pro Glu Asp Glu Gly Asp Tyr Phe Cys Leu Gln
210 215 220
Gly Ser Lys Phe Pro Tyr Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu
225 230 235 240
Asn Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly
245 250 255
Val Val Gln Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly
260 265 270
Tyr Thr Phe Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly
275 280 285
Lys Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr
290 295 300
Asn Tyr Asn Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn
305 310 315 320
Ser Lys Asn Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp
325 330 335
Thr Gly Val Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu
340 345 350
Asp Tyr Trp Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly
355 360 365
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
370 375 380
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
385 390 395 400
Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln
405 410 415
Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys
420 425 430
Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr
435 440 445
Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr
450 455 460
Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly
465 470 475 480
Thr Lys Leu Gln Ile Thr Arg His His His His His His
485 490
<210> 43
<211> 493
<212> PRT
<213> Artificial Sequence
<400> 43
Asp Ile Gln Met Thr Gln Ser Pro Ala Ser Leu Ser Ala Ser Leu Gly
1 5 10 15
Glu Thr Val Ser Ile Glu Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ser Pro Gln Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Gln Phe Ser Leu Lys Ile Ser Gly Met Gln Pro
65 70 75 80
Glu Asp Glu Gly Asp Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu Asn Gly Gly Gly Gly Ser
100 105 110
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Gln
115 120 125
Ser Gly Ala Glu Leu Val Lys Pro Gly Ser Ser Val Lys Ile Ser Cys
130 135 140
Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile Lys
145 150 155 160
Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro Gly
165 170 175
Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe Asn Gly Lys Ala Thr Leu
180 185 190
Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu
195 200 205
Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys Ala Arg Gly Asn Tyr Asn
210 215 220
Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly Val Met Val Thr Val Ser
225 230 235 240
Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly
245 250 255
Val Val Gln Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly
260 265 270
Tyr Thr Phe Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly
275 280 285
Lys Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr
290 295 300
Asn Tyr Asn Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn
305 310 315 320
Ser Lys Asn Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp
325 330 335
Thr Gly Val Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu
340 345 350
Asp Tyr Trp Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly
355 360 365
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
370 375 380
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
385 390 395 400
Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln
405 410 415
Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys
420 425 430
Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr
435 440 445
Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr
450 455 460
Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly
465 470 475 480
Thr Lys Leu Gln Ile Thr Arg His His His His His His
485 490
<210> 44
<211> 493
<212> PRT
<213> Artificial Sequence
<400> 44
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
225 230 235 240
Arg Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Gln Ser Gly Ala Glu
245 250 255
Leu Val Lys Pro Gly Ser Ser Val Lys Ile Ser Cys Lys Ala Ser Gly
260 265 270
Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile Lys Gln Gln Pro Gly
275 280 285
Asn Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr
290 295 300
Glu Tyr Asn Gln Lys Phe Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys
305 310 315 320
Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp
325 330 335
Ser Ala Val Tyr Phe Cys Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe
340 345 350
Asp Tyr Trp Gly Gln Gly Val Met Val Thr Val Ser Ser Gly Gly Gly
355 360 365
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
370 375 380
Thr Gln Ser Pro Ala Ser Leu Ser Ala Ser Leu Gly Glu Thr Val Ser
385 390 395 400
Ile Glu Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr Leu Ala Trp Tyr
405 410 415
Gln Gln Lys Pro Gly Lys Ser Pro Gln Leu Leu Ile Phe Ala Ala Asn
420 425 430
Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly
435 440 445
Thr Gln Phe Ser Leu Lys Ile Ser Gly Met Gln Pro Glu Asp Glu Gly
450 455 460
Asp Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr Thr Phe Gly Pro
465 470 475 480
Gly Thr Lys Leu Glu Leu Asn His His His His His His
485 490
<210> 45
<211> 493
<212> PRT
<213> Artificial Sequence
<400> 45
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
225 230 235 240
Arg Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ala Ser
245 250 255
Leu Ser Ala Ser Leu Gly Glu Thr Val Ser Ile Glu Cys Leu Ala Ser
260 265 270
Glu Asp Ile Tyr Ser Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys
275 280 285
Ser Pro Gln Leu Leu Ile Phe Ala Ala Asn Arg Leu Gln Asp Gly Val
290 295 300
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Gln Phe Ser Leu Lys
305 310 315 320
Ile Ser Gly Met Gln Pro Glu Asp Glu Gly Asp Tyr Phe Cys Leu Gln
325 330 335
Gly Ser Lys Phe Pro Tyr Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu
340 345 350
Asn Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
355 360 365
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
370 375 380
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
385 390 395 400
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
405 410 415
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
420 425 430
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
435 440 445
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
450 455 460
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
465 470 475 480
Val Met Val Thr Val Ser Ser His His His His His His
485 490
<210> 46
<211> 449
<212> PRT
<213> Artificial Sequence
<400> 46
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Cys Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Trp
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys
<210> 47
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 47
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Cys Thr
340 345 350
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Ser
355 360 365
Cys Ala Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Val Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly
450 455 460
Val Val Gln Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly
465 470 475 480
Tyr Thr Phe Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly
485 490 495
Lys Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr
500 505 510
Asn Tyr Asn Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn
515 520 525
Ser Lys Asn Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp
530 535 540
Thr Gly Val Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu
545 550 555 560
Asp Tyr Trp Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly
565 570 575
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
580 585 590
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
595 600 605
Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln
610 615 620
Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys
625 630 635 640
Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr
645 650 655
Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr
660 665 670
Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly
675 680 685
Thr Lys Leu Gln Ile Thr Arg
690 695
<210> 48
<211> 214
<212> PRT
<213> Artificial Sequence
<400> 48
Asp Ile Gln Met Thr Gln Ser Pro Ala Ser Leu Ser Ala Ser Leu Gly
1 5 10 15
Glu Thr Val Ser Ile Glu Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ser Pro Gln Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Gln Phe Ser Leu Lys Ile Ser Gly Met Gln Pro
65 70 75 80
Glu Asp Glu Gly Asp Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu Asn Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 49
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 49
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly
450 455 460
Val Val Gln Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly
465 470 475 480
Tyr Thr Phe Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly
485 490 495
Lys Gly Leu Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr
500 505 510
Asn Tyr Asn Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn
515 520 525
Ser Lys Asn Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp
530 535 540
Thr Gly Val Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu
545 550 555 560
Asp Tyr Trp Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly
565 570 575
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met
580 585 590
Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr
595 600 605
Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln
610 615 620
Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys
625 630 635 640
Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr
645 650 655
Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr
660 665 670
Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly
675 680 685
Thr Lys Leu Gln Ile Thr Arg
690 695
<210> 50
<211> 473
<212> PRT
<213> Artificial Sequence
<400> 50
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
225 230 235 240
Arg Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro
245 250 255
Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys
260 265 270
Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val
275 280 285
Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr
290 295 300
Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu
305 310 315 320
Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His
325 330 335
Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys
340 345 350
Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln
355 360 365
Pro Arg Glu Pro Gln Val Cys Thr Leu Pro Pro Ser Arg Glu Glu Met
370 375 380
Thr Lys Asn Gln Val Ser Leu Ser Cys Ala Val Lys Gly Phe Tyr Pro
385 390 395 400
Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn
405 410 415
Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu
420 425 430
Val Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val
435 440 445
Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln
450 455 460
Lys Ser Leu Ser Leu Ser Pro Gly Lys
465 470
<210> 51
<211> 474
<212> PRT
<213> Artificial Sequence
<400> 51
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg His His His His His His
465 470
<210> 52
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 52
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 53
<211> 580
<212> PRT
<213> Artificial Sequence
<400> 53
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Ala Ala Ala Gly Gly Gly Gln Pro Arg Glu Pro Gln
465 470 475 480
Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val
485 490 495
Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val
500 505 510
Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro
515 520 525
Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr
530 535 540
Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val
545 550 555 560
Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu
565 570 575
Ser Pro Gly Lys
580
<210> 54
<211> 701
<212> PRT
<213> Artificial Sequence
<400> 54
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Gln Ser
465 470 475 480
Gly Ala Glu Leu Val Lys Pro Gly Ser Ser Val Lys Ile Ser Cys Lys
485 490 495
Ala Ser Gly Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile Lys Gln
500 505 510
Gln Pro Gly Asn Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro Gly Asp
515 520 525
Gly Asp Thr Glu Tyr Asn Gln Lys Phe Asn Gly Lys Ala Thr Leu Thr
530 535 540
Ala Asp Lys Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr
545 550 555 560
Ser Glu Asp Ser Ala Val Tyr Phe Cys Ala Arg Gly Asn Tyr Asn Tyr
565 570 575
Glu Tyr Phe Asp Tyr Trp Gly Gln Gly Val Met Val Thr Val Ser Ser
580 585 590
Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys
595 600 605
Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr
610 615 620
Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser
625 630 635 640
Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser
645 650 655
Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr
660 665 670
Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys
675 680 685
Arg Val Glu Pro Lys Ser Cys His His His His His His
690 695 700
<210> 55
<211> 474
<212> PRT
<213> Artificial Sequence
<400> 55
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
225 230 235 240
Arg Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Gln Ser Gly Ala Glu
245 250 255
Leu Val Lys Pro Gly Ser Ser Val Lys Ile Ser Cys Lys Ala Ser Gly
260 265 270
Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile Lys Gln Gln Pro Gly
275 280 285
Asn Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr
290 295 300
Glu Tyr Asn Gln Lys Phe Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys
305 310 315 320
Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp
325 330 335
Ser Ala Val Tyr Phe Cys Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe
340 345 350
Asp Tyr Trp Gly Gln Gly Val Met Val Thr Val Ser Ser Ala Ser Thr
355 360 365
Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser
370 375 380
Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu
385 390 395 400
Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His
405 410 415
Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser
420 425 430
Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys
435 440 445
Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu
450 455 460
Pro Lys Ser Cys His His His His His His
465 470
<210> 56
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 56
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
225 230 235 240
Arg Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Gln Ser Gly Ala Glu
245 250 255
Leu Val Lys Pro Gly Ser Ser Val Lys Ile Ser Cys Lys Ala Ser Gly
260 265 270
Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile Lys Gln Gln Pro Gly
275 280 285
Asn Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr
290 295 300
Glu Tyr Asn Gln Lys Phe Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys
305 310 315 320
Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp
325 330 335
Ser Ala Val Tyr Phe Cys Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe
340 345 350
Asp Tyr Trp Gly Gln Gly Val Met Val Thr Val Ser Ser Ala Ser Thr
355 360 365
Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser
370 375 380
Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu
385 390 395 400
Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His
405 410 415
Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser
420 425 430
Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys
435 440 445
Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu
450 455 460
Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 57
<211> 580
<212> PRT
<213> Artificial Sequence
<400> 57
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
225 230 235 240
Arg Gly Gly Gly Gly Ser Gln Val Gln Leu Gln Gln Ser Gly Ala Glu
245 250 255
Leu Val Lys Pro Gly Ser Ser Val Lys Ile Ser Cys Lys Ala Ser Gly
260 265 270
Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile Lys Gln Gln Pro Gly
275 280 285
Asn Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr
290 295 300
Glu Tyr Asn Gln Lys Phe Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys
305 310 315 320
Ser Ser Ser Thr Ala Tyr Met Gln Leu Ser Ser Leu Thr Ser Glu Asp
325 330 335
Ser Ala Val Tyr Phe Cys Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe
340 345 350
Asp Tyr Trp Gly Gln Gly Val Met Val Thr Val Ser Ser Ala Ser Thr
355 360 365
Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser
370 375 380
Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu
385 390 395 400
Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His
405 410 415
Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser
420 425 430
Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys
435 440 445
Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu
450 455 460
Pro Lys Ser Cys Ala Ala Ala Gly Gly Gly Gln Pro Arg Glu Pro Gln
465 470 475 480
Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val
485 490 495
Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val
500 505 510
Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro
515 520 525
Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr
530 535 540
Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val
545 550 555 560
Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu
565 570 575
Ser Pro Gly Lys
580
<210> 58
<211> 228
<212> PRT
<213> Artificial Sequence
<400> 58
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys His His
210 215 220
His His His His
225
<210> 59
<211> 460
<212> PRT
<213> Artificial Sequence
<400> 59
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
225 230 235 240
Arg Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ala Ser
245 250 255
Leu Ser Ala Ser Leu Gly Glu Thr Val Ser Ile Glu Cys Leu Ala Ser
260 265 270
Glu Asp Ile Tyr Ser Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys
275 280 285
Ser Pro Gln Leu Leu Ile Phe Ala Ala Asn Arg Leu Gln Asp Gly Val
290 295 300
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Gln Phe Ser Leu Lys
305 310 315 320
Ile Ser Gly Met Gln Pro Glu Asp Glu Gly Asp Tyr Phe Cys Leu Gln
325 330 335
Gly Ser Lys Phe Pro Tyr Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu
340 345 350
Asn Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp
355 360 365
Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn
370 375 380
Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu
385 390 395 400
Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp
405 410 415
Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr
420 425 430
Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser
435 440 445
Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
450 455 460
<210> 60
<211> 449
<212> PRT
<213> Artificial Sequence
<400> 60
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys
<210> 61
<211> 334
<212> PRT
<213> Artificial Sequence
<400> 61
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Ala Ala
210 215 220
Ala Gly Gly Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro
225 230 235 240
Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val
245 250 255
Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly
260 265 270
Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp
275 280 285
Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp
290 295 300
Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His
305 310 315 320
Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
325 330
<210> 62
<211> 2142
<212> DNA
<213> Artificial Sequence
<400> 62
caggtgcaac tgcagcagtc cggggctgag ctggtgaagc ctggtagctc tgtaaagatc 60
tcttgcaagg caagcggcta cacttttacc cgaaacttca tccattggat caaacagcaa 120
ccaggcaatg gactagagtg gattggatgg atctttcctg gcgatgggga caccgaatac 180
aatcagaaat tcaacgggaa agccacctta actgctgata agtcttcctc aaccgcatac 240
atgcagttaa gcagcctgac atccgaggat tcagccgtgt acttttgtgc tagaggcaac 300
tacaattacg agtatttcga ttattggggc cagggcgtta tggtcaccgt gtcatccggt 360
ggtggcggga gtggcggagg tggctctggt ggtggaggat ctgatataca gatgacgcag 420
agtcccgcca gcttatctgc gtccctgggg gaaaccgtgt cgattgaatg cctagcaagt 480
gaggacatct atagctacct tgcatggtac caacagaaac ccggtaaaag tcctcagttg 540
ttgatatttg ccgccaaccg gttacaggac ggagtcccca gcaggttttc tgggtcaggg 600
agcggtacac agttttccct gaagatctca gggatgcagc cagaagacga gggcgattac 660
ttctgtctgc agggttctaa gttcccgtac accttcggac ctggcactaa gctggaactc 720
aatggcggcg gcggtagcca ggtccagctt gttcagtctg ggggaggggt agtgcaacca 780
ggaagatccc tgaggctgtc atgcaaagcc tccgggtata cattcacccg ctatacgatg 840
cattgggtga gacaggcacc gggaaagggg cttgaatgga tcggctatat taacccatca 900
agaggctaca ctaactataa ccagaaagtg aaagaccggt ttactatctc gcgtgataac 960
agcaaaaaca ctgccttctt gcagatggat agcctgaggc cagaggacac aggcgtgtat 1020
ttttgtgcgc ggtattatga cgaccattac tcgctcgact attgggggca aggcactcct 1080
gtcaccgtca gctctggagg cgggggaagt ggaggaggag ggtccggtgg cgggggatca 1140
gacatccaaa tgactcagag cccctcaagt ctgtcagctt cggtgggcga tcgcgtcacg 1200
attacttgta gcgccagtag tagcgttagc tacatgaact ggtatcagca aacaccaggt 1260
aaagccccca aacgctggat ttatgacacc agcaaattgg cttctggagt gcctagtcgt 1320
tttagcggat ctggatcagg cacagactac accttcacca tttcctccct tcaacccgag 1380
gacatagcga catactactg tcagcagtgg agttccaatc cattcacgtt tggtcaagga 1440
acgaagctgc agataaccag agacaagact cacacttgcc ctccttgtcc tgcccccgaa 1500
gccgccggcg gcccttcagt atttctcttt ccaccgaaac ctaaggacac attgatgatc 1560
tcacgcactc cagaagtgac ctgcgtggtg gttgatgtct cacacgaaga tcctgaggtg 1620
aaattcaact ggtacgtaga tggcgtggaa gtccataacg cgaagacaaa gcccagagag 1680
gagcagtata attcgaccta tcgggtggtt tcggtactga ccgtcctgca tcaggactgg 1740
cttaacggca aggagtacaa gtgcaaggtt tctaataaag ccctcccagc tcccatcgag 1800
aaaacaatca gcaaggctaa gggccaaccc agggaacccc aagtctacac tttgccaccg 1860
agtcgtgacg agctcacaaa aaatcaggtg tctttaactt gcctcgtaaa gggcttttat 1920
cccagcgaca ttgccgtcga gtgggaatcg aatggccagc cagaaaacaa ctacaagact 1980
actccacccg tgctcgactc agacggctcc tttttcctgt actccaaact tactgtggat 2040
aagagtagat ggcagcaggg caatgtgttc tcctgttcag tgatgcatga agcccttcac 2100
aaccattaca cacagaaatc cttgtctctg tccccaggca ag 2142
<210> 63
<211> 2166
<212> DNA
<213> Artificial Sequence
<400> 63
gatatccaga tgacgcagag ccctgcttcc ctgtccgcca gcttgggcga aacagtgagc 60
atcgaatgtc tggcgtccga ggatatctac agctacctgg cttggtacca gcagaaaccc 120
gggaagtcac ctcagttgct gatatttgcc gctaacaggc tccaggatgg ggtgccaagc 180
agattttcag ggtccgggag tgggacgcag ttcagcctca aaatctccgg gatgcagccc 240
gaagacgaag gggactactt ttgcctccaa ggatctaagt ttccgtacac tttcggacct 300
ggaaccaaac ttgagctgaa tggcggcggc ggctccggcg gcggtggatc cggggggggc 360
gggagccagg tccaactgca gcagtctggc gccgaactcg tcaagccggg cagtagtgtg 420
aagatctctt gtaaagcaag cggctatacc tttacccgga attttattca ctggattaag 480
cagcaaccag gcaatggcct agagtggata ggatggatct ttccaggcga tggtgacaca 540
gaatacaatc agaagttcaa tggcaaagca acactgactg ccgacaaaag cagtagcact 600
gcctacatgc agctctcatc cttaacctca gaggactcag ccgtctactt ctgcgctaga 660
ggaaactaca actacgagta cttcgactac tggggccaag gcgtaatggt gactgtgtct 720
tcgggagggg gaggttcaca ggttcagctg gtgcagtctg gaggcggagt ggtccaacca 780
ggtcgctccc tgaggctgag ttgcaaggca tccggttata ccttcacccg ctacactatg 840
cactgggttc gacaagctcc aggtaaaggg ctcgaatgga ttgggtatat caacccttct 900
cgggggtata ccaactataa ccagaaggtt aaagaccggt tcaccattag ccgggataac 960
tctaagaaca ctgcatttct gcagatggat tccctcagac ccgaagatac gggtgtgtac 1020
ttctgtgcca gatactacga tgaccactac agcttggact attgggggca aggaactcct 1080
gtaaccgtga gcagtggagg agggggctct ggtggaggtg gatctggcgg aggaggctcc 1140
gacatacaga tgacccagtc tccctcgtcc ttgtccgcct ccgtaggaga tcgggtgact 1200
atcacctgtt cagcatcctc gtcagtgagc tatatgaact ggtatcaaca aacaccaggg 1260
aaagctccga agcgctggat ctacgatacc agcaagttag cgtcaggcgt cccctctcga 1320
tttagtggct ctgggtcagg gacagactat acatttacga tctcaagcct tcaacctgag 1380
gacattgcca cgtattattg ccagcagtgg tcttctaatc cattcacctt tggtcagggg 1440
actaaactgc agattactag gttggaggta ctcttccaag gtcctgacaa gacacatact 1500
tgtcccccat gtcccgctcc agaattgctt ggtggtccaa gcgtattcct atttcccccg 1560
aaacccaagg atactctcat gatatcacgt acacccgaag tgacatgcgt tgtcgtagac 1620
gttagtcatg aggatcctga ggtgaaattc aactggtatg tggacggcgt tgaagtgcac 1680
aatgccaaga caaagccacg tgaggaacag tacaatagca cctatagggt ggtttcagtg 1740
ttaacagtcc tgcatcagga ttggcttaat ggcaaggagt acaagtgcaa agtctcgaac 1800
aaggcactgc ctgctccgat tgagaagaca atctcgaaag cgaagggaca gcctagagaa 1860
ccacaggtgt acacactccc tcccagtagg gacgagctaa caaagaatca ggtgagctta 1920
acctgcctcg tgaaaggctt ttatccctcc gatattgcag tcgagtggga gtccaacggt 1980
caacccgaga acaactataa gacaactccc cctgtgttgg acagtgacgg atccttcttc 2040
ctgtatagca aacttaccgt cgataaaagt cgctggcagc agggaaatgt tttcagttgc 2100
agcgtgatgc atgaggccct gcacaatcac tatacccaga agagtctttc tctatctcct 2160
ggcaaa 2166
<210> 64
<211> 2142
<212> DNA
<213> Artificial Sequence
<400> 64
caggttcaac tggtgcagtc cggcggtggc gtggtgcaac ctggcagatc cttacggctg 60
tcttgtaagg catctggcta cactttcacc cggtatacga tgcattgggt gaggcaggca 120
ccaggaaagg ggttggagtg gatcggttac attaatccca gccgaggcta taccaactat 180
aaccagaagg tcaaagacag gtttacaatc agccgagaca atagcaagaa taccgccttt 240
cttcagatgg actccctaag acctgaggac actggcgtgt atttctgcgc ccgttattac 300
gatgaccact actccctgga ctattggggc caggggaccc cggtaacagt gtcttccgga 360
ggcggcggat ctggcggagg tggatccggc ggcggtgggt ccgatatcca aatgactcag 420
tcaccgagca gtctgtccgc cagcgttggg gacagagtga ccatcacatg cagtgctagt 480
tcctccgtct cttacatgaa ttggtatcag cagactccgg gtaaggcgcc taaaaggtgg 540
atttacgata cctccaagct cgcatccggt gttccttcca gatttagcgg gtccggctct 600
gggactgact acacattcac cataagtagc ctacaacccg aagatatcgc aacctattac 660
tgtcagcagt ggtcttcgaa tccttttacg tttggacagg gaaccaaact gcagattaca 720
cggggagggg gcggctctca agtgcagtta caacagtcgg gcgctgaact tgtgaaacca 780
ggctcttcag tcaagatcag ttgcaaagcc tctggctata cattcactcg caatttcatc 840
cactggataa agcagcaacc tggaaatggc ctggaatgga taggatggat tttccccggt 900
gatggcgata cagagtacaa ccagaagttc aacgggaaag ctaccctcac tgccgataag 960
tccagttcta ccgcatacat gcagcttagt agcttgacaa gtgaagatag cgctgtctac 1020
ttttgcgcca gaggaaacta caattacgag tattttgact actggggcca aggggtcatg 1080
gtcacagtta gctcaggggg aggcgggtca ggagggggag ggagcggagg cggtggcagc 1140
gacattcaga tgactcagag ccccgcttct ctttccgcct cactcgggga gactgtgagc 1200
atcgagtgtc tcgcaagcga ggatatctat tcctatctgg cttggtacca gcagaaaccc 1260
ggcaaatcgc cacagctctt gattttcgcc gcgaaccggc tgcaggatgg ggttcctagc 1320
cgcttcagcg gttccgggag cggaacacag ttctcactga aaatttcagg gatgcagccc 1380
gaggacgaag gtgactactt ttgtctgcaa gggtcgaagt tcccctatac gttcggtcca 1440
ggaaccaagc tggagctcaa cgacaagact cacacttgcc ctccttgtcc tgcccccgaa 1500
gccgccggcg gcccttcagt atttctcttt ccaccgaaac ctaaggacac attgatgatc 1560
tcacgcactc cagaagtgac ctgcgtggtg gttgatgtct cacacgaaga tcctgaggtg 1620
aaattcaact ggtacgtaga tggcgtggaa gtccataacg cgaagacaaa gcccagagag 1680
gagcagtata attcgaccta tcgggtggtt tcggtactga ccgtcctgca tcaggactgg 1740
cttaacggca aggagtacaa gtgcaaggtt tctaataaag ccctcccagc tcccatcgag 1800
aaaacaatca gcaaggctaa gggccaaccc agggaacccc aagtctacac tttgccaccg 1860
agtcgtgacg agctcacaaa aaatcaggtg tctttaactt gcctcgtaaa gggcttttat 1920
cccagcgaca ttgccgtcga gtgggaatcg aatggccagc cagaaaacaa ctacaagact 1980
actccacccg tgctcgactc agacggctcc tttttcctgt actccaaact tactgtggat 2040
aagagtagat ggcagcaggg caatgtgttc tcctgttcag tgatgcatga agcccttcac 2100
aaccattaca cacagaaatc cttgtctctg tccccaggca ag 2142
<210> 65
<211> 2142
<212> DNA
<213> Artificial Sequence
<400> 65
caagtgcaac tcgtccagtc cggtggaggc gtagtacagc caggcagatc attgagactg 60
agctgcaagg ccagcgggta cacttttacg cgctacacta tgcattgggt gagacaggca 120
ccaggcaagg ggttggaatg gatagggtac atcaatccca gccgcggata taccaattac 180
aatcagaagg tcaaagatcg gttcaccatt tctagggata acagcaagaa cactgccttc 240
ctgcagatgg actctctgcg gcctgaggat actggggtgt acttctgtgc tcgctactac 300
gacgaccact attccctaga ttactgggga cagggcaccc cagtcacagt ttcgtcagga 360
ggaggtgggt ccggcggagg gggtagcggg ggcggaggct cagatatcca gatgactcag 420
agtccctcga gcctttctgc ttccgtaggc gatcgggtga ccatcacttg ttctgcgtcc 480
agcagtgtca gttacatgaa ctggtatcaa cagactccag ggaaagctcc caaaaggtgg 540
atctatgaca caagtaagtt ggccagcggc gtcccctcgc gcttcagtgg gtctggctcc 600
ggcaccgact atacctttac aatctcaagc cttcagcccg aagacattgc tacatactac 660
tgtcagcagt ggtcaagtaa cccattcacc ttcgggcagg gcacaaagct ccagattaca 720
cgagggggag gaggcagcga catccaaatg acccagagcc ccgctagctt gagcgccagt 780
cttggcgaga ctgtgtctat agagtgctta gcctctgagg atatctactc ttatctggca 840
tggtatcagc agaagcctgg gaaatcccct cagctgctga tctttgccgc gaatcggcta 900
caggatggag tcccttctcg ttttagtggc tctggcagtg gtacgcaatt ttccctgaag 960
atctcaggca tgcagccgga agacgagggc gactatttct gcttacaggg cagcaaattt 1020
ccctatacct tcggtccggg tacaaaactt gagctgaatg gtgggggggg ctccgggggt 1080
ggcgggtcag gcggcggcgg atcccaggtt cagctgcagc agtcaggagc tgaactggtg 1140
aaacccggat cgagcgttaa gatttcttgc aaagcatcag ggtatacgtt tacgcgaaac 1200
ttcatccact ggattaagca gcagccaggt aacggcttgg agtggatagg ctggattttt 1260
cccggagacg gagacaccga gtataaccag aagttcaatg gcaaggcaac actgacagct 1320
gacaagtcca gtagcacagc ctacatgcaa ctgtcttcac tgactagcga agattcagcc 1380
gtctactttt gcgcacgggg gaattacaac tacgagtact tcgactattg gggtcaaggc 1440
gttatggtga ctgtgagttc cgataagaca catacctgtc ctccatgccc tgctcctgaa 1500
gctgctggag gtcccagcgt ctttttgttt cctccaaaac cgaaagacac actgatgatt 1560
tcccgtaccc cggaagttac ctgtgtggtg gtggatgttt ctcacgagga tccggaagtg 1620
aagttcaact ggtatgttga tggtgtagag gtccacaatg cgaagaccaa acctagggag 1680
gagcaataca actccaccta tagggtggtc agcgtgctaa ctgtgctcca tcaggactgg 1740
ctgaatggga aggagtacaa gtgcaaagtc tccaataaag cattacctgc accaatcgag 1800
aaaaccatct ccaaggccaa aggacaacca agagaacctc aggtgtacac actgccccca 1860
tccagagatg agctcaccaa aaaccaggtg tctctgactt gcctcgtaaa gggattctat 1920
cccagtgaca ttgccgtgga atgggagtcc aatggacaac ccgaaaacaa ctacaagaca 1980
accccacctg tgctggactc ggatggtagc ttcttcctgt attctaagct cacggtggat 2040
aaatctaggt ggcagcaggg gaatgtgttt agttgtagcg taatgcatga agccttacac 2100
aaccactata cgcagaaatc cctttcactg tcacctggta ag 2142
<210> 66
<211> 2151
<212> DNA
<213> Artificial Sequence
<400> 66
caggtccagt tggtccaatc tggaggcggt gtagttcagc ctgggaggtc tttacgcctg 60
agctgtaaag caagcggata tacattcacc cggtacacca tgcactgggt gagacaggct 120
cccggaaagg gacttgagtg gatagggtat atcaacccgt ctcgtggtta taccaactac 180
aaccagaagg tgaaagacag attcaccatc tctagggaca actccaagaa cacagcgttt 240
ctgcagatgg atagcttacg gccagaggat actggcgtgt atttctgcgc cagatactac 300
gatgaccact acagcctgga ttattggggc cagggtaccc ctgtgactgt ctcgtcaggc 360
gggggaggta gtgatatcca gatgacccag tccccagctt ctctatccgc ttcattggga 420
gaaaccgttt ccattgaatg tctggcttct gaggacattt acagctacct ggcgtggtat 480
cagcagaaac ccgggaaatc ccctcagctc ctcattttcg ctgccaatcg cctgcaagat 540
ggggttccat cccggtttag cgggagcggg tctggaaccc agttctccct gaagatctcc 600
ggcatgcaac ctgaggatga gggggactac ttttgcctgc aggggagcaa attcccctat 660
acatttggtc cgggtacgaa actggagctc aatggaggtg ggggatccgg aggcggagga 720
agcggcggag ggggcagcgg ggggggtggt agtcaggtgc agctacaaca gagtggagct 780
gagctggtca agcccgggag tagtgtcaag atttcctgca aagccagtgg atatacgttc 840
acgcgaaatt tcattcactg gattaagcag cagccaggca acggcttaga gtggatcgga 900
tggatctttc ctggggatgg tgataccgag tataaccaga aattcaatgg taaagccact 960
ctaacagccg ataagagcag tagcactgcc tatatgcaat tgtcatccct aacctctgaa 1020
gacagtgcag tgtacttctg tgcacgaggg aattacaatt atgagtactt cgactattgg 1080
gggcagggag ttatggtaac cgtgagcagt ggaggtggtg ggagcgacat acagatgact 1140
caatctccta gctctctgtc agcaagtgtg ggagatcgag tgaccataac gtgcagcgcc 1200
tccagctcag tctcatacat gaactggtac caacagacgc caggaaaagc acccaaacgg 1260
tggatttacg acacatcgaa gctggccagt ggggtgccgt ctcgcttctc cgggtctggc 1320
tcaggcaccg actacacctt tacaatctca tctctgcagc ccgaagatat agccacatat 1380
tattgtcaac agtggagcag caatcccttt acatttggcc aaggcaccaa gctccagatt 1440
acgaggctgg aagtgctgtt tcaaggccct gacaagactc acacttgccc tccttgtcct 1500
gcccccgaag ccgccggcgg cccttcagta tttctctttc caccgaaacc taaggacaca 1560
ttgatgatct cacgcactcc agaagtgacc tgcgtggtgg ttgatgtctc acacgaagat 1620
cctgaggtga aattcaactg gtacgtagat ggcgtggaag tccataacgc gaagacaaag 1680
cccagagagg agcagtataa ttcgacctat cgggtggttt cggtactgac cgtcctgcat 1740
caggactggc ttaacggcaa ggagtacaag tgcaaggttt ctaataaagc cctcccagct 1800
cccatcgaga aaacaatcag caaggctaag ggccaaccca gggaacccca agtctacact 1860
ttgccaccga gtcgtgacga gctcacaaaa aatcaggtgt ctttaacttg cctcgtaaag 1920
ggcttttatc ccagcgacat tgccgtcgag tgggaatcga atggccagcc agaaaacaac 1980
tacaagacta ctccacccgt gctcgactca gacggctcct ttttcctgta ctccaaactt 2040
actgtggata agagtagatg gcagcagggc aatgtgttct cctgttcagt gatgcatgaa 2100
gcccttcaca accattacac acagaaatcc ttgtctctgt ccccaggcaa g 2151
<210> 67
<211> 2127
<212> DNA
<213> Artificial Sequence
<400> 67
gatatccaga tgactcaaag tccctcctct cttagcgcaa gcgtaggaga tcgggtgacc 60
attacatgct ctgcatcgag ctcagtatca tacatgaatt ggtaccagca gacaccagga 120
aaagccccga agcggtggat ttatgacact agtaaactcg cttctggagt cccaagccgc 180
ttcagtgggt ctggaagtgg gacagactat actttcacaa tcagcagtct acagccagag 240
gacattgcta cttactactg ccaacagtgg tcttccaacc ctttcacctt tggccagggc 300
actaaattgc agattaccag aggtggaggt ggatcccagg tgcagttaca gcagtctggc 360
gctgaactgg tgaaacccgg gtcatctgtg aagatatcct gcaaggctag cggatataca 420
ttcacccgaa acttcatcca ctggataaag cagcagcctg ggaatggctt ggagtggatt 480
ggttggattt ttcccggcga cggggatact gagtacaatc agaagttcaa cggcaaagcc 540
accttaaccg cggataagtc gagtagcaca gcttacatgc agttgtcatc cctaacatct 600
gaggatagcg ccgtgtattt ctgcgcaaga gggaattata actacgaata cttcgattat 660
tgggggcaag gagttatggt gacagtgagc tctggcggcg ggggatccgg tgggggaggc 720
tcaggaggag gaggcagcgg aggaggggga agcgacatcc aaatgactca gtcccctgcc 780
tcactcagtg ccagtttggg agaaacggtg tccatcgaat gtttggcctc tgaggacata 840
tacagctacc tcgcctggta tcagcagaag cctggcaagt cccctcaact gctcattttt 900
gctgccaatc gcttacagga cggcgtacct agccggtttt caggttctgg ctcaggtact 960
caattcagtt taaagatatc cggcatgcag ccagaagatg agggcgatta tttctgcttg 1020
cagggtagca agtttcccta caccttcggt cccggcacta agctcgaact caatggaggc 1080
ggcgggtcac aggtccaact agtccagtcc ggtggcggcg tggttcagcc tgggcgttcc 1140
cttagactga gctgtaaggc cagcgggtac accttcacca gatacaccat gcactgggtg 1200
cgccaagcac cagggaaagg ccttgagtgg atcggttaca tcaatccatc gaggggatac 1260
acgaactata accagaaagt caaagatcgg tttacaatca gtcgggacaa ctctaagaac 1320
acggcctttc tacaaatgga ctcacttaga cccgaggata caggggtcta cttttgtgca 1380
cgctactatg acgaccacta ttccctggat tactgggggc agggcacacc cgtcaccgtg 1440
tcctcggaca aaacacacac gtgtccacca tgtccagccc ctgaagccgc cggtgggccg 1500
agcgtgtttc tgtttccccc caaaccgaaa gacaccctca tgatcagtcg aacacctgaa 1560
gtaacctgtg tggttgtgga cgtgtcccat gaggacccgg aagtcaagtt taactggtat 1620
gtagacggtg ttgaggttca caacgccaag accaaaccca gggaagagca gtataacagc 1680
acgtatcgtg tcgtgagcgt cctgacagtc ctgcatcagg attggctgaa tggtaaggag 1740
tataagtgca aagtgagcaa caaggctctg ccagcgccca tcgaaaaaac catttccaag 1800
gcaaaagggc agccaaggga accccaagtg tacacgctgc caccttctag ggacgagctg 1860
actaaaaatc aggtgtcact gacctgcctg gttaagggct tctatcccag tgatattgcg 1920
gttgagtggg agtctaatgg ccagccggaa aataactaca agacaactcc tcctgttctg 1980
gactccgatg ggtcattctt cctgtattcc aaactgactg tggataagag caggtggcaa 2040
cagggcaatg tcttctcatg ctcggtgatg catgaggcac tgcataacca ctacactcag 2100
aagtctctga gtctgtctcc tgggaaa 2127
<210> 68
<211> 2127
<212> DNA
<213> Artificial Sequence
<400> 68
caagtacagc tccagcagtc aggagctgag ctggtaaaac ctgggagtag cgtgaagatt 60
agctgcaaag ctagtggata cacctttacc cgtaacttca tccattggat caagcaacag 120
cctgggaatg ggctcgaatg gataggctgg atctttccgg gggatgggga taccgagtac 180
aatcagaagt tcaatggcaa ggccacactg accgcagata agtcttcttc caccgcatac 240
atgcagctgt ccagccttac aagcgaggat tctgccgttt atttttgcgc cagaggaaac 300
tacaactatg agtactttga ctattggggt caaggtgtga tggtgaccgt ctcctccggg 360
ggtgggggtt cggacattca gatgactcag tcgccttcct cattaagtgc ctcagttggg 420
gaccgggtaa ccattacctg cagcgcatct tcaagcgtct catacatgaa ctggtaccaa 480
caaacgccag gcaaagcacc caaacgctgg atctatgaca cttcaaagct ggcttccggg 540
gttccttcgc gattttctgg gagtggctct ggcactgatt acaccttcac aatatcctca 600
ctgcaacccg aggatatcgc cacttattac tgccagcagt ggtctagcaa tcctttcact 660
tttgggcagg ggacaaaact ccagattacc cgaggtggcg gcggatcagg tggcggtggc 720
agcggaggcg gagggtctgg gggaggcggg agccaggtac agcttgtcca gtctggcgga 780
ggcgttgtcc agccaggcag gagtcttcgc ttgagctgta aggcttcagg ctacactttc 840
acccggtata ctatgcactg ggttagacaa gccccaggga agggtctgga gtggatcggc 900
tatatcaatc ctagtagggg gtacacgaat tacaaccaga aagtgaagga ccggtttaca 960
ataagcaggg acaattcgaa aaacaccgct tttctgcaaa tggacagtct gcgacccgaa 1020
gacacaggcg tgtatttctg tgccagatac tatgatgacc actactcgct ggattactgg 1080
gggcagggaa cacccgtgac cgtgagtagc ggaggagggg gctctgacat acaaatgact 1140
cagagtcctg cctccttgag cgcatctctg ggagaaactg tgtccattga atgccttgcg 1200
agtgaggaca tctacagcta tctagcctgg tatcagcaga agcccggtaa atcacctcaa 1260
ttgctcattt ttgccgcgaa tcgcctacag gatggagtcc cttccaggtt cagcggctcc 1320
ggatctggaa cacaattcag cctcaagatt tcaggcatgc agccggaaga tgaaggagat 1380
tacttctgcc tacagggaag caaattcccc tacacattcg gacccggtac aaaacttgaa 1440
ctgaacgata agacacacac ctgtccacca tgtcctgcac cagaagccgc cggcggccct 1500
agtgtcttcc tgtttccccc gaaaccgaag gacacactca tgatcagcag gactcccgag 1560
gtgacatgcg tggtggtcga cgtttcccat gaggacccag aagtcaaatt caattggtat 1620
gtggacgggg tggaggtgca caatgcgaag acgaagccac gcgaagagca gtataatagc 1680
acctatcggg ttgtgtccgt cctcacagtc ctgcatcagg attggctgaa cggtaaagag 1740
tacaagtgca aggtgagtaa caaggcattg cccgctccca ttgagaagac aatctctaag 1800
gccaaaggtc agccacggga accgcaggta tatacgctcc cacccagcag agatgagctg 1860
actaagaacc aggtatcact cacgtgtctg gtgaaaggct tttatccatc cgatattgct 1920
gttgaatggg agtcaaatgg ccagcctgaa aacaactaca agactacgcc tccagtgtta 1980
gactctgatg gatccttctt tctatattct aaactgaccg tggacaaatc ccgttggcag 2040
cagggcaacg tgttttcctg ttccgtgatg catgaggctc tgcacaacca ctacacccag 2100
aagagtctgt ctctgtcccc cggtaaa 2127
<210> 69
<211> 2151
<212> DNA
<213> Artificial Sequence
<400> 69
gacattcaga tgacacagag tccagcaagt ctgtccgcaa gccttggtga gactgtaagc 60
atcgagtgcc tggccagcga agacatttat tcctatctgg cgtggtacca gcagaagcca 120
gggaagtcac cccagctcct catttttgcc gctaatcgct tacaggacgg cgtgccctca 180
cgattcagcg ggagcggaag tggcactcag ttttccctga agatttccgg aatgcagcca 240
gaagacgaag gggattattt ctgcctacaa ggatcaaagt tcccgtatac gtttggccct 300
ggtactaaac tggaactgaa tgggggggga gggtcccagg ttcagctggt gcagtcagga 360
gggggagtgg ttcaaccggg cagatctctg aggttatcct gcaaagctag tggctatacc 420
tttacacggt acacaatgca ctgggtgagg caggcacctg gtaaggggct ggagtggata 480
gggtatatca atcccagcag aggctatacg aattacaatc agaaggtgaa agaccgcttt 540
actataagcc gtgacaacag taagaacacc gcctttctcc agatggactc gttgcgacca 600
gaagatacag gggtctattt ctgcgccaga tactatgacg accattactc cctagactac 660
tggggtcaag gaacaccagt caccgtcagt agcggcggag gaggctctgg cggtggcggg 720
tccggtggcg gtggttccgg gggaggagga tccgatatcc agatgaccca aagcccttct 780
tcactctcgg catccgtagg cgatagagtc accataacat gcagtgcttc aagctccgtg 840
tcctacatga actggtatca gcaaactcct ggtaaagcac ccaagaggtg gatttacgat 900
acctcaaagc tggcctctgg cgtaccctcc aggttttctg gctcgggctc cgggacagac 960
tatacgttca cgatcagttc tctccagcct gaggatattg ccacttacta ctgtcagcag 1020
tggagcagca atccctttac cttcggccag ggaacaaagt tacagatcac gagaggtggc 1080
ggcgggagtc aagtgcagct ccaacagtct ggcgccgaac tcgtgaaacc cggatctagc 1140
gtgaaaatct catgcaaggc cagcggctat acattcaccc ggaacttcat ccactggatt 1200
aagcaacagc ctggaaatgg tctagaatgg atcggttgga tttttccggg agatggagac 1260
accgagtaca accaaaaatt caacgggaaa gcgactctga ccgccgataa atcgagctct 1320
acggcttaca tgcagctgtc ttctctcact tcagaggact cagccgttta cttttgtgct 1380
cgcggcaact acaactacga gtactttgat tattggggtc agggcgtaat ggtgaccgtc 1440
tcctctctcg aagtgctgtt ccagggacca gacaaaactc acacatgtcc accttgtccc 1500
gctcctgagg ccgccggggg cccatcggtc tttctgttcc cccctaaacc aaaagacacc 1560
ctgatgatct ctcgtacacc cgaggtgacc tgtgtcgttg tggacgttag ccacgaggac 1620
cccgaagtga agttcaactg gtatgtggat ggcgtggagg ttcataatgc caaaacaaag 1680
cctcgggaag agcagtataa ttctacatac cgcgttgtat cagtattgac cgtcctgcat 1740
caggattggt tgaatggaaa ggagtacaag tgcaaggtgt ctaacaaggc actgcctgcg 1800
cctatagaga agaccatctc caaggctaaa gggcaaccac gggaaccaca agtctacaca 1860
cttcccccca gcagggatga actcaccaaa aaccaggtga gtctgacttg cttggttaaa 1920
ggcttctacc cgtccgatat tgccgtcgaa tgggagagca acggacagcc ggagaacaac 1980
tataagacca cacctccagt gttggatagc gatgggagct tcttccttta cagtaagctg 2040
actgtcgaca agtctcgatg gcaacagggg aatgtgttta gctgtagtgt gatgcatgag 2100
gcattacaca atcactatac tcagaaatcc ttgagtctat cacccgggaa a 2151
<210> 70
<211> 1479
<212> DNA
<213> Artificial Sequence
<400> 70
caggtacagc tgcaacagtc tggggctgag ttagtcaaac cagggtcctc ggtgaagatc 60
tcttgcaagg catcaggcta cacattcacc cgtaatttca ttcactggat taagcagcag 120
ccaggaaatg gcctcgagtg gattgggtgg atatttcccg gggatggaga taccgagtac 180
aatcagaagt ttaatggaaa ggccacactg accgctgaca agtcgagttc aactgcctat 240
atgcagctga gttccctgac cagcgaggat agcgccgttt atttctgcgc aagagggaac 300
tacaactacg agtacttcga ctattgggga cagggtgtca tggtcacagt gagttctggg 360
gggggaggtt caggcggcgg agggtctggc ggaggcggct ctgacattca gatgacacag 420
agtcctgcaa gtctgagtgc gtcccttggc gagactgtgt ccatcgaatg tctcgcatct 480
gaagacatct actcctattt ggcgtggtac cagcaaaagc cagggaaatc ccctcagtta 540
ctgatcttcg ccgctaatag gctgcaagat ggagtgccta gccgattttc tggtagcgga 600
tccggcaccc agttctcgct caagatctcc ggtatgcagc ccgaagatga aggagactac 660
ttctgcttgc agggcagcaa gttcccctat acctttggac cggggaccaa gttggagctc 720
aatgggggcg gaggtagcca ggttcagcta gttcagtcag gtgggggcgt agtgcaaccc 780
ggaaggtccc ttagactgag ttgcaaagct tccggctata catttacccg gtatacgatg 840
cattgggtga gacaagcgcc aggcaaaggc ttggaatgga ttggctacat caacccttct 900
cggggttata caaactacaa ccagaaggtg aaagatcggt ttactatcag tcgcgacaac 960
agcaaaaaca ccgcatttct gcagatggac agccttagac ccgaagacac aggcgtctat 1020
ttctgtgcca ggtattacga cgatcactac agcctagatt actggggtca aggcactccc 1080
gtcacagtgt ctagcggagg tggaggctca gggggtggcg ggtctggtgg aggaggcagc 1140
gacatacaga tgactcagtc tcctagctcc ctttcagcca gcgtaggcga tcgcgtgaca 1200
atcacttgta gcgccagcag ctcagtgtcg tacatgaact ggtatcagca gactcctggg 1260
aaagccccca aacgatggat ttatgacaca tcaaagctgg catcaggggt tccaagccgc 1320
ttttccggca gtggtagtgg aaccgactat acgttcacga tctcttccct ccaaccagag 1380
gatattgcca cttactactg tcaacagtgg tcatctaatc cgtttacctt tggccagggg 1440
acgaaactcc aaattaccag gcaccatcac caccatcac 1479
<210> 71
<211> 1479
<212> DNA
<213> Artificial Sequence
<400> 71
gatatacaga tgacccaatc accagcatct ctttccgcta gccttggcga aactgtgtcc 60
atcgaatgcc ttgcctccga agacatctat agctatctgg cctggtatca gcagaaaccc 120
ggcaagtcac ctcagctgct aatcttcgcg gccaatagac tccaggacgg ggtaccatct 180
cgttttagcg ggtccggctc gggaacacag tttagcctga agatttcagg gatgcagcct 240
gaggacgaag gggactactt ctgtctccag ggatccaagt tcccctacac atttggccca 300
ggtaccaaac tggagctgaa tggtgggggg ggctctggag gcggtgggtc tgggggcggt 360
ggcagtcaag tccagctaca gcaaagtggg gccgaattgg tgaaaccagg cagcagcgtg 420
aaaatctcct gcaaagccag tgggtatacg ttcacaagga acttcatcca ctggatcaaa 480
cagcagcctg gcaatggctt agaatggatt ggctggattt ttcccgggga tggagacacc 540
gagtataatc agaagttcaa cgggaaggcc actctcactg cggataagtc atcgagtact 600
gcctatatgc agctgtcctc gctgacttct gaggatagcg ctgtgtactt ttgtgctcgc 660
ggcaactaca actacgagta ctttgactac tggggacagg gtgtaatggt cacagtgtcg 720
tccggcgggg gaggatctca ggtacagctg gttcaatccg gaggaggagt ggtgcaaccg 780
ggtagatctt tgaggctgtc atgcaaggcc tccgggtaca catttacccg gtataccatg 840
cattgggtgc gacaagcacc gggaaagggt ttagagtgga tcggatatat caatcccagc 900
agaggttaca ccaattacaa ccagaaagtc aaggacagat tcaccatcag ccgcgataac 960
tcaaagaaca cggcttttct ccagatggat tccctgcgac cagaggatac tggcgtgtat 1020
ttctgtgctc ggtattacga tgatcactat agtctcgact attggggcca gggcacacca 1080
gtcaccgtgt ctagtggggg agggggctca ggaggagggg gatcaggcgg cggtggttct 1140
gacattcaga tgacgcaatc tccttctagc ttgagtgctt ccgttggcga tcgcgtcact 1200
attacctgta gcgcaagcag cagtgtgtcc tacatgaatt ggtaccagca aacgcctggc 1260
aaagcaccga aacggtggat ttacgacact agcaagctcg catcaggagt tcccagcagg 1320
ttttccggaa gtggttctgg cacagactac acattcacca taagctccct tcagcccgag 1380
gacattgcca cctactattg ccaacagtgg tcaagtaacc ctttcacttt cgggcaggga 1440
accaagctgc aaattaccag gcatcaccac catcaccat 1479
<210> 72
<211> 1479
<212> DNA
<213> Artificial Sequence
<400> 72
caggtgcagc tggttcagtc tggtggcgga gttgtgcagc ctggcagatc tctgagactg 60
agctgtaaag ccagcggcta caccttcacc agatacacca tgcactgggt ccgacaggcc 120
cctggaaaag gactggaatg gatcggctac atcaacccca gccggggcta caccaactac 180
aaccagaaag tgaaggaccg gttcaccatc agccgggaca acagcaagaa taccgccttc 240
ctgcagatgg acagcctgag gcctgaagat accggcgtgt acttctgcgc ccggtactac 300
gatgaccact acagcctgga ttactggggc cagggcacac ctgtgacagt ttctagcgga 360
ggcggaggaa gtggcggcgg aggatctggc ggtggtggtt ctgatatcca gatgacacag 420
agccctagca gcctgtctgc ctctgtgggc gatagagtga ccatcacatg tagcgccagc 480
agcagcgtgt cctacatgaa ctggtatcag cagacccctg gcaaggcccc taagagatgg 540
atctacgata ccagcaagct ggcctccggc gtgccaagca gattttctgg ctctggcagc 600
ggaaccgatt acacgttcac cattagctcc ctgcagccag aggatatcgc cacctactac 660
tgccagcagt ggtccagcaa tcccttcacc tttggacagg gcaccaagct gcagatcaca 720
agaggtggtg gtggcagcca ggttcagctg caacaatctg gcgccgagct ggttaagcct 780
ggctctagcg tgaagatctc ttgcaaggcc tccggataca cattcacccg gaacttcatc 840
cactggatca agcagcagcc cggcaatgga ctcgagtgga tcggatggat tttccccggc 900
gacggcgaca ccgagtacaa tcagaagttc aacggcaagg ccacactgac cgccgataag 960
agcagcagca cagcctacat gcagctgagc agcctgacaa gcgaggacag cgccgtgtat 1020
ttctgtgcca gaggcaacta caattacgag tacttcgact attggggaca gggcgtgatg 1080
gttaccgttt catctggcgg aggcggaagc ggtggtggtg gaagcggagg tggcggctca 1140
gatattcaga tgacccagtc tcctgccagc ctgagcgctt ctctgggaga gacagtgtct 1200
atcgagtgcc tggccagcga ggatatctac agctacctgg cttggtatca acagaagcca 1260
ggcaagagcc ctcagctgct gatcttcgcc gccaatagac tgcaggatgg cgtgccatct 1320
agattcagcg gctctggctc cggcacacag ttcagcctga aaatctctgg catgcagccc 1380
gaggacgagg gcgattactt ttgcctgcaa ggcagcaagt tcccctacac atttggccct 1440
ggcacaaagc tggaactgaa ccaccatcat caccaccac 1479
<210> 73
<211> 1479
<212> DNA
<213> Artificial Sequence
<400> 73
caggtccagc tggtgcaatc gggtggggga gtggtgcaac ctgggagatc cttacggctt 60
agttgcaaag cctccgggta tacgtttact aggtacacca tgcattgggt aagacaggca 120
cctggaaagg gactggaatg gattggctac atcaacccca gtcgaggata taccaactac 180
aatcagaagg tgaaggatag gttcacaatt agccgtgaca acagcaagaa caccgccttt 240
ctgcagatgg attctctaag accggaggat actggcgtct acttctgtgc tcgctattat 300
gacgaccact attccctgga ttattggggg caaggcactc cagtgaccgt tagctctgga 360
ggagggggta gcggcggagg aggctctggg ggaggggggt ctgacataca gatgactcaa 420
tcccctagct cactgtcagc atcggttggc gacagagtga ccattacctg tagcgccagc 480
tctagtgtca gctacatgaa ctggtatcag cagacaccag gtaaagcccc aaaaaggtgg 540
atctacgaca cgagcaagtt ggcctctggt gtgcccagtc gcttctcagg gtcaggttcc 600
gggactgatt acacattcac aatcagctct ctccaaccgg aagacatagc gacttactat 660
tgccagcagt ggtcatcgaa tccattcacc tttggccagg gcactaagct acagattaca 720
cgggggggag gtggctcaga cattcagatg acacaaagtc ccgcttctct gagtgcttcc 780
ctgggagaaa ccgtgtctat cgagtgtctc gcgagtgagg acatttactc ctatctggca 840
tggtatcaac agaaacctgg gaaatccccc cagttgctga tctttgccgc taatcgactc 900
caggatggcg taccttcacg cttcagcggc agcggatccg gaacgcagtt tagtctcaag 960
atatctggga tgcagccgga agatgagggg gactatttct gcttacaggg atctaaattc 1020
ccctatacat tcggccctgg caccaagctg gagcttaatg gcggtggggg tagtggtggt 1080
ggcggttcgg gaggcggtgg gtcacaggtg cagcttcagc aatctggcgc agagttggtg 1140
aagccaggat cctcagtcaa gatcagctgc aaggcttccg gctatacctt taccaggaat 1200
ttcattcact ggatcaaaca gcaacccggc aatggcctcg aatggatcgg gtggatcttt 1260
cccggggatg gcgataccga gtacaaccag aagtttaacg gcaaagccac tcttacagcc 1320
gacaaaagca gcagcacagc ctacatgcag ctctcctcac tgacctccga agactccgct 1380
gtgtactttt gcgcacgggg aaactacaat tacgagtact tcgattactg gggccaaggc 1440
gtcatggtta cggtatccag tcaccatcac caccatcat 1479
<210> 74
<211> 1347
<212> DNA
<213> Artificial Sequence
<400> 74
caggtacagt tgcagcaatc tggggcagaa ctggtcaaac ccgggagttc tgtgaaaatc 60
tcctgtaagg ccagtggata taccttcacc cgtaatttca tccactggat caaacaacag 120
cctggcaatg gcctcgaatg gatcggatgg atttttcccg gtgatggcga taccgagtat 180
aaccagaagt tcaatgggaa ggcaacacta acagccgaca aatcctcatc cacagcctat 240
atgcaactta gtagcctcac atctgaagat agcgccgtgt acttttgcgc aaggggcaac 300
tataactacg agtatttcga ctactggggt cagggggtga tggtgaccgt atcttccgct 360
agtactaaag gacccagcgt gtttccactg gcaccatcct ctaaatctac aagcggaggc 420
actgccgcac ttggctgcct ggtcaaagac tattttcctg aacccgtcac tgtgtcttgg 480
aactctggag ctttgacatc tggcgttcac acttttcccg cagtactcca gtcatctggc 540
ctgtattctc tgtcaagtgt tgtgactgtt cccagcagta gtctgggaac ccagacctac 600
atatgcaacg tcaaccataa acccagcaac acaaaggtgg ataagcgcgt cgagcctaag 660
agctgcgata agacccatac atgcccacca tgtcccgctc cagaggccgc cggaggtcca 720
tccgtattct tgtttcctcc caaacccaag gataccctga tgatcagccg gacacctgaa 780
gtcacttgtg tggttgtgga cgtatcccat gaagatccag aggtgaagtt caactggtac 840
gtcgacggtg tcgaagtcca taatgccaaa accaaaccta gggaggaaca gtacaacagt 900
acctaccgag tagtgtcagt cctgactgtg ttgcaccagg actggctgaa tggtaaggag 960
tacaagtgta aggtgtccaa taaggccctt cctgctccca ttgaaaagac catctccaaa 1020
gcaaaagggc agccaagaga gccccaggtg tatacactgc ctccatgcag agaggagatg 1080
accaagaatc aggttagtct gtggtgcctg gttaaggggt tttatccctc agatattgcc 1140
gtggagtggg agtccaatgg ccaacccgag aataactaca agaccacgcc tcccgtgctt 1200
gacagcgacg ggagtttctt cctgtattcc aagctgactg ttgacaagtc ccgttggcag 1260
cagggaaacg tgtttagctg ttccgtgatg cacgaagccc tgcacaacca ctacacccag 1320
aaaagcctct ctctctctcc agggaag 1347
<210> 75
<211> 2085
<212> DNA
<213> Artificial Sequence
<400> 75
caggtccagt tgcagcagag cggcgcggag ctggtgaagc ctggcagtag cgtcaagatc 60
tcttgcaagg cgagtggcta taccttcaca cggaacttca tccactggat aaagcagcaa 120
cccggcaatg gactagagtg gattgggtgg attttcccgg gagatggcga taccgagtat 180
aaccagaagt tcaatggtaa ggcgacatta accgccgata agtccagtag taccgcctat 240
atgcagttgt cttcattgac atctgaagac tcagccgtgt atttttgcgc taggggcaac 300
tacaactatg agtactttga ctactgggga caaggggtga tggtgactgt atcctccgct 360
tccacaaagg gtccatccgt atttcccctt gctccaagca gcaaatcaac ctctggtggt 420
acagctgccc ttggatgtct tgttaaggac tattttcccg aaccggttac ggtaagctgg 480
aacagtggcg cactgacatc cggcgttcac acctttcctg ccgtgcttca aagtagcgga 540
ctctattcac tgagctccgt agtgaccgta ccatcctcct cccttgggac ccagacttac 600
atctgcaatg tgaaccataa gccctctaat accaaggtcg acaagcgggt cgaacccaaa 660
tcgtgtgata agacccacac ttgtcccccg tgtcctgctc ctgaagccgc aggcgggcca 720
tccgtcttcc tcttccctcc caaaccgaag gacacactga tgatctcccg tacgcctgag 780
gtgacatgtg tggttgtcga tgtgagccat gaagatcctg aagtgaagtt taattggtat 840
gttgacggag tcgaagtaca caacgcaaag accaaaccta gggaggagca gtataactcc 900
acataccgcg tcgtctcggt cttaactgtc ctgcatcagg attggctgaa tggcaaagag 960
tacaagtgca aggtttccaa taaggcacta cccgccccaa tcgagaaaac catcagcaaa 1020
gccaaagggc agcctagaga gccccaggtg tgcactttgc ctcccagtag ggaggaaatg 1080
accaaaaatc aagtgtccct cagctgtgcc gttaaaggct tttacccatc tgacatagct 1140
gtggaatggg agtcaaacgg acaaccagag aacaactata agacaacacc acccgtgctg 1200
gactctgacg ggtcattctt tctggtgagc aaactcaccg tggacaaatc tcgctggcaa 1260
caggggaatg tgttcagctg cagtgtgatg catgaagcac tgcacaacca ctacacgcag 1320
aaaagcctct ctctgtcacc tgggaaaggg ggaggcggct cccaagttca gctcgttcag 1380
tccggagggg gagtagtgca gccagggaga agccttcggc tgagctgcaa agctagcggc 1440
tacactttta cgcgatacac catgcactgg gttcgtcagg ctcctggcaa gggcctggag 1500
tggatcggct acatcaatcc gagtcgaggg tataccaact acaatcagaa agtcaaagat 1560
cgcttcacga tctcacggga caactctaag aatacagcat ttctccagat ggattcttta 1620
cggcctgagg atactggcgt gtacttttgc gccagatact atgacgatca ctatagcctg 1680
gactattggg gtcaaggcac tcccgtgaca gtgtcctcag ggggaggagg tagtggagga 1740
gggggttctg ggggtggagg ctcagatatt caaatgactc agtcaccctc ctctctgagc 1800
gcgagcgtcg gggacagagt gaccattaca tgctctgcct ctagtagcgt gagttacatg 1860
aactggtatc agcagacccc cggaaaagcc ccaaagaggt ggatctacga cacttcaaaa 1920
ctggcttcgg gagtcccaag cagattctca ggttcgggct ctggtacgga ttacaccttc 1980
accataagca gtctacagcc agaagacatt gccacatact actgtcagca atggtcctct 2040
aatcccttca cttttggtca gggcactaag ctccagatta caagg 2085
<210> 76
<211> 642
<212> DNA
<213> Artificial Sequence
<400> 76
gatatacaga tgacacagag ccccgcaagc ctatccgcct ccctggggga gacagtgtct 60
atagagtgct tagcttccga ggacatctat agctacttgg cttggtatca gcaaaagcct 120
gggaaatcac cacagctgtt gatctttgcg gccaacaggc ttcaggacgg agtccctagc 180
cggtttagtg gatctggctc aggtacacag ttcagtctga agatctccgg gatgcagccc 240
gaagacgaag gagactactt ctgcttgcag ggatctaaat tcccatacac ttttggccct 300
ggcacgaaac tggagttaaa tcgcactgtt gcagctccct cagtgttcat cttccctccc 360
agcgatgagc agctgaaaag tggaactgcc agtgttgtgt gcttgctgaa caacttttac 420
cccagggaag ccaaggtgca gtggaaggta gacaatgctc ttcagtcagg gaactctcag 480
gaatccgtga ctgagcaaga cagcaaggat tccacctaca gtctcagcag cacactgacc 540
ctctccaaag cagactacga gaagcacaag gtgtatgcct gtgaggtaac ccatcaaggg 600
cttagctccc cagtcaccaa gagtttcaat aggggcgagt gt 642
<210> 77
<211> 2085
<212> DNA
<213> Artificial Sequence
<400> 77
caagttcagc ttcaacaaag tggtgcggag ctagtgaaac ccggatctag tgtcaagatc 60
tcttgtaagg caagcggcta tacgtttacc cgcaacttca tacactggat caaacagcaa 120
cctggtaatg ggctggagtg gatcgggtgg atttttccgg gagatggaga cacagagtat 180
aatcagaaat tcaatggcaa agctactctg acggccgata aaagctccag cacagcctac 240
atgcagttat cttccctgac aagtgaggat agcgccgtgt acttttgcgc aagagggaac 300
tacaactacg agtatttcga ctattggggc caaggcgtaa tggtaaccgt atcctccgcc 360
agtacaaagg gcccaagtgt gtttccactg gcaccgtctt caaagagcac atcaggtggg 420
actgctgcct tgggctgtct ggtgaaggac tactttccag aacccgtgac cgtgtcctgg 480
aatagtgggg ctttgacaag tggcgttcac acttttcccg ctgtactgca gagttcaggg 540
ctgtatagct tgtcgtccgt tgtcactgtt cctagcagca gcctaggaac ccagacctac 600
atttgcaatg tgaatcacaa gccatctaat accaaggtgg acaagagggt cgagccaaag 660
tcttgcgaca agactcatac ttgtccccca tgtccagcgc ctgaagccgc tggcggaccc 720
tctgtgtttc tgttccctcc aaagcccaaa gatactctca tgatcagccg gactccggag 780
gtcacttgtg tcgttgtcga cgtgtcacat gaggatcctg aagtgaagtt caactggtat 840
gtcgatggag tcgaggtgca caatgccaag accaaacccc gagaagagca gtacaacagc 900
acataccggg tagtgtccgt gctgaccgtg ctccatcagg attggttgaa cggtaaggag 960
tacaaatgca aggtgagcaa caaagctctg ccagcaccca ttgagaagac catctccaag 1020
gccaaagggc agcctagaga accccaagtg tacaccctcc ctccaagccg ggaagagatg 1080
acaaagaatc aggttagcct cacatgcctt gtcaagggct tttatccctc cgacattgcc 1140
gtagaatggg agtccaatgg ccaacccgaa aacaattaca aaaccacacc acccgtcctc 1200
gatagcgatg gctccttctt tctctactcc aagttaacgg ttgacaaaag ccggtggcag 1260
caggggaatg tgttcagctg ctccgtaatg cacgaggccc ttcacaatca ctatacccag 1320
aaatcgctgt ctctttctcc cgggaaaggc gggggcggat cacaggtgca actcgtccag 1380
tctgggggag gtgtggtgca acctggccgg agtttacgac tgagttgcaa ggcatcgggc 1440
tatactttta ccaggtatac tatgcattgg gtgagacagg cacccggcaa aggcctagaa 1500
tggattggct acatcaaccc ttcaaggggg tatactaact acaaccagaa ggtgaaagac 1560
aggtttacca tatcgcgtga taacagcaaa aacacagcct tcctgcagat ggactccctt 1620
agacctgaag acacaggggt gtatttctgt gctcgttact acgacgacca ctatagtctg 1680
gactactggg ggcagggtac accggttacc gtttctagtg gtggaggtgg atcaggcgga 1740
gggggatccg gtggaggcgg atccgatatt cagatgacac agagcccctc ttccctttcc 1800
gcgtcagtgg gagacagggt caccattacc tgttccgcct ctagctccgt ctcatacatg 1860
aactggtatc agcagacccc tgggaaagca ccaaagcgct ggatctatga tacgtcgaag 1920
ttggcttctg gagttccgtc acgcttctca ggatcaggtt caggtaccga ctacactttt 1980
acgatctctt ctctccagcc tgaagatata gcgacgtact attgccagca gtggtctagt 2040
aaccctttca cattcggcca agggaccaaa ctgcagatca ctcgc 2085
<210> 78
<211> 1419
<212> DNA
<213> Artificial Sequence
<400> 78
caggtccagt tggtgcaatc gggcggcggc gttgtccagc cgggtcgctc tctacggctc 60
agctgcaaag caagtgggta tacctttact cgctatacta tgcattgggt acgacaggct 120
cccggtaaag gactggaatg gattggctac atcaatccca gtcgcggcta tacaaactac 180
aaccaaaagg tcaaagacag gtttacgatt tcccgggata actctaagaa tacagccttt 240
ttgcagatgg acagtctgag gccagaggat acaggcgtct acttttgtgc cagatactat 300
gacgatcact actcactcga ctattggggc caagggaccc ccgtgactgt gagctcagga 360
ggaggtggat ctggcggcgg agggagtggg ggagggggtt ccgatatcca gatgacccag 420
tcccccagtt cactgagcgc ttctgtgggc gatcgggtca ccattacatg cagtgccagc 480
agctccgttt cctacatgaa ttggtaccag cagacacccg gaaaagcgcc aaaacggtgg 540
atctatgaca ccagtaaact ggcaagcggc gtgcccagtc gattctcggg aagtgggtca 600
ggtaccgact acacatttac gataagcagc ctgcagcctg aggacatagc cacatactac 660
tgccagcagt ggtcgtcgaa cccgtttact ttcggccagg gtacgaaact gcagattact 720
cgagagccta agagctgcga taagacccat acatgcccac catgtcccgc tccagaggcc 780
gccggaggtc catccgtatt cttgtttcct cccaaaccca aggataccct gatgatcagc 840
cggacacctg aagtcacttg tgtggttgtg gacgtatccc atgaagatcc agaggtgaag 900
ttcaactggt acgtcgacgg tgtcgaagtc cataatgcca aaaccaaacc tagggaggaa 960
cagtacaaca gtacctaccg agtagtgtca gtcctgactg tgttgcacca ggactggctg 1020
aatggtaagg agtacaagtg taaggtgtcc aataaggccc ttcctgctcc cattgaaaag 1080
accatctcca aagcaaaagg gcagccaaga gagccccagg tgtgtacact gcctccatct 1140
agagaggaga tgaccaagaa tcaggttagt ctgagttgcg ccgttaaggg gttttatccc 1200
tcagatattg ccgtggagtg ggagtccaat ggccaacccg agaataacta caagaccacg 1260
cctcccgtgc ttgacagcga cgggagtttc ttcctggttt ccaagctgac tgttgacaag 1320
tcccgttggc agcagggaaa cgtgtttagc tgttccgtga tgcacgaagc cctgcacaac 1380
cactacaccc agaaaagcct ctctctctct ccagggaag 1419
<210> 79
<211> 1422
<212> DNA
<213> Artificial Sequence
<400> 79
caggtacagt tgcagcaatc tggggcagaa ctggtcaaac ccgggagttc tgtgaaaatc 60
tcctgtaagg ccagtggata taccttcacc cgtaatttca tccactggat caaacaacag 120
cctggcaatg gcctcgaatg gatcggatgg atttttcccg gtgatggcga taccgagtat 180
aaccagaagt tcaatgggaa ggcaacacta acagccgaca aatcctcatc cacagcctat 240
atgcaactta gtagcctcac atctgaagat agcgccgtgt acttttgcgc aaggggcaac 300
tataactacg agtatttcga ctactggggt cagggggtga tggtgaccgt atcttccgct 360
agtactaaag gacccagcgt gtttccactg gcaccatcct ctaaatctac aagcggaggc 420
actgccgcac ttggctgcct ggtcaaagac tattttcctg aacccgtcac tgtgtcttgg 480
aactctggag ctttgacatc tggcgttcac acttttcccg cagtactcca gtcatctggc 540
ctgtattctc tgtcaagtgt tgtgactgtt cccagcagta gtctgggaac ccagacctac 600
atatgcaacg tcaaccataa acccagcaac acaaaggtgg ataagcgcgt cgagcctaag 660
agctgcggag gtggaggctc acaggttcag ctagttcagt caggtggggg cgtagtgcaa 720
cccggaaggt cccttagact gagttgcaaa gcttccggct atacatttac ccggtatacg 780
atgcattggg tgagacaagc gccaggcaaa ggcttggaat ggattggcta catcaaccct 840
tctcggggtt atacaaacta caaccagaag gtgaaagatc ggtttactat cagtcgcgac 900
aacagcaaaa acaccgcatt tctgcagatg gacagcctta gacccgaaga cacaggcgtc 960
tatttctgtg ccaggtatta cgacgatcac tacagcctag attactgggg tcaaggcact 1020
cccgtcacag tgtctagcgg aggtggaggc tcagggggtg gcgggtctgg tggaggaggc 1080
agcgacatac agatgactca gtctcctagc tccctttcag ccagcgtagg cgatcgcgtg 1140
acaatcactt gtagcgccag cagctcagtg tcgtacatga actggtatca gcagactcct 1200
gggaaagccc ccaaacgatg gatttatgac acatcaaagc tggcatcagg ggttccaagc 1260
cgcttttccg gcagtggtag tggaaccgac tatacgttca cgatctcttc cctccaacca 1320
gaggatattg ccacttacta ctgtcaacag tggtcatcta atccgtttac ctttggccag 1380
gggacgaaac tccaaattac caggcaccat caccaccatc ac 1422
<210> 80
<211> 2085
<212> DNA
<213> Artificial Sequence
<400> 80
caggtacagt tgcagcaatc tggggcagaa ctggtcaaac ccgggagttc tgtgaaaatc 60
tcctgtaagg ccagtggata taccttcacc cgtaatttca tccactggat caaacaacag 120
cctggcaatg gcctcgaatg gatcggatgg atttttcccg gtgatggcga taccgagtat 180
aaccagaagt tcaatgggaa ggcaacacta acagccgaca aatcctcatc cacagcctat 240
atgcaactta gtagcctcac atctgaagat agcgccgtgt acttttgcgc aaggggcaac 300
tataactacg agtatttcga ctactggggt cagggggtga tggtgaccgt atcttccgct 360
agtactaaag gacccagcgt gtttccactg gcaccatcct ctaaatctac aagcggaggc 420
actgccgcac ttggctgcct ggtcaaagac tattttcctg aacccgtcac tgtgtcttgg 480
aactctggag ctttgacatc tggcgttcac acttttcccg cagtactcca gtcatctggc 540
ctgtattctc tgtcaagtgt tgtgactgtt cccagcagta gtctgggaac ccagacctac 600
atatgcaacg tcaaccataa acccagcaac acaaaggtgg ataagcgcgt cgagcctaag 660
agctgcggag gtggaggctc acaggttcag ctagttcagt caggtggggg cgtagtgcaa 720
cccggaaggt cccttagact gagttgcaaa gcttccggct atacatttac ccggtatacg 780
atgcattggg tgagacaagc gccaggcaaa ggcttggaat ggattggcta catcaaccct 840
tctcggggtt atacaaacta caaccagaag gtgaaagatc ggtttactat cagtcgcgac 900
aacagcaaaa acaccgcatt tctgcagatg gacagcctta gacccgaaga cacaggcgtc 960
tatttctgtg ccaggtatta cgacgatcac tacagcctag attactgggg tcaaggcact 1020
cccgtcacag tgtctagcgg aggtggaggc tcagggggtg gcgggtctgg tggaggaggc 1080
agcgacatac agatgactca gtctcctagc tccctttcag ccagcgtagg cgatcgcgtg 1140
acaatcactt gtagcgccag cagctcagtg tcgtacatga actggtatca gcagactcct 1200
gggaaagccc ccaaacgatg gatttatgac acatcaaagc tggcatcagg ggttccaagc 1260
cgcttttccg gcagtggtag tggaaccgac tatacgttca cgatctcttc cctccaacca 1320
gaggatattg ccacttacta ctgtcaacag tggtcatcta atccgtttac ctttggccag 1380
gggacgaaac tccaaattac cagggataag acccatacat gcccaccatg tcccgctcca 1440
gaggccgccg gaggtccatc cgtattcttg tttcctccca aacccaagga taccctgatg 1500
atcagccgga cacctgaagt cacttgtgtg gttgtggacg tatcccatga agatccagag 1560
gtgaagttca actggtacgt cgacggtgtc gaagtccata atgccaaaac caaacctagg 1620
gaggaacagt acaacagtac ctaccgagta gtgtcagtcc tgactgtgtt gcaccaggac 1680
tggctgaatg gtaaggagta caagtgtaag gtgtccaata aggcccttcc tgctcccatt 1740
gaaaagacca tctccaaagc aaaagggcag ccaagagagc cccaggtgta tacactgcct 1800
ccatctagag aggagatgac caagaatcag gttagtctga catgcctggt taaggggttt 1860
tatccctcag atattgccgt ggagtgggag tccaatggcc aacccgagaa taactacaag 1920
accacgcctc ccgtgcttga cagcgacggg agtttcttcc tgtattccaa gctgactgtt 1980
gacaagtccc gttggcagca gggaaacgtg tttagctgtt ccgtgatgca cgaagccctg 2040
cacaaccact acacccagaa aagcctctct ctctctccag ggaag 2085
<210> 81
<211> 1740
<212> DNA
<213> Artificial Sequence
<400> 81
caggtacagt tgcagcaatc tggggcagaa ctggtcaaac ccgggagttc tgtgaaaatc 60
tcctgtaagg ccagtggata taccttcacc cgtaatttca tccactggat caaacaacag 120
cctggcaatg gcctcgaatg gatcggatgg atttttcccg gtgatggcga taccgagtat 180
aaccagaagt tcaatgggaa ggcaacacta acagccgaca aatcctcatc cacagcctat 240
atgcaactta gtagcctcac atctgaagat agcgccgtgt acttttgcgc aaggggcaac 300
tataactacg agtatttcga ctactggggt cagggggtga tggtgaccgt atcttccgct 360
agtactaaag gacccagcgt gtttccactg gcaccatcct ctaaatctac aagcggaggc 420
actgccgcac ttggctgcct ggtcaaagac tattttcctg aacccgtcac tgtgtcttgg 480
aactctggag ctttgacatc tggcgttcac acttttcccg cagtactcca gtcatctggc 540
ctgtattctc tgtcaagtgt tgtgactgtt cccagcagta gtctgggaac ccagacctac 600
atatgcaacg tcaaccataa acccagcaac acaaaggtgg ataagcgcgt cgagcctaag 660
agctgcggag gtggaggctc acaggttcag ctagttcagt caggtggggg cgtagtgcaa 720
cccggaaggt cccttagact gagttgcaaa gcttccggct atacatttac ccggtatacg 780
atgcattggg tgagacaagc gccaggcaaa ggcttggaat ggattggcta catcaaccct 840
tctcggggtt atacaaacta caaccagaag gtgaaagatc ggtttactat cagtcgcgac 900
aacagcaaaa acaccgcatt tctgcagatg gacagcctta gacccgaaga cacaggcgtc 960
tatttctgtg ccaggtatta cgacgatcac tacagcctag attactgggg tcaaggcact 1020
cccgtcacag tgtctagcgg aggtggaggc tcagggggtg gcgggtctgg tggaggaggc 1080
agcgacatac agatgactca gtctcctagc tccctttcag ccagcgtagg cgatcgcgtg 1140
acaatcactt gtagcgccag cagctcagtg tcgtacatga actggtatca gcagactcct 1200
gggaaagccc ccaaacgatg gatttatgac acatcaaagc tggcatcagg ggttccaagc 1260
cgcttttccg gcagtggtag tggaaccgac tatacgttca cgatctcttc cctccaacca 1320
gaggatattg ccacttacta ctgtcaacag tggtcatcta atccgtttac ctttggccag 1380
gggacgaaac tccaaattac cagggccgct gcaggcggtg ggcagccaag agagccccag 1440
gtgtatacac tgcctccatc tagagaggag atgaccaaga atcaggttag tctgacatgc 1500
ctggttaagg ggttttatcc ctcagatatt gccgtggagt gggagtccaa tggccaaccc 1560
gagaataact acaagaccac gcctcccgtg cttgacagcg acgggagttt cttcctgtat 1620
tccaagctga ctgttgacaa gtcccgttgg cagcagggaa acgtgtttag ctgttccgtg 1680
atgcacgaag ccctgcacaa ccactacacc cagaaaagcc tctctctctc tccagggaag 1740
<210> 82
<211> 2103
<212> DNA
<213> Artificial Sequence
<400> 82
caggtacagt tgcagcaatc tggggcagaa ctggtcaaac ccgggagttc tgtgaaaatc 60
tcctgtaagg ccagtggata taccttcacc cgtaatttca tccactggat caaacaacag 120
cctggcaatg gcctcgaatg gatcggatgg atttttcccg gtgatggcga taccgagtat 180
aaccagaagt tcaatgggaa ggcaacacta acagccgaca aatcctcatc cacagcctat 240
atgcaactta gtagcctcac atctgaagat agcgccgtgt acttttgcgc aaggggcaac 300
tataactacg agtatttcga ctactggggt cagggggtga tggtgaccgt atcttccgct 360
agtactaaag gacccagcgt gtttccactg gcaccatcct ctaaatctac aagcggaggc 420
actgccgcac ttggctgcct ggtcaaagac tattttcctg aacccgtcac tgtgtcttgg 480
aactctggag ctttgacatc tggcgttcac acttttcccg cagtactcca gtcatctggc 540
ctgtattctc tgtcaagtgt tgtgactgtt cccagcagta gtctgggaac ccagacctac 600
atatgcaacg tcaaccataa acccagcaac acaaaggtgg ataagcgcgt cgagcctaag 660
agctgcggag gtggaggctc acaggttcag ctagttcagt caggtggggg cgtagtgcaa 720
cccggaaggt cccttagact gagttgcaaa gcttccggct atacatttac ccggtatacg 780
atgcattggg tgagacaagc gccaggcaaa ggcttggaat ggattggcta catcaaccct 840
tctcggggtt atacaaacta caaccagaag gtgaaagatc ggtttactat cagtcgcgac 900
aacagcaaaa acaccgcatt tctgcagatg gacagcctta gacccgaaga cacaggcgtc 960
tatttctgtg ccaggtatta cgacgatcac tacagcctag attactgggg tcaaggcact 1020
cccgtcacag tgtctagcgg aggtggaggc tcagggggtg gcgggtctgg tggaggaggc 1080
agcgacatac agatgactca gtctcctagc tccctttcag ccagcgtagg cgatcgcgtg 1140
acaatcactt gtagcgccag cagctcagtg tcgtacatga actggtatca gcagactcct 1200
gggaaagccc ccaaacgatg gatttatgac acatcaaagc tggcatcagg ggttccaagc 1260
cgcttttccg gcagtggtag tggaaccgac tatacgttca cgatctcttc cctccaacca 1320
gaggatattg ccacttacta ctgtcaacag tggtcatcta atccgtttac ctttggccag 1380
gggacgaaac tccaaattac caggggaggt ggaggctcac aggtacagtt gcagcaatct 1440
ggggcagaac tggtcaaacc cgggagttct gtgaaaatct cctgtaaggc cagtggatat 1500
accttcaccc gtaatttcat ccactggatc aaacaacagc ctggcaatgg cctcgaatgg 1560
atcggatgga tttttcccgg tgatggcgat accgagtata accagaagtt caatgggaag 1620
gcaacactaa cagccgacaa atcctcatcc acagcctata tgcaacttag tagcctcaca 1680
tctgaagata gcgccgtgta cttttgcgca aggggcaact ataactacga gtatttcgac 1740
tactggggtc agggggtgat ggtgaccgta tcttccgcta gtactaaagg acccagcgtg 1800
tttccactgg caccatcctc taaatctaca agcggaggca ctgccgcact tggctgcctg 1860
gtcaaagact attttcctga acccgtcact gtgtcttgga actctggagc tttgacatct 1920
ggcgttcaca cttttcccgc agtactccag tcatctggcc tgtattctct gtcaagtgtt 1980
gtgactgttc ccagcagtag tctgggaacc cagacctaca tatgcaacgt caaccataaa 2040
cccagcaaca caaaggtgga taagcgcgtc gagcctaaga gctgccacca tcaccaccat 2100
cac 2103
<210> 83
<211> 1422
<212> DNA
<213> Artificial Sequence
<400> 83
caggttcaac tcgtccagag tggaggcggg gttgtacagc cagggagaag cctcaggctt 60
agttgtaaag catctggcta taccttcaca cgctatacca tgcactgggt gagacaggct 120
ccagggaagg gactggagtg gatagggtat atcaatccct ctcgtggtta tacaaactat 180
aaccagaagg tgaaggatcg gttcactatc agccgagata attcaaagaa cacagcattt 240
ctgcagatgg atagcctgcg acctgaagat accggtgtct acttttgcgc caggtattac 300
gacgatcatt atagcttgga ctactggggc caaggcaccc ctgtgacggt ttccagcggc 360
ggaggaggca gtggaggagg aggctccgga ggtggcggat ctgacatcca aatgacccaa 420
agccccagtt ctttgagcgc ctcagttgga gatcgggtga ccattacttg cagcgccagc 480
agtagcgtgt cttacatgaa ctggtatcag cagaccccgg ggaaggctcc aaagcgctgg 540
atctacgata cgtccaagct ggcttccggc gtgccctcta gattctcagg gtctggcagt 600
ggtactgact acactttcac gatctcctct ttgcagccag aggatatagc gacctactac 660
tgtcagcagt ggtcctctaa tcccttcact tttggtcaag gtaccaagct gcagattaca 720
agaggcggtg gaggcagcca ggtgcagctc cagcagtcag gggccgagct ggtaaaaccg 780
ggttcatcag tgaagattag ctgcaaagcc tccggttaca cctttacaag gaacttcatt 840
cactggatca agcagcaacc cgggaatggg ctcgagtgga ttgggtggat attcccaggg 900
gacggagaca cagagtacaa ccagaaattt aacggcaaag ctacactgac agccgacaaa 960
tcatcaagta cagcatacat gcagctctcc tcactgactt ccgaggacag cgcggtgtac 1020
ttctgtgcgc gcggaaatta taactacgaa tactttgact attggggtca aggcgtgatg 1080
gtaacagtca gttctgcatc aacgaaaggc cctagcgtct ttcctctggc ccctagctct 1140
aagtctactt ccggcggaac agccgctctg gggtgtcttg tcaaggacta tttccctgaa 1200
cccgtcacag tgagctggaa tagcggggcc cttacttcag gcgtccacac ctttcctgct 1260
gtgcttcaga gttccggcct gtattccctg agttctgtgg tcactgttcc aagctccagc 1320
ctggggaccc agacctacat ctgcaatgtg aatcataaac cgtccaacac gaaagtggat 1380
aaacgggttg aacccaagag ctgccaccat caccatcatc ac 1422
<210> 84
<211> 2085
<212> DNA
<213> Artificial Sequence
<400> 84
caggttcaac tcgtccagag tggaggcggg gttgtacagc cagggagaag cctcaggctt 60
agttgtaaag catctggcta taccttcaca cgctatacca tgcactgggt gagacaggct 120
ccagggaagg gactggagtg gatagggtat atcaatccct ctcgtggtta tacaaactat 180
aaccagaagg tgaaggatcg gttcactatc agccgagata attcaaagaa cacagcattt 240
ctgcagatgg atagcctgcg acctgaagat accggtgtct acttttgcgc caggtattac 300
gacgatcatt atagcttgga ctactggggc caaggcaccc ctgtgacggt ttccagcggc 360
ggaggaggca gtggaggagg aggctccgga ggtggcggat ctgacatcca aatgacccaa 420
agccccagtt ctttgagcgc ctcagttgga gatcgggtga ccattacttg cagcgccagc 480
agtagcgtgt cttacatgaa ctggtatcag cagaccccgg ggaaggctcc aaagcgctgg 540
atctacgata cgtccaagct ggcttccggc gtgccctcta gattctcagg gtctggcagt 600
ggtactgact acactttcac gatctcctct ttgcagccag aggatatagc gacctactac 660
tgtcagcagt ggtcctctaa tcccttcact tttggtcaag gtaccaagct gcagattaca 720
agaggcggtg gaggcagcca ggtgcagctc cagcagtcag gggccgagct ggtaaaaccg 780
ggttcatcag tgaagattag ctgcaaagcc tccggttaca cctttacaag gaacttcatt 840
cactggatca agcagcaacc cgggaatggg ctcgagtgga ttgggtggat attcccaggg 900
gacggagaca cagagtacaa ccagaaattt aacggcaaag ctacactgac agccgacaaa 960
tcatcaagta cagcatacat gcagctctcc tcactgactt ccgaggacag cgcggtgtac 1020
ttctgtgcgc gcggaaatta taactacgaa tactttgact attggggtca aggcgtgatg 1080
gtaacagtca gttctgcatc aacgaaaggc cctagcgtct ttcctctggc ccctagctct 1140
aagtctactt ccggcggaac agccgctctg gggtgtcttg tcaaggacta tttccctgaa 1200
cccgtcacag tgagctggaa tagcggggcc cttacttcag gcgtccacac ctttcctgct 1260
gtgcttcaga gttccggcct gtattccctg agttctgtgg tcactgttcc aagctccagc 1320
ctggggaccc agacctacat ctgcaatgtg aatcataaac cgtccaacac gaaagtggat 1380
aaacgggttg aacccaagag ctgcgataag acccatacat gcccaccatg tcccgctcca 1440
gaggccgccg gaggtccatc cgtattcttg tttcctccca aacccaagga taccctgatg 1500
atcagccgga cacctgaagt cacttgtgtg gttgtggacg tatcccatga agatccagag 1560
gtgaagttca actggtacgt cgacggtgtc gaagtccata atgccaaaac caaacctagg 1620
gaggaacagt acaacagtac ctaccgagta gtgtcagtcc tgactgtgtt gcaccaggac 1680
tggctgaatg gtaaggagta caagtgtaag gtgtccaata aggcccttcc tgctcccatt 1740
gaaaagacca tctccaaagc aaaagggcag ccaagagagc cccaggtgta tacactgcct 1800
ccatctagag aggagatgac caagaatcag gttagtctga catgcctggt taaggggttt 1860
tatccctcag atattgccgt ggagtgggag tccaatggcc aacccgagaa taactacaag 1920
accacgcctc ccgtgcttga cagcgacggg agtttcttcc tgtattccaa gctgactgtt 1980
gacaagtccc gttggcagca gggaaacgtg tttagctgtt ccgtgatgca cgaagccctg 2040
cacaaccact acacccagaa aagcctctct ctctctccag ggaag 2085
<210> 85
<211> 1740
<212> DNA
<213> Artificial Sequence
<400> 85
caggttcaac tcgtccagag tggaggcggg gttgtacagc cagggagaag cctcaggctt 60
agttgtaaag catctggcta taccttcaca cgctatacca tgcactgggt gagacaggct 120
ccagggaagg gactggagtg gatagggtat atcaatccct ctcgtggtta tacaaactat 180
aaccagaagg tgaaggatcg gttcactatc agccgagata attcaaagaa cacagcattt 240
ctgcagatgg atagcctgcg acctgaagat accggtgtct acttttgcgc caggtattac 300
gacgatcatt atagcttgga ctactggggc caaggcaccc ctgtgacggt ttccagcggc 360
ggaggaggca gtggaggagg aggctccgga ggtggcggat ctgacatcca aatgacccaa 420
agccccagtt ctttgagcgc ctcagttgga gatcgggtga ccattacttg cagcgccagc 480
agtagcgtgt cttacatgaa ctggtatcag cagaccccgg ggaaggctcc aaagcgctgg 540
atctacgata cgtccaagct ggcttccggc gtgccctcta gattctcagg gtctggcagt 600
ggtactgact acactttcac gatctcctct ttgcagccag aggatatagc gacctactac 660
tgtcagcagt ggtcctctaa tcccttcact tttggtcaag gtaccaagct gcagattaca 720
agaggcggtg gaggcagcca ggtgcagctc cagcagtcag gggccgagct ggtaaaaccg 780
ggttcatcag tgaagattag ctgcaaagcc tccggttaca cctttacaag gaacttcatt 840
cactggatca agcagcaacc cgggaatggg ctcgagtgga ttgggtggat attcccaggg 900
gacggagaca cagagtacaa ccagaaattt aacggcaaag ctacactgac agccgacaaa 960
tcatcaagta cagcatacat gcagctctcc tcactgactt ccgaggacag cgcggtgtac 1020
ttctgtgcgc gcggaaatta taactacgaa tactttgact attggggtca aggcgtgatg 1080
gtaacagtca gttctgcatc aacgaaaggc cctagcgtct ttcctctggc ccctagctct 1140
aagtctactt ccggcggaac agccgctctg gggtgtcttg tcaaggacta tttccctgaa 1200
cccgtcacag tgagctggaa tagcggggcc cttacttcag gcgtccacac ctttcctgct 1260
gtgcttcaga gttccggcct gtattccctg agttctgtgg tcactgttcc aagctccagc 1320
ctggggaccc agacctacat ctgcaatgtg aatcataaac cgtccaacac gaaagtggat 1380
aaacgggttg aacccaagag ctgcgctgca gccggaggcg ggcagccaag agagccccag 1440
gtgtatacac tgcctccatc tagagaggag atgaccaaga atcaggttag tctgacatgc 1500
ctggttaagg ggttttatcc ctcagatatt gccgtggagt gggagtccaa tggccaaccc 1560
gagaataact acaagaccac gcctcccgtg cttgacagcg acgggagttt cttcctgtat 1620
tccaagctga ctgttgacaa gtcccgttgg cagcagggaa acgtgtttag ctgttccgtg 1680
atgcacgaag ccctgcacaa ccactacacc cagaaaagcc tctctctctc tccagggaag 1740
<210> 86
<211> 684
<212> DNA
<213> Artificial Sequence
<400> 86
caggttcagc ttcagcagtc cggtgcagag ctggtgaaac cagggtcatc tgtgaagatt 60
agctgcaaag cctctggcta tacctttaca cgcaatttca tccactggat caagcaacag 120
cctggaaatg gcctcgaatg gattggctgg atctttcctg gagatgggga taccgagtac 180
aaccagaagt tcaatggcaa agccacattg acagccgaca aatcctccag taccgcctat 240
atgcagctca gctctctgac ttcagaggat tccgctgtat acttctgtgc gagagggaac 300
tacaactatg agtacttcga ttattggggt caaggcgtca tggtgaccgt gagttcagcc 360
agcaccaagg gaccatctgt gtttccactg gcaccctcca gcaagagtac tagcggtgga 420
actgctgcgt tgggatgtct ggtgaaggac tactttcccg aaccggttac tgtgagttgg 480
aactcaggcg cccttacgtc cggcgtccac acctttcctg ctgttctgca aagctctggg 540
ctgtatagcc tgtcaagcgt cgtgactgtg ccttcctcca gtctggggac acagacgtac 600
atttgcaacg tcaatcacaa acccagcaat accaaggtcg acaaacgggt tgaacccaag 660
agctgccatc atcaccatca ccat 684
<210> 87
<211> 1380
<212> DNA
<213> Artificial Sequence
<400> 87
caggtgcagc tcgtccaaag cggcggaggt gtggtccaac cagggagatc cctgaggctg 60
tcctgcaaag ccagtgggta cacattcacc cgatatacaa tgcactgggt acggcaagct 120
cctggcaaag gcctggagtg gataggctac atcaatcctt cccgtggcta tacgaactac 180
aaccagaaag tgaaggaccg gtttacgatt agcagagaca actctaagaa taccgccttt 240
ctgcagatgg acagtctgcg accagaggat actggcgtct atttctgtgc tcgctattac 300
gatgaccact attccctgga ttattggggc cagggaacac ctgtgacagt gagtagcggt 360
ggaggtgggt caggaggtgg agggagtgga ggcggcggca gcgatatcca gatgacgcag 420
agtccttcat ctttgtcagc ctccgttggg gacagggtca ccattacttg ctcagccagc 480
agctccgtgt catacatgaa ttggtatcaa cagactcccg gcaaggctcc aaaacggtgg 540
atttacgata catccaaact ggcaagcggt gtaccctcca ggttttctgg cagcgggtct 600
ggaacagact acaccttcac cattagctcc ttgcagccag aagatattgc aacctactac 660
tgtcagcagt ggtctagcaa cccctttacc ttcgggcagg gaaccaagct gcagataact 720
cggggcggcg gtggatctga catccaaatg actcagtccc cagctagcct gagtgctagc 780
cttggagaga ctgtgtcaat cgagtgtctt gcctctgagg acatctacag ctatctcgcc 840
tggtaccaac agaagcccgg aaagagccct cagctgctga tctttgccgc caatcgcctc 900
caggatggcg tacctagccg tttctccgga tcaggttcag ggactcagtt ttcactgaag 960
atatcaggta tgcagcccga ggacgaaggc gattactttt gcctgcaagg gtctaagttc 1020
ccgtatactt ttgggcccgg caccaaattg gagctgaaca ggacagtcgc ggcacctagt 1080
gtctttatct tcccacccag cgatgaacag ctgaagtctg ggaccgcaag cgttgtgtgc 1140
ctgctgaata acttctatcc gagagaagcc aaggttcagt ggaaagttga caatgcgttg 1200
cagagtggca atagccagga atccgtgacc gagcaggatt ccaaagactc cacatactct 1260
cttagtagca cactcaccct cagtaaagct gattacgaga agcacaaggt gtatgcctgt 1320
gaagtgaccc atcaagggct ttcttctccg gtgacaaaat ccttcaacag aggggaatgc 1380
<210> 88
<211> 1347
<212> DNA
<213> Artificial Sequence
<400> 88
caggtacagt tgcagcaatc tggggcagaa ctggtcaaac ccgggagttc tgtgaaaatc 60
tcctgtaagg ccagtggata taccttcacc cgtaatttca tccactggat caaacaacag 120
cctggcaatg gcctcgaatg gatcggatgg atttttcccg gtgatggcga taccgagtat 180
aaccagaagt tcaatgggaa ggcaacacta acagccgaca aatcctcatc cacagcctat 240
atgcaactta gtagcctcac atctgaagat agcgccgtgt acttttgcgc aaggggcaac 300
tataactacg agtatttcga ctactggggt cagggggtga tggtgaccgt atcttccgct 360
agtactaaag gacccagcgt gtttccactg gcaccatcct ctaaatctac aagcggaggc 420
actgccgcac ttggctgcct ggtcaaagac tattttcctg aacccgtcac tgtgtcttgg 480
aactctggag ctttgacatc tggcgttcac acttttcccg cagtactcca gtcatctggc 540
ctgtattctc tgtcaagtgt tgtgactgtt cccagcagta gtctgggaac ccagacctac 600
atatgcaacg tcaaccataa acccagcaac acaaaggtgg ataagcgcgt cgagcctaag 660
agctgcgata agacccatac atgcccacca tgtcccgctc cagaggccgc cggaggtcca 720
tccgtattct tgtttcctcc caaacccaag gataccctga tgatcagccg gacacctgaa 780
gtcacttgtg tggttgtgga cgtatcccat gaagatccag aggtgaagtt caactggtac 840
gtcgacggtg tcgaagtcca taatgccaaa accaaaccta gggaggaaca gtacaacagt 900
acctaccgag tagtgtcagt cctgactgtg ttgcaccagg actggctgaa tggtaaggag 960
tacaagtgta aggtgtccaa taaggccctt cctgctccca ttgaaaagac catctccaaa 1020
gcaaaagggc agccaagaga gccccaggtg tatacactgc ctccatctag agaggagatg 1080
accaagaatc aggttagtct gacatgcctg gttaaggggt tttatccctc agatattgcc 1140
gtggagtggg agtccaatgg ccaacccgag aataactaca agaccacgcc tcccgtgctt 1200
gacagcgacg ggagtttctt cctgtattcc aagctgactg ttgacaagtc ccgttggcag 1260
cagggaaacg tgtttagctg ttccgtgatg cacgaagccc tgcacaacca ctacacccag 1320
aaaagcctct ctctctctcc agggaag 1347
<210> 89
<211> 1002
<212> DNA
<213> Artificial Sequence
<400> 89
caggtacagt tgcagcaatc tggggcagaa ctggtcaaac ccgggagttc tgtgaaaatc 60
tcctgtaagg ccagtggata taccttcacc cgtaatttca tccactggat caaacaacag 120
cctggcaatg gcctcgaatg gatcggatgg atttttcccg gtgatggcga taccgagtat 180
aaccagaagt tcaatgggaa ggcaacacta acagccgaca aatcctcatc cacagcctat 240
atgcaactta gtagcctcac atctgaagat agcgccgtgt acttttgcgc aaggggcaac 300
tataactacg agtatttcga ctactggggt cagggggtga tggtgaccgt atcttccgct 360
agtactaaag gacccagcgt gtttccactg gcaccatcct ctaaatctac aagcggaggc 420
actgccgcac ttggctgcct ggtcaaagac tattttcctg aacccgtcac tgtgtcttgg 480
aactctggag ctttgacatc tggcgttcac acttttcccg cagtactcca gtcatctggc 540
ctgtattctc tgtcaagtgt tgtgactgtt cccagcagta gtctgggaac ccagacctac 600
atatgcaacg tcaaccataa acccagcaac acaaaggtgg ataagcgcgt cgagcctaag 660
agctgcgctg cagccggagg cgggcagcca agagagcccc aggtgtatac actgcctcca 720
tctagagagg agatgaccaa gaatcaggtt agtctgacat gcctggttaa ggggttttat 780
ccctcagata ttgccgtgga gtgggagtcc aatggccaac ccgagaataa ctacaagacc 840
acgcctcccg tgcttgacag cgacgggagt ttcttcctgt attccaagct gactgttgac 900
aagtcccgtt ggcagcaggg aaacgtgttt agctgttccg tgatgcacga agccctgcac 960
aaccactaca cccagaaaag cctctctctc tctccaggga ag 1002
<210> 90
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 90
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser
115
<210> 91
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 91
Gln Val Gln Leu Gln Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Arg Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Arg Asp Thr Ser Ala Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 92
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 92
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ser Leu Glu Trp Val
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Ile Thr Ile Thr Arg Asp Thr Ser Ala Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Lys Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 93
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 93
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 94
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 94
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Gln Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser
115
<210> 95
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 95
Asp Ile Gln Met Thr Gln Ser Pro Ser Phe Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Gly Gly Ser Gly Thr Gly Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Asn
100 105
<210> 96
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 96
Asp Ile Gln Leu Thr Gln Ser Pro Ala Phe Leu Ser Ala Ser Leu Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Ser Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Ser Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
100 105
<210> 97
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 97
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Gly Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Leu Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
100 105
<210> 98
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 98
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Thr Val Thr Ile Ala Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Phe Thr Asp Phe Thr Leu Thr Ile Asn Ser Leu Gln Pro
65 70 75 80
Asp Asp Ser Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gly Gly Thr Lys Val Asp Ile Lys
100 105
<210> 99
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 99
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly
1 5 10 15
Asp Ser Val Thr Ile Glu Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ser Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Gln Phe Thr Leu Lys Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Glu Tyr Phe Cys Leu Gln Ala Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu Asn
100 105
<210> 100
<211> 357
<212> DNA
<213> Artificial Sequence
<400> 100
caggttcagc tcgttcagtc tggcgcggaa gtcaagaaac caggagcgtc tgtgaaagtg 60
agttgcaaag catccggtta cacgtttacc cgcaacttca ttcactgggt taggcaagca 120
cctggccaag ggttggagtg gatgggatgg atttttcctg gagatggcga cactgagtac 180
aaccagaagt tcaatggcag agtgacaatg acacgcgata catccatcag tacagcctac 240
atggagctat cccggttacg gtccgatgac actgccgtgt actactgtgc cagagggaat 300
tacaactacg agtacttcga ctattgggga caggggacta tggtaaccgt gtcctca 357
<210> 101
<211> 357
<212> DNA
<213> Artificial Sequence
<400> 101
caggttcagc tgcaagaatc aggcgccgaa gtcaagaaac cgggagcaag cgttaaggtg 60
agttgtaaag cgtctggcta tacattcacc cgtaatttta tccattgggt gagacaggcc 120
cctggccagc gcttagagtg gatgggctgg attttccccg gcgacggcga tacggagtat 180
aaccagaagt tcaatggacg ggtgacaatc acaagagaca ctagcgcctc aaccgcgtac 240
atggagctga gttccctccg atcagaggat acagccgttt actactgcgc aagggggaat 300
tacaactacg agtacttcga ctattggggg caggggactc ttgtgacggt ttcgtcc 357
<210> 102
<211> 357
<212> DNA
<213> Artificial Sequence
<400> 102
caagtccagc tggtacagtc cggtgctgaa gtaaagaaac caggcgcctc agttaagatc 60
agctgcaagg cttctggtta caccttcact cgcaacttca tccactgggt gagacaagcc 120
cctgggcagt ctctcgaatg ggttggctgg atatttcccg gggacggaga tactgaatac 180
aaccaaaagt tcaatggccg gattaccata acacgagata cttctgcgaa tactgcctat 240
atggaactga gctctcttaa aagcgaggac actgcagtct actattgcgc tagagggaat 300
tacaattacg agtactttga ctactgggga cagggaacac tggtgacagt tagctcc 357
<210> 103
<211> 357
<212> DNA
<213> Artificial Sequence
<400> 103
cagatgcagc tcgtacagag cggtgccgag gtgaagaaaa ccgggagcag cgttaaagtc 60
tcctgtaaag cctccggcta cacctttacc cggaatttca tccattgggt acggcaggca 120
cccggccaag cactggaatg gatggggtgg atattcccgg gtgacggaga tactgagtac 180
aaccagaagt tcaatggaag agtgactatt acgagagatc gctcaatgag tactgcgtat 240
atggaactgt cctcattgcg cagcgaagat acggcgatgt attactgtgc acgcgggaac 300
tacaactacg agtacttcga ttactggggc caagggaccc ttgtcacggt ttcatcc 357
<210> 104
<211> 357
<212> DNA
<213> Artificial Sequence
<400> 104
caggttcaac tggttcagtc aggtgcagag gtaaagaagc cagggagctc agtgaaagtc 60
tcatgcaaag ccagcggata cacctttact cggaacttta tccactgggt gagacagcag 120
cctgggcaag gcttggagtg gatgggctgg atctttccag gcgatggaga caccgagtat 180
aaccagaagt tcaatggcag agtgactatt accgccgata aaagcacatc tacagcctat 240
atgcagctga gcagcctgac aagtgaagat accgccgtct acttctgtgc cagaggcaac 300
tacaactacg agtatttcga ctactggggt cagggggtaa tggtcacggt gagcagt 357
<210> 105
<211> 321
<212> DNA
<213> Artificial Sequence
<400> 105
gacatccaga tgacccaatc cccttcattc gtgagtgcct cagtgggcga cagagtcacc 60
attacgtgtc ttgcttcaga ggacatttac agctatctcg catggtatca gcagaaacct 120
gggaaagcac ccaaactgct gatattcgct gccaatcggc tgcaagatgg cgtaccatcc 180
aggttttctg gaggaggatc tggtactggg tttaccctga ctatcagctc ccttcagccc 240
gaggattttg ccacatactt ctgcctccaa ggcagcaaat tcccgtacac atttgggcag 300
ggtaccaagc tggagatcaa c 321
<210> 106
<211> 321
<212> DNA
<213> Artificial Sequence
<400> 106
gacattcagc tcactcagag tcctgcgttt ctgtccgcat cacttggcga cagagtcacc 60
atcacttgct tggccagtga ggacatctac agctatctgg cttggtacca gcagaaaccc 120
ggaaaagccc cgaagctgtt gatctctgct gcgaatcggt tgcaggatgg agtaccatca 180
cgcttctcag gctctggaag cggtacagag ttcaccctta ccattagctc tctccaaccc 240
gaagattttg ccacctactc ttgcctgcaa gggagcaaat tcccctatac ctttggccaa 300
gggaccaaac tggagattaa g 321
<210> 107
<211> 321
<212> DNA
<213> Artificial Sequence
<400> 107
gacattcagc tgacccagtc accaagctca ctgagtgctt ctgtgggtga tcgtgtgacg 60
attacttgcc tggctagtga ggacatctac agctacttgg cctggtatca gcagaaacct 120
gggaaaggcc ccaagctgct gatctacgct gccaataggc tgcaagacgg ggtacctagc 180
cgcttttccg gatctggctc aggcacagac ttcagcctta ccatatccag cctccaacca 240
gaggatcttg ccacctatta ctgccttcag ggctccaagt ttccctacac gtttggaggt 300
ggtactaagg tggagatcaa a 321
<210> 108
<211> 321
<212> DNA
<213> Artificial Sequence
<400> 108
gacatccaga tgactcaatc cccaagcagt ctgagcgcct ctgtaggcga taccgtgacg 60
attgcgtgtc tggcttccga ggacatctac agttacctcg catggtatca gcagaaaccg 120
gggaaagcac ctaagctgct gatttatgcg gctaacagac tgcaggatgg cgtacccagt 180
cgcttctcag gttccggcag ctttaccgac tttaccctga ccatcaacag ccttcagccc 240
gatgatagcg ccacttacta ctgtctgcaa ggctctaagt tcccctatac gtttggagga 300
ggcactaagg tcgacataaa g 321
<210> 109
<211> 321
<212> DNA
<213> Artificial Sequence
<400> 109
gatatccaga tgacacagag ccctagcagc gttagcgcat cagtagggga cagtgtgacc 60
attgaatgcc ttgcaagcga ggacatctac agctatttgg cgtggtatca gcaaaagcca 120
ggcaaatctc ccaaactgct cattttcgcc gccaataggc tccaagatgg tgtcccttcc 180
cgattttccg ggtcaggctc aggaacccag ttcacactga agatttcctc tcttcagcca 240
gaggactttg cagagtactt ctgtctccag gccagtaagt ttccctacac ctttgggcct 300
ggaacgaaac tggaactgaa t 321
<210> 110
<211> 472
<212> PRT
<213> Artificial Sequence
<400> 110
Gln Val Thr Leu Lys Glu Ser Gly Pro Val Leu Val Lys Pro Thr Glu
1 5 10 15
Thr Leu Thr Leu Thr Cys Thr Val Ser Gly Tyr Ser Ile Thr Ser Asp
20 25 30
Tyr Ala Trp Asn Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu Trp
35 40 45
Leu Ala Tyr Ile Ser Tyr Ser Gly Ser Thr Ser Tyr Asn Pro Ser Leu
50 55 60
Lys Ser Arg Leu Ser Ile Thr Lys Asp Thr Ser Lys Ser Gln Val Val
65 70 75 80
Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr Cys
85 90 95
Ala Arg Asp Pro Pro Tyr Tyr Tyr Gly Ser Trp Gly Gln Gly Thr Thr
100 105 110
Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu
115 120 125
Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys
130 135 140
Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser
145 150 155 160
Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser
165 170 175
Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser
180 185 190
Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn
195 200 205
Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly Gly Gly
210 215 220
Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly
225 230 235 240
Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg
245 250 255
Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp
260 265 270
Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys
275 280 285
Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala
290 295 300
Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe
305 310 315 320
Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln
325 330 335
Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly
340 345 350
Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser
355 360 365
Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala
370 375 380
Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys
385 390 395 400
Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val
405 410 415
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr
420 425 430
Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln
435 440 445
Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile
450 455 460
Thr Arg His His His His His His
465 470
<210> 111
<211> 219
<212> PRT
<213> Artificial Sequence
<400> 111
Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly
1 5 10 15
Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu Asp Ser
20 25 30
Asp Gly Lys Thr Tyr Leu Asn Trp Leu Gln Gln Arg Pro Gly Gln Ser
35 40 45
Pro Arg Arg Leu Ile Tyr Leu Val Ser Lys Leu Asp Ser Gly Val Pro
50 55 60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65 70 75 80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr His Cys Trp Gln Gly
85 90 95
Thr His Phe Pro Tyr Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
100 105 110
Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 112
<211> 468
<212> PRT
<213> Artificial Sequence
<400> 112
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ser Phe Thr Gly Tyr
20 25 30
Tyr Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Ser Ala Tyr Asn Gly Ala Ser Ser Tyr Asn Gln Lys Phe
50 55 60
Lys Gly Arg Ala Thr Phe Thr Val Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Ser Ser Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser
100 105 110
Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser
115 120 125
Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp
130 135 140
Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr
145 150 155 160
Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr
165 170 175
Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln
180 185 190
Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp
195 200 205
Lys Arg Val Glu Pro Lys Ser Cys Gly Gly Gly Gly Ser Gln Val Gln
210 215 220
Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg Ser Leu Arg
225 230 235 240
Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr Thr Met His
245 250 255
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile Gly Tyr Ile
260 265 270
Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val Lys Asp Arg
275 280 285
Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe Leu Gln Met
290 295 300
Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys Ala Arg Tyr
305 310 315 320
Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly Thr Pro Val
325 330 335
Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly
340 345 350
Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala
355 360 365
Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Ser Val
370 375 380
Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Arg
385 390 395 400
Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ser Arg Phe
405 410 415
Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser Ser Leu
420 425 430
Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn
435 440 445
Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr Arg His His
450 455 460
His His His His
465
<210> 113
<211> 219
<212> PRT
<213> Artificial Sequence
<400> 113
Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly
1 5 10 15
Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu Asp Ser
20 25 30
Asp Gly Lys Thr Tyr Leu Asn Trp Leu Gln Gln Arg Pro Gly Gln Ser
35 40 45
Pro Lys Arg Leu Ile Tyr Leu Val Ser Lys Leu Asp Ser Gly Val Pro
50 55 60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65 70 75 80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr His Cys Trp Gln Gly
85 90 95
Thr His Phe Pro Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
100 105 110
Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 114
<211> 471
<212> PRT
<213> Artificial Sequence
<400> 114
Asp Val Gln Leu Lys Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Asn
1 5 10 15
Ser Gln Ser Leu Ser Leu Thr Cys Thr Val Thr Gly Tyr Ser Ile Thr
20 25 30
Ser Asp Tyr Ala Trp Asn Trp Ile Arg Gln Phe Pro Gly Asn Lys Leu
35 40 45
Glu Trp Met Gly Tyr Ile Ser Tyr Ser Gly Ser Thr Ser Tyr Asn Pro
50 55 60
Ser Leu Lys Ser Arg Ile Ser Ile Thr Arg Asp Thr Ser Lys Asn Gln
65 70 75 80
Phe Phe Leu Gln Leu Asn Ser Val Thr Pro Glu Asp Thr Ala Thr Tyr
85 90 95
Tyr Cys Ala Arg Asp Pro Pro Tyr Tyr Tyr Gly Ser Asn Gly Thr Leu
100 105 110
Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala
115 120 125
Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu
130 135 140
Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly
145 150 155 160
Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser
165 170 175
Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu
180 185 190
Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr
195 200 205
Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly Gly Gly Ser
210 215 220
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
225 230 235 240
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
245 250 255
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
260 265 270
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
275 280 285
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
290 295 300
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
305 310 315 320
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
325 330 335
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
340 345 350
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
355 360 365
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
370 375 380
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
385 390 395 400
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
405 410 415
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
420 425 430
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
435 440 445
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
450 455 460
Arg His His His His His His
465 470
<210> 115
<211> 219
<212> PRT
<213> Artificial Sequence
<400> 115
Asp Val Val Met Thr Gln Thr Pro Leu Thr Leu Ser Val Thr Ile Gly
1 5 10 15
Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu Asp Ser
20 25 30
Asp Gly Lys Thr Tyr Leu Asn Trp Leu Leu Gln Arg Pro Gly Gln Ser
35 40 45
Pro Lys Arg Leu Ile Tyr Leu Val Ser Lys Leu Asp Ser Gly Val Pro
50 55 60
Asp Arg Phe Thr Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65 70 75 80
Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr His Cys Trp Gln Gly
85 90 95
Thr His Phe Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys
100 105 110
Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210> 116
<211> 474
<212> PRT
<213> Artificial Sequence
<400> 116
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg His His His His His His
465 470
<210> 117
<211> 474
<212> PRT
<213> Artificial Sequence
<400> 117
Gln Val Gln Leu Gln Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Arg Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Arg Asp Thr Ser Ala Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg His His His His His His
465 470
<210> 118
<211> 474
<212> PRT
<213> Artificial Sequence
<400> 118
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ser Leu Glu Trp Val
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Ile Thr Ile Thr Arg Asp Thr Ser Ala Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Lys Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg His His His His His His
465 470
<210> 119
<211> 474
<212> PRT
<213> Artificial Sequence
<400> 119
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg His His His His His His
465 470
<210> 120
<211> 474
<212> PRT
<213> Artificial Sequence
<400> 120
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Gln Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Val Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg His His His His His His
465 470
<210> 121
<211> 214
<212> PRT
<213> Artificial Sequence
<400> 121
Asp Ile Gln Met Thr Gln Ser Pro Ser Phe Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Gly Gly Ser Gly Thr Gly Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Asn Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 122
<211> 214
<212> PRT
<213> Artificial Sequence
<400> 122
Asp Ile Gln Leu Thr Gln Ser Pro Ala Phe Leu Ser Ala Ser Leu Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Ser Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Ser Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 123
<211> 214
<212> PRT
<213> Artificial Sequence
<400> 123
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Gly Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Leu Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 124
<211> 214
<212> PRT
<213> Artificial Sequence
<400> 124
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Thr Val Thr Ile Ala Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Phe Thr Asp Phe Thr Leu Thr Ile Asn Ser Leu Gln Pro
65 70 75 80
Asp Asp Ser Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gly Gly Thr Lys Val Asp Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 125
<211> 214
<212> PRT
<213> Artificial Sequence
<400> 125
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly
1 5 10 15
Asp Ser Val Thr Ile Glu Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ser Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Gln Phe Thr Leu Lys Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Glu Tyr Phe Cys Leu Gln Ala Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Leu Glu Leu Asn Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 126
<211> 17
<212> PRT
<213> Artificial Sequence
<400> 126
Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe Ser
1 5 10 15
Gly
<210> 127
<211> 7
<212> PRT
<213> Artificial Sequence
<400> 127
Ala Ala Asn Arg Leu Gln Ser
1 5
<210> 128
<211> 17
<212> PRT
<213> Artificial Sequence
<400> 128
Tyr Ile Asn Pro Ser Met Gly Ala Thr Asn Tyr Asn Gln Lys Val Lys
1 5 10 15
Asp
<210> 129
<211> 10
<212> PRT
<213> Artificial Sequence
<400> 129
Tyr Tyr Asn Asp His Tyr Ser Leu Asp Tyr
1 5 10
<210> 130
<211> 10
<212> PRT
<213> Artificial Sequence
<400> 130
Tyr Tyr Asp Asp His Phe Ser Leu Asp Tyr
1 5 10
<210> 131
<211> 10
<212> PRT
<213> Artificial Sequence
<400> 131
Ser Ala Ser Ser Ser Val Ala Tyr Met Asn
1 5 10
<210> 132
<211> 7
<212> PRT
<213> Artificial Sequence
<400> 132
Asn Thr Ser Lys Leu Ala Ser
1 5
<210> 133
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 133
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser
115
<210> 134
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 134
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser
115
<210> 135
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 135
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser
115
<210> 136
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 136
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser
115
<210> 137
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 137
Asp Ile Gln Met Thr Gln Ser Pro Ser Phe Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Gly Gly Ser Gly Thr Gly Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Asn
100 105
<210> 138
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 138
Asp Ile Gln Met Thr Gln Ser Pro Ser Phe Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Gly Gly Ser Gly Thr Gly Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
100 105
<210> 139
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 139
Asp Ile Gln Met Thr Gln Ser Pro Ser Phe Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Gly Gly Ser Gly Thr Gly Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
100 105
<210> 140
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 140
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys
100 105
<210> 141
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 141
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys
100 105
<210> 142
<211> 357
<212> DNA
<213> Artificial Sequence
<400> 142
caaatgcagc tcgtacagtc gggagcagaa gtcaagaaga ccggcagctc agttaaggtg 60
tcgtgcaaag cctctggata tacattcacg cggaatttca ttcactgggt gagacaggca 120
ccaggccagg ccttggaatg gatgggctgg atttttcctg gggatgccga cacagagtat 180
aaccagaaat tctcgggcag ggtaacaatt actcgggata gatcaatgtc tacggcgtat 240
atggagctca gcagcctgag atccgaagat acagccatgt attactgtgc cagaggcaat 300
tacaattatg agtacttcga ctattggggc caagggacac tggtcaccgt ttcatcc 357
<210> 143
<211> 357
<212> DNA
<213> Artificial Sequence
<400> 143
caagttcagc tggttcaatc tggggctgaa gtcaagaagc ctgggtcctc agtgaaagtt 60
tcctgcaagg cttctggcta caccttcacc cgtaacttta tccactggat cagacaggca 120
cctggacaag gccttgagtg gattgggtgg atttttcctg gagatgcaga tacagagtac 180
aatcaaaagt tcagtgggag agcaacaatc acagcagaca aatcaaccag cacagcctat 240
atggagctca gcagcctgag atctgaggac actgcagtct attactgtgc aagaggaaat 300
tacaactacg agtactttga ttactggggc caaggaacca tggtcacagt ctcctca 357
<210> 144
<211> 357
<212> DNA
<213> Artificial Sequence
<400> 144
caagttcagc tggttcaatc tggggctgaa gtcaagaagc ctgggtcctc agtgaaagtt 60
tcctgcaagg cttctggcta caccttcacc cgtaacttta tccactggat cagacaggca 120
cctggacaag gccttgagtg gattgggtgg atttttcctg gagatgcaga tacagagtac 180
aatcaaaagt tcagtgggag agtgacaatc acagcagaca aatcaaccag cacagcctat 240
atggagctca gcagcctgag atctgaggac actgcagtct attactgtgc aagaggaaat 300
tacaactacg agtactttga ttactggggc caaggaacca tggtcacagt ctcctca 357
<210> 145
<211> 357
<212> DNA
<213> Artificial Sequence
<400> 145
caagttcagc tggttcaatc tggggctgaa gtcaagaagc ctgggtcctc agtgaaagtt 60
tcctgcaagg cttctggcta caccttcacc cgtaacttta tccactggat cagacaggca 120
cctggacaag gccttgagtg gattgggtgg atttttcctg gagatggaga tacagagtac 180
aatcaaaagt tcaatgggag agcaacaatc acagcagaca aatcaaccag cacagcctat 240
atggagctca gcagcctgag atctgaggac actgcagtct attactgtgc aagaggaaat 300
tacaactacg agtactttga ttactggggc caaggaacca tggtcacagt ctcctca 357
<210> 146
<211> 321
<212> DNA
<213> Artificial Sequence
<400> 146
gacatccaga tgacccaatc cccttcattc gtgagtgcct cagtgggcga cagagtcacc 60
attacgtgtc ttgcttcaga ggacatttac agctatctcg catggtatca gcagaaacct 120
gggaaagcac ccaaactgct gatattcgct gccaatcggc tgcaaagcgg cgtaccatcc 180
aggttttctg gaggaggatc tggtactggg tttaccctga ctatcagctc ccttcagccc 240
gaggattttg ccacatactt ctgcctccaa ggcagcaaat tcccgtacac atttgggcag 300
ggtaccaagc tggagatcaa c 321
<210> 147
<211> 321
<212> DNA
<213> Artificial Sequence
<400> 147
gacatccaga tgacccaatc cccttcattc gtgagtgcct cagtgggcga cagagtcacc 60
attacgtgtc ttgcttcaga ggacatttac agctatctcg catggtatca gcagaaacct 120
gggaaagcac ccaaactgct gatattcgct gccaatcggc tgcaaagcgg cgtaccatcc 180
aggttttctg gaggaggatc tggtactggg tttaccctga ctatcagctc ccttcagccc 240
gaggattttg ccacatactt ctgcctccaa ggcagcaaat tcccgtacac atttgggcag 300
ggtaccaagc tggagatcaa g 321
<210> 148
<211> 321
<212> DNA
<213> Artificial Sequence
<400> 148
gacatccaga tgacccaatc cccttcattc gtgagtgcct cagtgggcga cagagtcacc 60
attacgtgtc ttgcttcaga ggacatttac agctatctcg catggtatca gcagaaacct 120
gggaaagcac ccaaactgct gatattcgct gccaatcggc tgcaagatgg cgtaccatcc 180
aggttttctg gaggaggatc tggtactggg tttaccctga ctatcagctc ccttcagccc 240
gaggattttg ccacatactt ctgcctccaa ggcagcaaat tcccgtacac atttgggcag 300
ggtaccaagc tggagatcaa g 321
<210> 149
<211> 321
<212> DNA
<213> Artificial Sequence
<400> 149
gacatccaga tgacacagtc tccatcttcc ctgtctgcat ctgtgggaga cagagtcacc 60
atcacttgtc tggcaagcga ggacatttac agttatcttg catggtatca acagaagcca 120
gggaaagctc ctaagctcct gatctttgct gcaaataggc tgcaagatgg ggtcccatca 180
cggttcagtg gcagtggatc tggcacagac tttactctca ccatcagcag tctgcaacct 240
gaagatttcg caacttatta ctgtcttcag ggttccaagt ttccctacac ctttggacct 300
gggaccaagg tggacatcaa a 321
<210> 150
<211> 321
<212> DNA
<213> Artificial Sequence
<400> 150
gacatccaga tgacacagtc tccatcttcc ctgtctgcat ctgtgggaga cagagtcacc 60
atcacttgtc tggcaagcga ggacatttac agttatcttg catggtatca acagaagcca 120
gggaaagctc ctaagctcct gatctttgct gcaaataggc tgcaaagcgg ggtcccatca 180
cggttcagtg gcagtggatc tggcacagac tttactctca ccatcagcag tctgcaacct 240
gaagatttcg caacttatta ctgtcttcag ggttccaagt ttccctacac ctttggacct 300
gggaccaagg tggacatcaa a 321
<210> 151
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 151
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 152
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 152
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ala Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 153
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 153
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asn Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 154
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 154
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asn Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 155
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 155
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Phe Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 156
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 156
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Met Gly Ala Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 157
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 157
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 158
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 158
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ala Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 159
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 159
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asn Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 160
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 160
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asn Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 161
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 161
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Phe Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 162
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 162
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Met Gly Ala Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 163
<211> 449
<212> PRT
<213> Artificial Sequence
<400> 163
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys
<210> 164
<211> 449
<212> PRT
<213> Artificial Sequence
<400> 164
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Thr Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Val Arg Gln Ala Pro Gly Gln Ala Leu Glu Trp Met
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Arg Asp Arg Ser Met Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys
<210> 165
<211> 214
<212> PRT
<213> Artificial Sequence
<400> 165
Asp Ile Gln Met Thr Gln Ser Pro Ser Phe Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Gly Gly Ser Gly Thr Gly Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Asn Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 166
<211> 214
<212> PRT
<213> Artificial Sequence
<400> 166
Asp Ile Gln Met Thr Gln Ser Pro Ser Phe Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Gly Gly Ser Gly Thr Gly Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 167
<211> 214
<212> PRT
<213> Artificial Sequence
<400> 167
Asp Ile Gln Met Thr Gln Ser Pro Ser Phe Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Gly Gly Ser Gly Thr Gly Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 168
<211> 465
<212> PRT
<213> Artificial Sequence
<400> 168
Asp Ile Gln Met Thr Gln Ser Pro Ser Phe Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Gly Gly Ser Gly Thr Gly Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Asn Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
210 215 220
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
225 230 235 240
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
245 250 255
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
260 265 270
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
275 280 285
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
290 295 300
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
305 310 315 320
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
325 330 335
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
340 345 350
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
355 360 365
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
370 375 380
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
385 390 395 400
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
405 410 415
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
420 425 430
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
435 440 445
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
450 455 460
Arg
465
<210> 169
<211> 465
<212> PRT
<213> Artificial Sequence
<400> 169
Asp Ile Gln Met Thr Gln Ser Pro Ser Phe Val Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Gly Gly Ser Gly Thr Gly Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Phe Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Asn Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
210 215 220
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
225 230 235 240
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
245 250 255
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
260 265 270
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
275 280 285
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
290 295 300
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
305 310 315 320
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
325 330 335
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
340 345 350
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
355 360 365
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
370 375 380
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
385 390 395 400
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
405 410 415
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
420 425 430
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
435 440 445
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
450 455 460
Arg
465
<210> 170
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 170
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 171
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 171
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ala Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 172
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 172
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asn Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 173
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 173
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asn Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 174
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 174
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Phe Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 175
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 175
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Met Gly Ala Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 176
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 176
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 177
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 177
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ala Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 178
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 178
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asn Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 179
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 179
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asn Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 180
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 180
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Phe Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 181
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 181
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Met Gly Ala Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 182
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 182
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 183
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 183
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ala Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 184
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 184
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asn Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 185
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 185
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asn Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 186
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 186
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Phe Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 187
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 187
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Gly Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Asn Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Met Gly Ala Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 188
<211> 714
<212> PRT
<213> Artificial Sequence
<400> 188
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
225 230 235 240
Arg Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
245 250 255
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Leu Ala Ser
260 265 270
Glu Asp Ile Tyr Ser Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys
275 280 285
Ala Pro Lys Leu Leu Ile Phe Ala Ala Asn Arg Leu Gln Asp Gly Val
290 295 300
Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr
305 310 315 320
Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Leu Gln
325 330 335
Gly Ser Lys Phe Pro Tyr Thr Phe Gly Pro Gly Thr Lys Val Asp Ile
340 345 350
Lys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
355 360 365
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
370 375 380
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
385 390 395 400
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
405 410 415
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
420 425 430
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
435 440 445
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
450 455 460
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
465 470 475 480
Thr Met Val Thr Val Ser Ser Asp Lys Thr His Thr Cys Pro Pro Cys
485 490 495
Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro
500 505 510
Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys
515 520 525
Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp
530 535 540
Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu
545 550 555 560
Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu
565 570 575
His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn
580 585 590
Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly
595 600 605
Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu
610 615 620
Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr
625 630 635 640
Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn
645 650 655
Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe
660 665 670
Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn
675 680 685
Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr
690 695 700
Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
705 710
<210> 189
<211> 449
<212> PRT
<213> Artificial Sequence
<400> 189
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys
<210> 190
<211> 449
<212> PRT
<213> Artificial Sequence
<400> 190
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys
<210> 191
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 191
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Cys Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Trp Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
<210> 192
<211> 705
<212> PRT
<213> Artificial Sequence
<400> 192
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Lys
465 470 475 480
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro
485 490 495
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
500 505 510
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
515 520 525
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
530 535 540
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
545 550 555 560
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
565 570 575
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
580 585 590
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
595 600 605
Leu Pro Pro Cys Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Trp
610 615 620
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
625 630 635 640
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
645 650 655
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
660 665 670
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
675 680 685
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
690 695 700
Lys
705
<210> 193
<211> 700
<212> PRT
<213> Artificial Sequence
<400> 193
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Glu Pro Lys Ser Val Asp Lys Thr His Thr Cys Pro
465 470 475 480
Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe
485 490 495
Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val
500 505 510
Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe
515 520 525
Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro
530 535 540
Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr
545 550 555 560
Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val
565 570 575
Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala
580 585 590
Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Cys Arg
595 600 605
Glu Glu Met Thr Lys Asn Gln Val Ser Leu Trp Cys Leu Val Lys Gly
610 615 620
Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro
625 630 635 640
Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser
645 650 655
Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln
660 665 670
Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His
675 680 685
Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
690 695 700
<210> 194
<211> 474
<212> PRT
<213> Artificial Sequence
<400> 194
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg His His His His His His
465 470
<210> 195
<211> 449
<212> PRT
<213> Artificial Sequence
<400> 195
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Ala Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys
210 215 220
Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly Gly Pro
225 230 235 240
Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
245 250 255
Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp
260 265 270
Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
275 280 285
Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val
290 295 300
Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
305 310 315 320
Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys
325 330 335
Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
340 345 350
Leu Pro Pro Cys Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Trp
355 360 365
Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
370 375 380
Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
385 390 395 400
Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys
405 410 415
Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu
420 425 430
Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly
435 440 445
Lys
<210> 196
<211> 483
<212> PRT
<213> Artificial Sequence
<400> 196
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Gly Gly Gly Gly Ser
100 105 110
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln
115 120 125
Ser Gly Ala Glu Val Lys Lys Pro Gly Ser Ser Val Lys Val Ser Cys
130 135 140
Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile Arg
145 150 155 160
Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro Gly
165 170 175
Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe Ser Gly Arg Ala Thr Ile
180 185 190
Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr Met Glu Leu Ser Ser Leu
195 200 205
Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Gly Asn Tyr Asn
210 215 220
Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Met Val Thr Val Ser
225 230 235 240
Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
245 250 255
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly
260 265 270
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
275 280 285
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
290 295 300
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
305 310 315 320
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
325 330 335
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
340 345 350
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
355 360 365
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
370 375 380
Cys Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
385 390 395 400
Leu Ser Cys Ala Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
405 410 415
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
420 425 430
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Val Ser Lys Leu Thr Val
435 440 445
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
450 455 460
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
465 470 475 480
Pro Gly Lys
<210> 197
<211> 214
<212> PRT
<213> Artificial Sequence
<400> 197
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 198
<211> 214
<212> PRT
<213> Artificial Sequence
<400> 198
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210> 199
<211> 465
<212> PRT
<213> Artificial Sequence
<400> 199
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
210 215 220
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
225 230 235 240
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
245 250 255
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
260 265 270
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
275 280 285
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
290 295 300
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
305 310 315 320
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
325 330 335
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
340 345 350
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
355 360 365
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
370 375 380
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
385 390 395 400
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
405 410 415
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
420 425 430
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
435 440 445
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
450 455 460
Arg
465
<210> 200
<211> 227
<212> PRT
<213> Artificial Sequence
<400> 200
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly
1 5 10 15
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
20 25 30
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
35 40 45
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
50 55 60
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
65 70 75 80
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
85 90 95
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
100 105 110
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
115 120 125
Cys Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
130 135 140
Leu Ser Cys Ala Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
145 150 155 160
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
165 170 175
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Val Ser Lys Leu Thr Val
180 185 190
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
195 200 205
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
210 215 220
Pro Gly Lys
225
<210> 201
<211> 483
<212> PRT
<213> Artificial Sequence
<400> 201
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
115 120 125
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
130 135 140
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
145 150 155 160
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
165 170 175
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
180 185 190
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
195 200 205
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
210 215 220
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
225 230 235 240
Arg Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
245 250 255
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala Gly
260 265 270
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
275 280 285
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
290 295 300
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
305 310 315 320
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
325 330 335
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
340 345 350
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
355 360 365
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
370 375 380
Tyr Thr Leu Pro Pro Cys Arg Glu Glu Met Thr Lys Asn Gln Val Ser
385 390 395 400
Leu Trp Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
405 410 415
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
420 425 430
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
435 440 445
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
450 455 460
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
465 470 475 480
Pro Gly Lys
<210> 202
<211> 465
<212> PRT
<213> Artificial Sequence
<400> 202
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Arg Thr Val Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser
210 215 220
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
225 230 235 240
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
245 250 255
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
260 265 270
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
275 280 285
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
290 295 300
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
305 310 315 320
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
325 330 335
Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly
340 345 350
Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser Pro Ser Ser
355 360 365
Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Ser Ala Ser
370 375 380
Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala
385 390 395 400
Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser Gly Val Pro
405 410 415
Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile
420 425 430
Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp
435 440 445
Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr
450 455 460
Arg
465
<210> 203
<211> 468
<212> PRT
<213> Artificial Sequence
<400> 203
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Leu Ala Ser Glu Asp Ile Tyr Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
35 40 45
Phe Ala Ala Asn Arg Leu Gln Asp Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Phe Ala Thr Tyr Tyr Cys Leu Gln Gly Ser Lys Phe Pro Tyr
85 90 95
Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Gly Gly Gly Gly Ser
100 105 110
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Val Gln Leu Val Gln
115 120 125
Ser Gly Ala Glu Val Lys Lys Pro Gly Ser Ser Val Lys Val Ser Cys
130 135 140
Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn Phe Ile His Trp Ile Arg
145 150 155 160
Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile Gly Trp Ile Phe Pro Gly
165 170 175
Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe Ser Gly Arg Ala Thr Ile
180 185 190
Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr Met Glu Leu Ser Ser Leu
195 200 205
Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Gly Asn Tyr Asn
210 215 220
Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Met Val Thr Val Ser
225 230 235 240
Ser Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Ala Ala
245 250 255
Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu
260 265 270
Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser
275 280 285
His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu
290 295 300
Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr
305 310 315 320
Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn
325 330 335
Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro
340 345 350
Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln
355 360 365
Val Cys Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val
370 375 380
Ser Leu Ser Cys Ala Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val
385 390 395 400
Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro
405 410 415
Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Val Ser Lys Leu Thr
420 425 430
Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val
435 440 445
Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu
450 455 460
Ser Pro Gly Lys
465
<210> 204
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 204
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asn Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser
115
<210> 205
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 205
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Phe Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser
115
<210> 206
<211> 119
<212> PRT
<213> Artificial Sequence
<400> 206
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Arg
1 5 10 15
Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr
20 25 30
Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Ile
35 40 45
Gly Tyr Ile Asn Pro Ser Met Gly Ala Thr Asn Tyr Asn Gln Lys Val
50 55 60
Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Ala Phe
65 70 75 80
Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys
85 90 95
Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Pro Val Thr Val Ser Ser
115
<210> 207
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 207
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Ser Val Ala Tyr Met
20 25 30
Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr
35 40 45
Asp Thr Ser Lys Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser
50 55 60
Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu
65 70 75 80
Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr
85 90 95
Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr Arg
100 105
<210> 208
<211> 107
<212> PRT
<213> Artificial Sequence
<400> 208
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met
20 25 30
Asn Trp Tyr Gln Gln Thr Pro Gly Lys Ala Pro Lys Arg Trp Ile Tyr
35 40 45
Asn Thr Ser Lys Leu Ala Ser Gly Val Pro Ser Arg Phe Ser Gly Ser
50 55 60
Gly Ser Gly Thr Asp Tyr Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu
65 70 75 80
Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Phe Thr
85 90 95
Phe Gly Gln Gly Thr Lys Leu Gln Ile Thr Arg
100 105
<210> 209
<211> 217
<212> PRT
<213> Artificial Sequence
<400> 209
Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys
1 5 10 15
Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val
20 25 30
Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr
35 40 45
Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu
50 55 60
Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His
65 70 75 80
Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys
85 90 95
Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln
100 105 110
Pro Arg Glu Pro Gln Val Cys Thr Leu Pro Pro Ser Arg Glu Glu Met
115 120 125
Thr Lys Asn Gln Val Ser Leu Ser Cys Ala Val Lys Gly Phe Tyr Pro
130 135 140
Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn
145 150 155 160
Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu
165 170 175
Val Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val
180 185 190
Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln
195 200 205
Lys Ser Leu Ser Leu Ser Pro Gly Lys
210 215
<210> 210
<211> 217
<212> PRT
<213> Artificial Sequence
<400> 210
Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys
1 5 10 15
Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val
20 25 30
Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr
35 40 45
Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu
50 55 60
Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His
65 70 75 80
Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys
85 90 95
Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln
100 105 110
Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Cys Arg Glu Glu Met
115 120 125
Thr Lys Asn Gln Val Ser Leu Trp Cys Leu Val Lys Gly Phe Tyr Pro
130 135 140
Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn
145 150 155 160
Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu
165 170 175
Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val
180 185 190
Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln
195 200 205
Lys Ser Leu Ser Leu Ser Pro Gly Lys
210 215
<210> 211
<211> 217
<212> PRT
<213> Artificial Sequence
<400> 211
Ala Pro Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys
1 5 10 15
Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val
20 25 30
Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr
35 40 45
Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu
50 55 60
Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His
65 70 75 80
Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys
85 90 95
Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln
100 105 110
Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met
115 120 125
Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro
130 135 140
Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn
145 150 155 160
Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu
165 170 175
Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val
180 185 190
Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln
195 200 205
Lys Ser Leu Ser Leu Ser Pro Gly Lys
210 215
<210> 212
<211> 695
<212> PRT
<213> Artificial Sequence
<400> 212
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Asn
20 25 30
Phe Ile His Trp Ile Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile
35 40 45
Gly Trp Ile Phe Pro Gly Asp Ala Asp Thr Glu Tyr Asn Gln Lys Phe
50 55 60
Ser Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Asn Tyr Glu Tyr Phe Asp Tyr Trp Gly Gln Gly
100 105 110
Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe
115 120 125
Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu
130 135 140
Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp
145 150 155 160
Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu
165 170 175
Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser
180 185 190
Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro
195 200 205
Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Gly Gly
210 215 220
Gly Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln
225 230 235 240
Pro Gly Arg Ser Leu Arg Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe
245 250 255
Thr Arg Tyr Thr Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu
260 265 270
Glu Trp Ile Gly Tyr Ile Asn Pro Ser Arg Gly Tyr Thr Asn Tyr Asn
275 280 285
Gln Lys Val Lys Asp Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn
290 295 300
Thr Ala Phe Leu Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val
305 310 315 320
Tyr Phe Cys Ala Arg Tyr Tyr Asp Asp His Tyr Ser Leu Asp Tyr Trp
325 330 335
Gly Gln Gly Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly
340 345 350
Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Ile Gln Met Thr Gln Ser
355 360 365
Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys
370 375 380
Ser Ala Ser Ser Ser Val Ser Tyr Met Asn Trp Tyr Gln Gln Thr Pro
385 390 395 400
Gly Lys Ala Pro Lys Arg Trp Ile Tyr Asp Thr Ser Lys Leu Ala Ser
405 410 415
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Tyr Thr
420 425 430
Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala Thr Tyr Tyr Cys
435 440 445
Gln Gln Trp Ser Ser Asn Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu
450 455 460
Gln Ile Thr Arg Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro
465 470 475 480
Glu Ala Ala Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys
485 490 495
Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val
500 505 510
Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp
515 520 525
Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr
530 535 540
Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp
545 550 555 560
Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu
565 570 575
Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg
580 585 590
Glu Pro Gln Val Tyr Thr Leu Pro Pro Cys Arg Glu Glu Met Thr Lys
595 600 605
Asn Gln Val Ser Leu Trp Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp
610 615 620
Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys
625 630 635 640
Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser
645 650 655
Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser
660 665 670
Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser
675 680 685
Leu Ser Leu Ser Pro Gly Lys
690 695
Claims (22)
- 변이형 칼레티큘린 단백질에 특이적으로 결합하는 제1 도메인 및 CD3 항원에 특이적으로 결합하는 제2 도메인을 갖는 이중특이성 항체.
- 제1항에 있어서, 상기 제1 도메인이 서열 번호 1의 변이형 칼레티큘린 단백질의 에피토프에 결합하는 항체와 경합하는, 이중특이성 항체.
- 제1항 또는 제2항에 있어서, 변이형 칼레티큘린 단백질이 서열 번호 1로 표시되는 아미노산 서열로 이루어지는 폴리펩티드쇄 중, 또는 서열 번호 1에서 1개 또는 수개의 아미노산이 결실, 치환 또는 부가된 아미노산 서열로 이루어지는 폴리펩티드쇄 중에 항원 인식 부위를 갖는, 이중특이성 항체.
- 제1항 내지 제3항 중 어느 한 항에 있어서, 제1 도메인이 야생형 칼레티큘린 단백질에 결합하지 않고, 변이형 칼레티큘린 단백질에 대하여 높은 친화성을 갖는, 이중특이성 항체.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 제1 도메인이 절단 후의 변이형 칼레티큘린 단백질에 대하여 높은 친화성을 갖는, 이중특이성 항체.
- 제1항 내지 제5항 중 어느 한 항에 있어서, 제1 도메인과 변이형 칼레티큘린 단백질 간의 결합은, KD가 10-7M 이하인, 이중특이성 항체.
- 제1항 내지 제6항 중 어느 한 항에 있어서, 제1 도메인의 CDR이, (a) 서열 번호 10, 서열 번호 11 또는 126, 및 서열 번호 12(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 13, 서열 번호 14 또는 127, 및 서열 번호 15(VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖거나, (b) 서열 번호 16-18(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 19-21(VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖거나, 또는 (c) 서열 번호 22-24(VHCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 25-27(VLCDR)로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는, 이중특이성 항체.
- 제1항 내지 제7항 중 어느 한 항에 있어서, 제1 도메인이, (d) 서열 번호 2, 90, 91, 92, 93, 94, 133, 134, 135 및 136으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 3, 95, 96, 97, 98, 99, 137, 138, 139, 140 및 141로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖거나, (e) 서열 번호 4로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 5로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖거나, 또는 (f) 서열 번호 6으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 7로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖는, 이중특이성 항체.
- 제1항 내지 제8항 중 어느 한 항에 있어서, 제2 도메인의 CDR이, 서열 번호 28, 서열 번호 29 또는 128, 및 서열 번호 30, 129 또는 130(VHCDR)으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열, 및 서열 번호 31 또는 131, 서열 번호 32 또는 132, 및 서열 번호 33(VLCDR)으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는, 이중특이성 항체.
- 제1항 내지 제9항 중 어느 한 항에 있어서, 제2 도메인이, 서열 번호 8, 서열 번호 204, 서열 번호 205 및 206으로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VH 영역, 및 서열 번호 9, 서열 번호 207 및 208로 표시되는 아미노산 서열과 80% 이상의 상동성을 갖는 아미노산 서열을 갖는 VL 영역을 갖는, 이중특이성 항체.
- 제1항 내지 제10항 중 어느 한 항에 있어서, 이량체화 모듈이 한 개 또는 복수개의 노브 인투 홀 구조를 갖는 헤테로 H쇄이며, H쇄의 정상 영역의 349, 354, 366, 368 및 407번째로부터 선택되는 하나 이상의 위치의 아미노산을 각각 Y349C, T366S, L368A, Y407V(홀 또는 공동), S354C 또는 T366W(노브 또는 돌기)로 치환한 서열 번호 209 또는 210의 Fc 영역을 포함하는, 이중특이성 항체.
- 제1항 내지 제11항 중 어느 한 항에 있어서, H쇄 Fc 영역의 234 및 235로부터 선택되는 하나 이상의 위치의 아미노산을 각각 L234A 또는 L235A로 치환한 변이를 포함하는 서열 번호 211의 변이 Fc 영역을 포함하는, 이중특이성 항체.
- 제1항 내지 제12항 중 어느 한 항에 있어서, 인간 항체, 인간화 항체, 동물 유래 항체와 인간 항체의 키메라 항체, 또는 합성 항체인, 이중특이성 항체.
- 제1항 내지 제13항 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능성 단편을 함유하는 의약 조성물.
- 제14항에 있어서, 골수 증식성 종양 치료 또는 진단용 의약 조성물인, 의약 조성물.
- 제1항 내지 제13항 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능적 단편을 이용하여, 생체 시료 중의 다음의 (A) 또는 (B)의 폴리펩티드를 검출하는 것을 특징으로 하는 변이형 칼레티큘린 단백질의 검출 방법.
(A) 서열 번호 1로 표시되는 아미노산 서열로 이루어지는 폴리펩티드
(B) 서열 번호 1에서 1개 또는 수개의 아미노산이 결실, 치환 또는 부가된 아미노산 서열로 이루어지는 폴리펩티드. - 변이형 칼레티큘린 단백질의 검출에 이용하기 위한, 제1항 내지 제13항 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능적 단편.
- 제1항 내지 제13항 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능적 단편을 이용하여, 생체 시료 중의 다음의 (A) 또는 (B)의 폴리펩티드를 검출하는 것을 특징으로 하는 골수 증식성 종양의 진단 방법.
(A) 서열 번호 1로 표시되는 아미노산 서열로 이루어지는 폴리펩티드
(B) 서열 번호 1에서 1개 또는 수개의 아미노산이 결실, 치환 또는 부가된 아미노산 서열로 이루어지는 폴리펩티드. - 제1항 내지 제13항 중 어느 한 항에 있어서, 골수 증식성 종양의 치료 또는 진단에 이용하기 위한, 이중특이성 항체, 또는 그 기능적 단편.
- 제1항 내지 제13항 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능적 단편의 골수 증식성 종양 치료약 또는 진단약 제조를 위한 사용.
- 제1항 내지 제13항 중 어느 한 항에 기재된 이중특이성 항체, 또는 그 기능적 단편을 투여하는 것을 특징으로 하는 종양의 예방 또는 치료 방법.
- 제21항에 있어서, 종양이 혈액 종양, 바람직하게는 골수 증식성 종양, 골수성 백혈병, 혈소판 증가증, 적혈구 증가증, 원발성 골수 섬유증, 또는 이차성 골수성 섬유증인 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020143551 | 2020-08-27 | ||
JPJP-P-2020-143551 | 2020-08-27 | ||
PCT/JP2021/031355 WO2022045247A1 (ja) | 2020-08-27 | 2021-08-26 | 抗切断型変異calr-cd3二重特異性抗体及び医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230057351A true KR20230057351A (ko) | 2023-04-28 |
Family
ID=80353395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020237005772A KR20230057351A (ko) | 2020-08-27 | 2021-08-26 | 항절단형 변이 calr-cd3 이중특이성 항체 및 의약 조성물 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20240092890A1 (ko) |
EP (1) | EP4205764A1 (ko) |
JP (1) | JPWO2022045247A1 (ko) |
KR (1) | KR20230057351A (ko) |
CN (1) | CN116322763A (ko) |
AU (1) | AU2021331170A1 (ko) |
BR (1) | BR112023003511A2 (ko) |
CA (1) | CA3192768A1 (ko) |
IL (1) | IL300764A (ko) |
MX (1) | MX2023002374A (ko) |
TW (1) | TW202227492A (ko) |
WO (1) | WO2022045247A1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020232247A1 (en) | 2019-05-14 | 2020-11-19 | Provention Bio, Inc. | Methods and compositions for preventing type 1 diabetes |
US12006366B2 (en) | 2020-06-11 | 2024-06-11 | Provention Bio, Inc. | Methods and compositions for preventing type 1 diabetes |
WO2022163809A1 (en) * | 2021-01-29 | 2022-08-04 | Chugai Seiyaku Kabushiki Kaisha | Molecule specifically acting in a tissue where a cell death being observed |
WO2024024882A1 (en) * | 2022-07-28 | 2024-02-01 | Chugai Seiyaku Kabushiki Kaisha | Molecule specifically acting in a tissue where a cell death being observed |
CN116239684B (zh) * | 2023-02-12 | 2023-10-20 | 武汉爱博泰克生物科技有限公司 | 针对人钙网蛋白的兔单克隆抗体及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999054440A1 (en) | 1998-04-21 | 1999-10-28 | Micromet Gesellschaft Für Biomedizinische Forschung Mbh | CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
WO2015036599A1 (en) | 2013-09-16 | 2015-03-19 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Mutant calreticulin for the diagnosis of myeloid malignancies |
WO2016087514A1 (en) | 2014-12-02 | 2016-06-09 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Anti-mutant calreticulin antibodies and their use in the diagnosis and therapy of myeloid malignancies |
WO2019178362A1 (en) | 2018-03-14 | 2019-09-19 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58201994A (ja) | 1982-05-21 | 1983-11-25 | Hideaki Hagiwara | 抗原特異的ヒト免疫グロブリンの生産方法 |
WO1992020791A1 (en) | 1990-07-10 | 1992-11-26 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
WO1992003918A1 (en) | 1990-08-29 | 1992-03-19 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
AU665025B2 (en) | 1991-09-23 | 1995-12-14 | Cambridge Antibody Technology Limited | Production of chimeric antibodies - a combinatorial approach |
ATE275198T1 (de) | 1991-12-02 | 2004-09-15 | Medical Res Council | Herstellung von antikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken. |
EP0746609A4 (en) | 1991-12-17 | 1997-12-17 | Genpharm Int | NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES |
EP0656941B1 (en) | 1992-03-24 | 2005-06-01 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
NZ255101A (en) | 1992-07-24 | 1997-08-22 | Cell Genesys Inc | A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor |
EP0754225A4 (en) | 1993-04-26 | 2001-01-31 | Genpharm Int | HETEROLOGIC ANTIBODY-PRODUCING TRANSGENIC NON-HUMAN ANIMALS |
GB9313509D0 (en) | 1993-06-30 | 1993-08-11 | Medical Res Council | Chemisynthetic libraries |
AU690171B2 (en) | 1993-12-03 | 1998-04-23 | Medical Research Council | Recombinant binding proteins and peptides |
EP1978033A3 (en) | 1995-04-27 | 2008-12-24 | Amgen Fremont Inc. | Human antibodies derived from immunized xenomice |
CA2219486A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
AU2004242846A1 (en) | 2003-05-31 | 2004-12-09 | Micromet Ag | Pharmaceutical compositions comprising bispecific anti-CD3, anti-CD19 antibody constructs for the treatment of B-cell related disorders |
RU2605390C2 (ru) | 2011-08-23 | 2016-12-20 | Рош Гликарт Аг | Биспецифические антитела, специфичные к антигенам, активирующим т-клетки, и опухолевому антигену, и способы их применения |
EP2970484B2 (en) | 2013-03-15 | 2022-09-21 | Amgen Inc. | Heterodimeric bispecific antibodies |
EP3932952A4 (en) * | 2019-02-28 | 2022-11-30 | Juntendo Educational Foundation | ANTIBODIES CAPABLE OF BINDING TO MUTANT CALRETICULIN TRUNCATED, AND DIAGNOSTIC, PROPHYLACTIC OR THERAPEUTIC MEDICINAL PRODUCT FOR MYELOPROLIFERATIVE NEOPLASMS |
-
2021
- 2021-08-26 IL IL300764A patent/IL300764A/en unknown
- 2021-08-26 US US18/041,818 patent/US20240092890A1/en active Pending
- 2021-08-26 MX MX2023002374A patent/MX2023002374A/es unknown
- 2021-08-26 EP EP21861669.6A patent/EP4205764A1/en active Pending
- 2021-08-26 KR KR1020237005772A patent/KR20230057351A/ko active Search and Examination
- 2021-08-26 WO PCT/JP2021/031355 patent/WO2022045247A1/ja unknown
- 2021-08-26 BR BR112023003511A patent/BR112023003511A2/pt unknown
- 2021-08-26 AU AU2021331170A patent/AU2021331170A1/en active Pending
- 2021-08-26 CN CN202180053108.5A patent/CN116322763A/zh active Pending
- 2021-08-26 CA CA3192768A patent/CA3192768A1/en active Pending
- 2021-08-26 JP JP2022545699A patent/JPWO2022045247A1/ja active Pending
- 2021-08-27 TW TW110131875A patent/TW202227492A/zh unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999054440A1 (en) | 1998-04-21 | 1999-10-28 | Micromet Gesellschaft Für Biomedizinische Forschung Mbh | CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
WO2015036599A1 (en) | 2013-09-16 | 2015-03-19 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Mutant calreticulin for the diagnosis of myeloid malignancies |
WO2016087514A1 (en) | 2014-12-02 | 2016-06-09 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Anti-mutant calreticulin antibodies and their use in the diagnosis and therapy of myeloid malignancies |
WO2019178362A1 (en) | 2018-03-14 | 2019-09-19 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
Non-Patent Citations (6)
Title |
---|
Araki M, Yang Y, Masubuchi N, et al. Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms. Blood. 2016; 127: 1307-16. |
Elf S, Abdelfattah NS, Chen E, et al. Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation. Cancer Discov. 2016; 6: 368-81. |
Klampfl T, Gisslinger H, Harutyunyan AS, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. The New England journal of medicine. 2013; 369: 2379-90. |
Marty C, Pecquet C, Nivarthi H, et al. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis. Blood. 2016; 127: 1317-24. |
Nangalia J, Massie CE, Baxter EJ, et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. The New England journal of medicine. 2013; 369: 2391-405. |
Vainchenker W, Kralovics R. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood. 2017; 129: 667-79. |
Also Published As
Publication number | Publication date |
---|---|
AU2021331170A1 (en) | 2023-03-23 |
BR112023003511A2 (pt) | 2023-04-11 |
TW202227492A (zh) | 2022-07-16 |
WO2022045247A1 (ja) | 2022-03-03 |
IL300764A (en) | 2023-04-01 |
JPWO2022045247A1 (ko) | 2022-03-03 |
US20240092890A1 (en) | 2024-03-21 |
EP4205764A1 (en) | 2023-07-05 |
CA3192768A1 (en) | 2022-03-03 |
MX2023002374A (es) | 2023-03-23 |
CN116322763A (zh) | 2023-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113402609B (zh) | 具有经修饰的ch2-ch3序列的犬抗体 | |
AU2021254602A1 (en) | Humanized anti-MUC1* antibodies | |
KR20230057351A (ko) | 항절단형 변이 calr-cd3 이중특이성 항체 및 의약 조성물 | |
CN106939050B (zh) | 抗pd1和cd19双特异性抗体及其应用 | |
WO2021058000A1 (zh) | 抗人Claudin18.2抗体及其应用 | |
CN111954680B (zh) | IL2Rβ/共同γ链抗体 | |
KR20110066960A (ko) | 종간 특이적 PSCAxCD3, CD19xCD3, c-METxCD3, 엔도시알린xCD3, EpCAMxCD3, IGF-1RxCD3 또는 FAPαxCD3 이중특이적 단일쇄 항체 | |
US11639388B2 (en) | CD3 antigen binding fragment and application thereof | |
JP2023093642A (ja) | モジュラー四価二重特異性抗体プラットフォーム | |
CN112794916B (zh) | 三特异性抗原结合构建体及构建方法和应用 | |
CN111153995A (zh) | Nkg2a抗体及其制备方法和应用 | |
AU2021388650A9 (en) | Cldn18.2 antibody and use thereof | |
KR102607629B1 (ko) | 아밀로이드 침착 질환의 치료를 위한 키메라 항체 | |
CN117279953A (zh) | 靶向bcma、gprc5d和cd3的三特异性抗体 | |
WO2021170082A1 (zh) | 抗cd47/抗pd-l1抗体及其应用 | |
KR20210143096A (ko) | Cd22에 특이적인 항체 및 이의 용도 | |
TW201000129A (en) | Interleukin-21 receptor binding proteins | |
KR20230059789A (ko) | 항-가변 muc1* 항체 및 이의 용도 | |
KR102548256B1 (ko) | Cd22에 특이적인 항체 및 이의 용도 | |
WO2023185256A1 (zh) | 特异性结合cd7的抗体及其在制备嵌合抗原受体中的应用 | |
KR20220155943A (ko) | Cd22에 특이적인 항체 및 이의 용도 | |
CN115772544A (zh) | 抗vegf-a和ang-2的aav载体 | |
TW202305011A (zh) | 靶向pd-1和/或ox40的特異性結合蛋白 | |
TW202214705A (zh) | 抗tigit抗體及雙抗體和它們的應用 | |
KR20230162597A (ko) | 안정적인 다중 특이성 분자 및 그 이용 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination |